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ABSTRACT 
Asthma is among the most common chronic diseases in children, among the leading 
causes of hospitalization for children, and one of the leading causes of school 
absenteeism. Discovery of preventable factors and the underlying mechanisms that 
exacerbate asthma among prevalent cases is important for mitigating the health burden 
of this childhood disease. Environmental factors such as exposure to particulate matter 
(PM) or nutritional deficiencies can lead to poor respiratory health among susceptible 
children. Recent animal studies suggest that PM exposures and dietary nutrients may 
influence asthma pathways through epigenetic mechanisms. Epigenetic modifications 
are heritable changes that can regulate gene activity without altering the primary DNA 
sequence. With respect to allergic or asthma phenotypes, several cytokine and 
transcriptional factors relevant to the allergy/asthma response pathway and its counter 
regulation have been shown to be modulated by epigenetic processes. The results of the 
following research aims may help to elucidate the relationship between PM and dietary 
exposures, epigenetic responses, and respiratory health outcomes among asthmatic 
children.   
 
Aims 1 and 2 occur within the context of an ongoing randomized trial of indoor air quality 
interventions and quality of life among asthmatic children living in homes that heat with 
wood stoves. Our laboratory has demonstrated that children in wood stove homes are 
exposed to elevated concentrations of indoor PM smaller than 2.5 microns (PM2.5) due to 
biomass combustion. Aims 1 and 2 take advantage of the extensive research 
infrastructure currently in place for exposure assessment, health outcomes 
characterization and biomarker analysis.  
 
Human epidemiological studies are limited by ethical considerations and subject to a 
number of variables, which make interpretation of results problematic in some cases. 
Aim 3 is an exploratory aim to establish the utility of using dogs as sentinels for human 
health effects with respect to PM2.5 exposure. Domestic animals, specifically dogs, have 
been used in this way both in lieu of human studies and in parallel.  This multifaceted 
approach will increase opportunities for success in determining the effects of 
environmental exposures on human health outcomes in this study and may inform future 
intervention strategies and study design. 
 
Overall hypothesis: PM2.5 and dietary factors will cause hypo- and hypermethylation 
changes modulating cytokine expression associated with asthma symptoms. 
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CHAPTER 1 
 
INTRODUCTION 
 
This dissertation describes how exposures to particulate matter (PM) or dietary nutrients 
influence respiratory health in a cohort of asthmatic children and investigates the 
potential for these exposures to work through an epigenetic mechanism (i.e. DNA 
methylation). As a compliment to the research aimed at determining the effect of PM 
exposure in the cohort of asthmatic children, a sentinel sled dog model will be explored.  
The introduction will 1) provide an overview of epigenetics and review the current 
research on DNA methylation and chronic diseases including asthma, 2) describe the 
potential impact of PM and dietary exposures in the context of asthma, 3) describe the 
parent study and give context to the subcohort (Aims 1 and 2) and lastly 4) discuss the 
rationale for animal sentinel models of environmental exposures and health effects (Aim 
3).   
 
Chronic Inflammatory Disease: Asthma 
According to the World Health Organization (WHO), over the next 20 years there will be 
a major disease paradigm shift as many countries enter the ‘developed’ world.  The 
WHO suggests that infectious diseases such as HIV or malaria are becoming less of a 
health burden worldwide.   In contrast, chronic diseases, also called non-communicable 
diseases, such as heart disease, lung disease, and diabetes are becoming the major 
causes of death worldwide.  At the present time, non-communicable diseases are 
responsible for 63% of deaths worldwide, which is about double the percentage of 
deaths attributed to infectious diseases.   
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The central feature to most of these chronic diseases is inflammation.  Inflammation is 
one of the human body’s immediate responses to insult by toxins, toxicants, or physical 
injury.  This mechanism evolved for the short-term healing of damaged tissues (Weiss 
2008).  While acute inflammation can be helpful and even necessary, chronic 
inflammation can be destructive and debilitating. Chronic inflammation is linked to 
several human diseases and in such cases the inflammation is characterized as 
dysregulated, maladaptive, and persistent. The pathways and molecular processes that 
lead to the development of asthma, diabetes, obesity, heart disease and other chronic 
inflammatory diseases (CIDs) have not been fully elucidated, though it is known that 
chronic inflammation plays a major role.  Studies in animals and humans suggest that 
environmental toxicants are capable of influencing the immunological pathways 
responsible for the inflammation involved in diseases such as asthma (Crinnion 2012). 
 
Asthma Description and Pathology 
Among children, asthma is the most common non-communicable disease.  Asthma is 
characterized by airway obstruction, bronchial hyperresponsiveness, and chronic 
inflammation (National Heart 2007).  Asthma as a disease diagnosis encompasses 
varying degrees of the above mentioned symptoms and this variability can change within 
a patient throughout their life (National Heart 2007). Asthma pathology is characterized 
by spasms by the smooth muscle surrounding the airways, a decrease in size of the 
inner airway space, infiltration by immune cells, and mucus production (see Figure 1.1.). 
The manifestation of asthma pathophysiology is driven largely by the underlying 
inflammation and its interaction with airflow and response to insult (Cohn et al. 2004).  
Asthma symptoms may include recurrent wheezing, breathlessness, chest tightness, 
and coughing (National Heart 1997). Rescue medications for these symptoms typically 
treat the bronchial spasms, but there are medications designed to treat the underlying 
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inflammation (National Heart 2007).  It can take up to weeks for the latter medications to 
completely resolve the inflammation and patient response is variable (Bateman et al. 
2004).   
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Figure 1.1.  Anatomy of an asthma attack. 
This figure shows the potential physiological changes that can occur during an asthma 
attack.  
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Allergic Asthma and Triggers 
Allergic asthma, also known as extrinsic asthma, is the most common form of asthma 
affecting the majority of the 25 million Americans with the disease (Asthma).  Allergic 
asthma accounts for nearly all cases of childhood asthma in contrast to intrinsic or adult-
onset asthma (Pearce et al. 1999).  For an individual with allergic asthma, the first time 
an allergen is inhaled, it is taken up by an antigen-presenting cell in the lining of the 
airway and presented to a T cell (Allergy).  Through series of cell-to-cell interactions, B-
cells produce allergen specific antibodies, which are released and prime mast cells.  
This prepares the immune system for a robust response the next time this allergen is 
inhaled.  This process is called sensitization.  According to the CDC, triggers for allergic 
asthma may include pollen, pet dander, dust mites, cockroach or pest such as mice, 
mold, ambient PM, chemical irritants and others.  
 
Asthma Mechanism: Th1/Th2 balance 
As mentioned above, a hallmark of asthma is infiltration of the airway blood vessels by 
immune cells.  Several cells and cellular factors (see Figure 1.2.) are known to play a 
role in asthma pathology including eosinophils, T lymphocytes, mast cells, 
macrophages, neutrophils, and epithelial cells (National Heart 2007).   Mast cells and 
eosinophils are considered the main effector cells and upon stimulation, these cells can 
secrete inflammatory mediators (Mazzarella et al. 2000).  The immune response is 
orchestrated by T lymphocytes, which are involved in cell-to-cell communication.  CD4+ 
T cells, also known as T helper (Th) cells, have been well studied. This group of cells 
has been divided into two main categories based on the cytokines and chemokines they 
produce (Mosmann and Coffman 1989).  Th1 cells produce interleukin-2 (IL-2), IL-12, 
interferon gamma (IFNγ), and other factors.  Th2 cells produce IL-4, IL-5, IL-13, and 
other factors.  Importantly, Th2 cells produce little or no IFNγ.  Research suggests that 
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there is interplay between Th1 and Th2 cells through the production of the cytokines and 
in this way can regulate each other.  For example, secretion of IFNγ by Th1 cells 
activates macrophages and increases their bactericidal activity (Fiorentino et al. 1989), 
while concomitantly down regulating Th2 cells and their ability to recruit mast cells and 
eosinophils (Wenner et al. 1996).  Th2 cells are suggested to play a major role in the 
pathogenesis of asthma and many studies have demonstrated a shift in the balance of 
Th1 toward a Th2 cellular phenotype in the asthmatic airway (Mazzarella et al. 2000).  
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Figure 1.2. Airway microenvironment and inflammatory mediators. 
A model depicting the factors involved in persistent inflammation in the lung environment 
after an insult.    
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Asthma Epidemiology and Economic Burden 
The incidence of asthma is increasing worldwide and here in the US.  According to the 
WHO, approximately 235 million people suffer from asthma globally with about 25 million 
of those people living in the US. Asthma is a common disease among children. About 1 
in 10 children have asthma in the US (http://www.aaaai.org/).  Asthma disproportionately 
affects some ethnic and racial minority groups, with African Americans currently having a 
higher incidence of asthma in the US compared to Caucasians (Association 2010).  
Epidemiologists have proposed that this disparity may be due to genetic predisposition 
to asthma, while others have suggested environmental factors such as stress, 
socioeconomic status, and access to healthcare as the causes. In addition to the pain 
and suffering felt by the affected individual and their family, there is a great economic 
burden placed on society directly through medical costs and indirectly through work and 
school absence due to illness or death (www.state.gov).  The cost of asthma in the US 
as of 2007 was $56 billion annually (http://www.aaaai.org/).  
 
Epigenetics Background 
In 2003 the Human Genome Project officially concluded and hopes of ‘cracking’ the 
genetic code allowing scientist to predict and prevent human disease did not come to 
fruition.  The human genome research produced information on about 20,000 genes and 
it became apparent that genetic variability alone was not sufficient to explain many of the 
complex and phenotypically diverse chronic diseases.  When considering disease states 
and their association with single nucleotide polymorphisms in genome wide association 
studies, it was discovered that genetic components explain less than 20% of phenotypic 
variation (Wallace 2010) 
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Gene-environment Interactions 
Studies in monozygotic twins looking at disease discordance have brought the 
importance of environmental exposures to the forefront.  In this context ‘environment’ is 
anything non-genetic (i.e. diet, physical activity, and other lifestyle factors in addition to 
environmental toxins).  Disease discordance is the idea that two people with the exact 
same genome are born disease-free, but later in life one, but not both, develops a 
disease.  Genes alone are not enough to explain the cause of the disease in this case, 
so researches have hypothesized that it could be an interaction between genes and the 
environment.  Studies of this nature have been done looking at a number of diseases 
including asthma (Runyon et al. 2012).  At the interface of genes and environment is the 
human epigenome.   
 
The Epigenome  
There are many metaphors used to describe the way that the epigenome relates to the 
genome. For example, some have referred to the genome as the hardware and the 
epigenome as the software.  The hardware cannot be operated correctly without the 
software.  The epigenome tells the genome when, where, and how to operate.  It is the 
epigenome that allows two cells in the human body, each with the exact same set of 
genetic information, to be phenotypically different cells with very different jobs; a liver cell 
and a red blood cell for example.   
 
Epigenetic Marks are Heritable and Reversible 
Epigenetic marks are modifications that can be added to the genome resulting in 
changes in gene expression.  These marks do not alter the genetic code and are 
heritable through cell division exclusive of genetic factors (Cortessis et al. 2012).  
Consistent with the example used above, the regiment and location of epigenetic marks 
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and resulting gene expression in the liver cell compared to the red blood cell is different.  
Most of the epigenetic alterations that occur throughout the life of an organism are 
natural and necessary, however some aberrant epigenetic marks can occur.  Unlike the 
inherited genetic code, which remains static, epigenetic marks are plastic and dynamic 
(Rozek et al. 2014).  This fact is the reason for the recent increase in interest and 
funding in the field of epigenetics (see Figure 1.3).  Epigenetic marks have the potential 
to serve as biomarkers of disease or exposure and even as targets for therapy.  
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Figure 1.3. Increases in epigenetic research papers over time. 
This graph shows the rise in epigenetics research over the last two decades and 
highlights the need for more environmental epigenetic studies.  From Burris et al. 2013. 
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Types of Epigenetic Modification 
Several different types of epigenetic alterations have been identified, but the most 
commonly studied are micro RNAs, histone modifications, and DNA methylation (see 
Figure 1.4).  Micro-RNAs are a class of non-coding RNAs that control genetic expression 
by binding to mRNAs and repressing protein production (Wei et al. 2015).  Recent 
findings suggest that micro-RNAs may be important regulators of cytokines involved in 
T-cell polarization and the allergic response (Tay et al. 2014).  Histone modifications and 
histone variants are epigenetic modifications that serve a wide range of purposes from 
nucleosome stability to chromatin dynamics and play a critical role in gene expression 
(Li and Fang 2015).   The most commonly studied epigenetic mechanism is DNA 
methylation, which has received more attention and funding than histone modifications 
or micro-RNAs (Rozek et al. 2014).  This is largely due to the difficulty in working with 
RNA.  DNA is more stable, which makes storage and handling easier.  The availability of 
high throughput methods for DNA methylation analysis that require small amounts of 
sample at a relatively low cost is also a driving factor for the discrepancy (Burris and 
Baccarelli 2014).  
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Figure	  1.4  Epigenetic Mechanisms. 
This figure show how several different types of epigenetic marks contribute to the overall 
chromatin structure and their potential role in gene transcription.	  	  
http://www.nih.gov/news/health/feb2015/niehs-18.htm 
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DNA Methylation 
DNA methylation is a phenomenon where a methyl group is covalently bonded to a 
cytosine-guanine dinucleotide, also called a CpG.  Genomic regions with high CpG 
densities are called CpG islands. In mammals, methylation typically occurs in these 
islands, which are disproportionately found in gene promoter regions relative to the 
whole genome (Jimenez-Chillaron et al. 2012). The “promoter region” is a somewhat 
ambiguously labeled region approximately 200-3000 base pairs upstream of the start 
site for a particular gene. Modification of this region can induce or inhibit transcription 
activity at a given locus. Some researchers suggest that in addition to the promoter 
region, the CpGs near the start site may also be important (Kwon et al. 2008).  Under 
normal circumstances the majority of these CpG islands are hypermethylated, which 
typically equates to suppression of the associated gene (see Figure 1.5). Methylation of 
the CpG requires an enzyme called DNA methyltransferase, which is able to transfer a 
methyl group from S-adenosylmethionine (SAM) to the fifth carbon of cytosine.  SAM is 
enzymatically made available through a process called one-carbon metabolism in the 
presence of micronutrients such as folate or choline.  Dietary intake of such nutrients 
has become a focal point of epigenetic research.   
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Figure 1.5. DNA Methylation paradigm.  
A simple model showing how DNA methylation can influence gene transcription.  The lit 
bulb represents gene expression and the dim bulb represents gene suppression.  This 
paradigm is true most of the time, however, there are instances were DNA methylation 
can result in gene expression.  https://www.elitenetzwerk.bayern.de 
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Aberrant Global DNA Methylation 
Aberrant methylation can lead to altered phenotypes (Wolff et al. 1998).  Data from 
cancer-related research has shown that genomic reductions in methylation, also called 
global hypomethylation, are a trademark of this altered cellular phenotype (Wu et al. 
2011).  In animal models, hypomethylation is associated with increased mutation rates 
and genomic instability (Chen et al. 1998; Eden et al. 2003).  Similarly, hypomethylation 
is also associated with genomic instability in human cancer tissue (Rodriguez et al. 
2006).  It has been established that genomic instability in the context of cancer is 
principally the result of demethylation in intergenic and intronic regions where repeated 
sequences and transposable elements are located (Wilson et al. 2007).  After initial 
observations in the cancer field, it was found that global changes in methylation can 
impact non-cancer diseases as well.  For example, immunodeficiency-centromeric 
instability-facial abnormality (ICF) syndrome is a rare human disease where DNA 
methyltransferase 3B (DNMT3B) is mutated resulting in global hypomethylation (Ehrlich 
2003).  Loss DNMT3B function leads to immune dysfunction, compromised lymphocyte 
function, and chromosome rearrangement in these patients.   
 
Aberrant Gene-specific DNA Methylation 
Aberrant gene-specific methylation can result in up-regulation of genes that are typically 
suppressed and suppression of genes that are typically up-regulated. Epigenetic 
modification within the CpG island of the promoter region is thought to interfere with 
binding of transcription factors and increase affinity for other epigenetic modifiers and 
co-repressors (Ji and Khurana Hershey 2012; Kuroda et al. 2009).  Removal of these 
marks is thought to make transcriptional binding sites more accessible and prime the 
system for increased protein production.  Leaders in the field have noted the need for 
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future molecular epidemiology studies to validate the epigenetic changes with RNA or 
protein expression (Rozek et al. 2014).   
 
Key Windows for Exposure-related Epigenetic Changes 
It is suggested that there are key developmental periods, or windows, that are important 
for epigenetic programming.  With the exception of imprinted genes, methylation 
patterns are reset during early development of the fetus and exposures during this 
period of epigenetic programming may affect disease susceptibility later in life (Tang and 
Ho 2007).  Considerable effort has been exerted to determine the epigenetic effects of 
the maternal environment on the offspring.  These studies were initially conducted in 
animal models and have more recently transitioned into human retrospective, cross-
sectional, and case control studies.  For example the agouti mouse gene has been 
exploited to show that gestational exposure to differing amounts of dietary nutrients can 
have phenotypic effects in the offspring (Waterland and Jirtle 2004).  The Dutch Famine 
of 1944 was an unfortunate incident but also a remarkable natural experiment.  Children 
born to mothers during the famine, in their first trimester of pregnancy compared to their 
third trimester, have differential methylation patterns at an imprinted gene related to 
insulin production (Heijmans et al. 2008). There are numerous examples of studies, 
which have investigated human perinatal exposures and found correlations with risk of 
disease later in life. Attention is only just recently being placed on exposure-epigenetic 
relationships in later windows of life.  Researchers have investigated how environmental 
exposures such as pesticides (Collotta et al. 2013), lead (Li et al. 2013), mercury 
(Goodrich et al. 2013), diisocyanate (Ouyang et al. 2013), and nano particles (Stoccoro 
et al. 2012) are associated with epigenetic modifications in adult human populations.  
These studies show that cumulative estimates of exposure have the potential to cause 
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epigenetic modifications at the global and gene specific level suggesting that these later 
windows of exposure are also important.  
 
Epigenetic Plasticity 
Authorities in the field of epigenetics have suggested that there are likely to be at least 
two categories of epigenetic “marks” (Nadeu 2013).  This paradigm is applicable to DNA 
methylation and other epigenetic alterations.  The paradigm suggests there are gene 
specific marks that happen very early on during natural development, and though these 
marks can hypothetically be reversed, it is highly unlikely that they ever will (Robertson 
2005).  Additionally, there are other gene specific marks that can be more flexible and 
may be reversed more readily due to a number of factors and in response to a number 
of potential exposures. Other authors have noted this dichotomy and called for more 
research to identify and characterize the nature of plasticity of the latter. It is currently 
unclear whether transient DNA methylation is a common feature of gene-environment 
interactions (Youngson and Morris 2013).   
 
 
DNA Methylation Analyses  
There are many ways to measure DNA methylation and there is no ‘best technique’.  A 
researcher must consider the overall study question, the funding available, 
bioinformatics capabilities, and most importantly what information is available in the 
current literature.  Some methylation analysis techniques are quantitative while others 
are qualitative.  The study model, matrix, or DNA quality/quantity may restrict the use of 
certain techniques.  To cast the broadest net, a genome-wide study could be done using 
microarray technology.  Assays like the Infinium450kb Chip have revolutionized the field 
of epigenomics, however assays like this can produce terabytes of data, which can be 
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challenging to store, process, and interpret. Unlike the chip arrays, which are extremely 
sensitive and produce CpG specific data for nearly all the CpGs, there are other 
techniques like the Luminometric Methylation Assay (LUMA) or 5-methylcytosine Assay 
(5-mC) that evaluate global methylation as an average percentage.  The latter assays 
are less helpful for generating hypothesis driven target genes compared to the chip 
arrays but are relatively inexpensive.  Repetitive elements like LINEs and SINEs can be 
used as targets for analyzing global methylation.  ALU for example is a CpG-rich SINE 
that contains approximately one-third of all human CpG dinucleotides (Yang et al. 2004). 
LINE-1, a retrotransposon-containing repetitive element, comprises about 20% of the 
human genome and is normally hypermethylated (Beck et al. 2010).  Both ALU and 
LINE-1 have been used as proxies for human global methylation analysis.  Workflow 
including storage and processing of DNA samples is highly dependent on the 
downstream assay that will be utilized.  Bisulfite-PCR pyrosequencing is a common 
strategy and necessary for the LINE-1 assay. This method exploits sodium bisulfite’s 
ability to selectively deaminate cytosine but not 5-methylcytosine to uracil (Clark et al. 
1994).  
 
The technology in the field of epigenetics is quickly evolving and with these advances 
comes a call for more mechanistic studies.  As these high-throughput methods become 
more cost effective it will be possible to move from studying mixed cell populations to 
sorted cell populations and generate cell specific epigenetic profiles.  Current techniques 
require cautious interpretation because changes in methylation patterns may simply 
represent a shift in cell population (Rozek et al. 2014).  Advances in this area of 
epigenetic research will help move the field from descriptive studies toward more 
mechanistic studies. 
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Novel Interdisciplinary Findings in Epigenetics 
In this relatively novel field, epigenetic mechanisms have been implicated in diseases 
from prostate cancer to obesity.  It is a field that has helped to bridge gaps between 
disciplines.  There have been some very interesting findings from interdisciplinary 
studies looking at the link between social and behavioral factors and epigenetic 
regulation.  The molecular mechanisms underlying gene expression following social and 
behavioral factors are not well understood (Rozek et al. 2014).  Novel research is often 
met with skepticism and that was the case for a couple of scientists at McGill University.  
In the early 2000s, Michael Meaney, a behavioral scientist, and Moshe Szyf, a molecular 
biologist, were trying to figure out why pups of attentive mother rats grew up to have less 
stress compared to pups of neglectful mothers.  They determined that these behavioral 
differences had to do with the levels of glucocorticoid receptor, a stress hormone 
(Weaver et al. 2004).  Szyf determined that contact between the mother and pup could 
result in demethylation at the gene that coded for the stress receptor and concluded this 
could lead to more receptor.  This novel finding was met with extreme skepticism and 
the publication was rejected from several journals including Nature and Science.  
Methylation was thought to be static and the journals were hesitant to stray from this 
dogma (Buchen 2010).  After two and half years the paper was published in the journal 
Dialogues in Clinical Neurosciences.  
 
The Frontier of Epigenetics 
The frontier of epigenetics is the transgenerational inheritance of epigenetic marks.  
Examples of environmental exposures that are suggested to produce transgeneration 
epigenetic changes can be found in Table 1.1.  This is probably the most fiercely 
debated subject in the field of epigenetics because it unearths the teachings of 
Lamarckian science (Hughes 2014).  If trangenerational inheritance were possible 
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through an epigenetic mechanism, then it would mean that an organism could pass on 
traits that it acquired in its lifetime to its progeny (Szyf 2015).   
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Table 1.1. Examples of Epigenetic Transgenerational Inheritance. 
From Guerrero-Bosagna et al. 2012 
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The phenomenon was first observed in plants.  There is an epigenetic mark at the locus 
that controls tomato ripening, and this mark is passed on to the next generation 
(Manning et al. 2006).  Following this finding in plants, large epidemiological studies in 
Europe started to publish data implicating transgenerational inheritance could occur in 
humans but these were (and still are) highly controversial findings because of the nature 
of epidemiological studies.  The difficulty with epidemiological studies is that it is often 
hard to control for confounding variables.  Because post-conception exposures to the 
mother could influence epigenetic data, it has become more commonplace to see 
studies focused on paternal exposures and associations with disease risk in the 
offspring.  Recent data from members of the Dutch Famine cohort have provided 
convincing evidence that under-nutrition can have effects on future generations.  
Children and grandchildren of men exposed to famine have higher risk for diseases such 
as heart disease and obesity relative to offspring from non-exposed men (Kaati et al. 
2002; Pembrey et al. 2006).   
 
In addition to human studies, researchers have also tried to show that this phenomenon 
is occurring by conducting the studies in the more controlled environment of a rodent 
model.  For example, Vinclozolin, a fungicide and known endocrine disruptor, has been 
used to show transgenerational effects in male rat sperm and these effects can be seen 
out to the F4 generation (Anway et al. 2005).  Using this model transgenerational 
inheritance, changes have also been detected in the prostate (Anway and Skinner 2008) 
and the brain (Skinner et al. 2008).  These particular studies have not helped to 
reconcile the debate, however. After two groups failed to reproduce this data, it was 
found that a member of the Skinner lab had fabricated data in a related paper.  Skinner 
and his laboratory did show that they were able to reproduce the retracted data (Skinner 
et al. 2013).  The debate over this frontier of epigenetic research remains and the 
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mechanism is still unclear.  The data exists to suggest that in addition to imprinted genes 
there are several types of epigenetic marks that escape reprogramming during 
development (see Figure 1.6.) (Hughes 2014).   
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Figure 1.6.  Resetting epigenetic marks during development. 
This figure depicts the reprogramming points that the epigenetic marks would need to 
elude to be inherited by the offspring. From Hughes 2014 Nature Sins of the Father. 
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Epigenetics and Asthma 
For Aims 1 and 2 we will investigate the effects of dietary exposure and airborne PM 
exposure on a representative measure of global and gene specific methylation.  LINE-1 
is discussed above and the potential for global methylation to affect immune function has 
also been covered. In the context of asthma LINE-1 methylation may be an indicator of 
asthma severity and could be related to health outcomes. Interferon gamma (IFNγ) was 
chosen for its involvement in the asthma pathway as a Th1 cytokine.  The differentiation 
and maintenance of T cells is dependent on the balance between Th1/Th2 (Robinson 
2010). Several studies have shown that IFNγ plays a key role in the counter-regulation 
of Th2 polarization (Crinnion 2012).  A study of asthma discordance in twins showed that 
IFNγ gene expression is suppressed in asthmatics compared to non-asthmatics (Runyon 
et al. 2012).  Modulation of the methylation profile in the promoter region of IFNγ has 
been shown to affect T cell polarization and/or differentiation in humans (cytosine 
phosphate guanine (CpG) -53 and -186) (Dong et al. 2013).  Tang et al. has shown that 
IFNγ hypermethylation is associated with reduced expression in an in vitro model (Tang 
et al. 2012).  This study also showed that there were differential patterns of IFNγ 
methylation in cord blood samples and these patterns were associated with maternal 
PAH-exposure.  Tang et al. did not show that these patterns were reflective of gene 
expression in the cord blood but suggests this is potentially the case based on the in 
vitro model.  The promoter region of the IFNγ gene has three proximally located CpG 
sites (see figure 1.7.), two of which have been shown to be mediated by environmental 
exposures.   
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Figure 1.7.  IFNγ CpG locations. 
Schematic of the CpG positioning for the promoter region of IFNγ.  Adapted from 
Lovinsky-Desir et al.  
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Rationale for Chosen IFNγ Promoter CpG Sites 
IFNγ CpG -54 (-53 is the corresponding murine CpG) and -186 have functional 
relevance to allergic outcomes in animal models (Liu et al. 2008a; Brand et al. 2012) and 
humans (Runyon et al. 2012; Kohli et al. 2012).  In an asthmatic cohort, Lovinsky-Desir 
et al. showed that there are differential methylation profiles for these CpGs relative to 
age, sex and tissue type (Lovinsky-Desir et al. 2014).  In the case of buccal cells, 
children had more methylation than adults at these two CpG sites.  In contrast to CD4+ 
lymphocytes, buccal cells methylation at these two CpG sites were not significantly 
different between males and females.  Methylation for CpG -186 was significantly 
correlated between CD4+ lymphocytes and buccal cells, but this was not the case for 
CpG -54.  
 
Particulate Matter Exposure 
Although it was nearly 2,500 years ago that Hippocrates wrote On Air, Water, and 
Places and noted that a person’s health could be affected by the air they breathe, the 
idea to protect an individual’s right to clean air and preserve the environment only came 
about recently. There are two catastrophic historical events that receive credit for raising 
public health concern regarding air quality.  Concomitantly, these events also mark the 
start of air pollution research.  In 1948, a pollution event occurred in Donora, 
Pennsylvania that killed 20 people and hospitalized 7,000 (1948).  The Donora Smog 
Disaster, as it was called, was attributed to stagnant air resulting from a temperature 
inversion, which allowed pollution from a number of sources including steel mills and 
smelting plants to accumulate until concentrations became deadly.  In 1952, another 
pollution event called The Great Smog of 1952 occurred in London, England 
(Metoffice.gov.uk).  This event killed between 4,000 and 12,000 people.  The full impact 
of this event was not realized until months later.   
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Definition of Particulate Matter 
Particulate Matter (PM) is a small subdivision of solid matter that is suspended in gas or 
liquid.  Airborne PM is a complex mixture of chemical species that is determined by the 
mechanism of formation, source, and environmental conditions.  Primary PM is 
unchanged from the time it was generated while secondary PM is formed through 
atmospheric reactions.  PM is categorized into three main types 1) PM10 which is all 
particles 10 micrometers in aerodynamic diameter and smaller, 2) PM2.5 which is all 
particles 2.5 micrometers in aerodynamic diameter and smaller, and lastly 3) Coarse 
Fraction, which is the particles that are between PM10 and PM2.5.  PM2.5 is especially 
important in the context of lung health because this subset of particles can bypass the 
body’s natural inhalation pathway defenses (i.e. nose hair and mucociliary escalator) 
and deposit in the alveolar spaces.  Depending on the chemical composition of the 
particles and the body’s reaction, this insult can start a chain of events leading to 
inflammation and even permanent structural changes such as fibrosis (EPA.gov).  PM 
has been shown to affect other organ systems and is therefore a major human health 
concern (see figure 1.8.).  Research suggests that there are susceptible populations (i.e. 
young, old, and those with pre-existing conditions) with regard to PM exposure and the 
Environmental Protection Agency (EPA) sets their standards to protect these individuals.  
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Figure 1.8. Potential health effects of PM exposure 
from Peters et al. 2011 
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Particulate Matter Regulations 
The Clean Air Act was enacted by Congress in 1970 and this was mostly prompted by 
visible pollution in many major cities (WWW.EPA.gov/air).  The latest amendments 
(1990) to the Clean Air Act require the EPA to set National Ambient Air Quality 
Standards for pollutants that are harmful to human health.  There are currently six 
pollutants that meet this criteria and particle pollution is on this list. Particle pollution is 
divided into PM2.5 and PM10.  The annual standard for PM2.5 is 12µg/m3 and the 24-hour 
standard is 35µg/m3 (WWW.EPA.gov/air/criteria).  Only a 24-hour standard is set for 
PM10, which is 150µg/m3. 
 
Particulate Matter and Health Outcomes 
PM is a key indicator of air pollution exposure and has the potential to significantly 
impact human health (Kim et al. 2015).  Certain populations are disproportionately 
affected therefore research and subsequent regulations should consider these 
populations.  Children are especially susceptible to PM exposure because humans lungs 
are not fully developed until age 6 (Schwartz 2004).  In addition to differences in 
physiology, children also have behavioral differences (i.e. activity level, time spent 
outdoors, etc.) compared to adults that make them vulnerable to PM exposure-related 
health effects.   
 
The following studies are examples of studies that have investigated the relationship 
between PM pollution and respiratory health in children with the majority of these studies 
occurring in the urban setting.  Researchers in the Netherlands looked at panels of 
children 7 to 11 years of age and found that associations between poor respiratory 
health and air pollution exposure were stronger among asthmatic children compared to 
healthy children (van der Zee et al. 1999).  A 7-week study with repeated measures 
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found that increased exposure to ambient air pollution was positively associated with 
exhaled nitric oxide (Fischer et al. 2002), which is a good marker of airway inflammation 
in children with asthma (Kharitonov et al. 1995).  In a panel of over 200 school aged 
children, researchers in Brazil found that air pollution, including PM2.5 generated from 
seasonal fires, was negatively associated with peak expiratory flow (PEF), a marker of 
respiratory health (Jacobson Lda et al. 2014). Gleason et al. investigated the relationship 
between summertime emergency department visits for asthmatic children and levels of 
PM2.5 and found that the association was the strongest when a pollution event occurred 
on the same day as the emergency department visit (i.e. no lag time). A recent study in 
approximately 1,500 school aged non-asthmatic children in Taiwan considered the 
relationship between lung function and air pollution including PM2.5.  The authors 
concluded that sub-chronic exposure to PM2.5 was associated with reduced lung 
capacity in children 6 to 15 years of age.  Additionally, the results of this study suggest 
that children 6 to 10 years of age may have airway obstructive patterns that are 
associated with acute exposure to PM2.5 (Chen et al. 2015).   
 
Impact of Community Based Strategies to Reduce Ambient Particulate Matter 
Concern for the impact of ambient PM on human health has grown over the last decade 
and intensified with formation of the Environmental Protection Agency (EPA) in the mid-
20th century. Major reductions in ambient PM are the result of changes in residential fuel 
sources (i.e. coal to gas or electric), improvements to automobile engine design and fuel, 
and regulations placed on industrial emissions (Lioy and Georgopoulos 2011).  Recently, 
there have been a small number of studies that have investigated the impact of 
strategies aimed at reducing biomass generated ambient PM at the community level 
(Johnston et al. 2013).  The majority of these studies have reported improvements in 
health-related outcomes associated with reductions in PM. 
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Opportunity for Indoor Particulate Matter Intervention 
Ambient pollution has been the focus of the EPA, but the indoor environment has 
become the target for some respiratory health related interventions because people 
today spend up to 90% of their time inside (Klepeis et al. 2001).  While it is not perfect, 
the home environment represents a more controlled research setting for determining the 
effectiveness of indoor intervention strategies.  Several strategies for reducing indoor 
PM have been employed.  For example, researchers have evaluated strategies to 
remove cockroach, mouse, or dust mite allergens, strategies to change subject behavior 
(i.e. having a parent of an asthmatic child smoke outside), removing or changing out an 
outdated heating source, and even multifaceted strategies that are tailored specifically to 
the subject (Matsui 2014).   With respect to asthma, several reviews have established 
the efficacy of air filtration units as a viable intervention strategy for reducing indoor PM 
exposure and improving respiratory health (McDonald et al. 2002; Fisk 2013).   
 
Particulate Exposure and IFNγ Methylation 
The mechanistic link between PM exposure, persistent inflammation, and asthma 
exacerbations is not fully understood.  Some environmental asthma triggers such as 
environmental tobacco smoke and traffic-related pollutants are known to induce 
epigenetic changes that may be important for the regulation of inflammatory mediators 
(Lovinsky-Desir and Miller 2012).  The relationship between PM exposure and the 
Th1/Th2 balance may be important in the context of asthma and epigenetics. A study in 
a mouse allergen model demonstrated that particulate matter exposure was associated 
with epigenetic effects at promoter sites of IL-4 and IFNγ. Diesel exhaust particulate 
exposure coupled with allergen-induced hypermethylation at three promoter sites for 
IFNγ and hypomethylation at one promoter site for IL-4 (Liu et al. 2008b). These 
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epigenetic outcomes would theoretically result in suppression of the Th1 pathway and 
promotion of the Th2 pathway, respectively.  
 
Nutritional Exposure 
People are not exposed to single insults in a bubble.  On the contrary, people are 
exposed to a concert of insults daily.  Humans are exposed to a myriad of chemicals and 
dietary factors through the consumption of foodstuffs daily and this may be one of the 
most important and ubiquitous exposures occurring in the 21st century (Cordain et al. 
2005).  From the time of the industrial revolution, human lifestyle has become urbanized 
(Popkin 1999) and this has led to changes in activity level and diet (Chilton et al. 2014).  
A number of epidemiological studies have investigated the role of nutrition and specific 
nutrients in the development of chronic inflammatory diseases (CIDs).  Evidence from 
these studies suggest that over-nutrition and gene-diet interactions may be driving a 
persistent systemic inflammatory state and contribute to diseases such as 
cardiovascular disease (CVD), diabetes, asthma, allergies, cancer, skin and digestive 
disorders, and neurological diseases (Ferrante 2007; Hamminga et al. 2006; Forsythe et 
al. 2008; Nguyen et al. 2009; Calle and Thun 2004; Naderali et al. 2009; Leveille et al. 
2005).  
 
Currently, researchers believe that nutrition, obesity, inflammation, and disease are all 
interconnected in a dynamic fashion.  The adaptation of the Western diet (i.e. high fats, 
sugars, and processed foods) is associated with a rise in obesity and inflammatory 
disease and exposure to these dietary factors seem to affect certain populations in a 
disproportionate way.  Obesity may be a susceptibility factor for nutritional-related 
exposures leading to inflammation as well as part of the pathway.  Early life exposure to 
dietary factors could be responsible for ‘epigenetic programing’ and this may affect 
	   35	  
disease risk later in life (Chilton et al. 2014) or even in the following generations (Hughes 
2014).  It is possible that recent changes to our diet are causing deleterious epigenetic 
changes leading to poor health outcomes.   
  
Dietary Patterns and Human Health 
The current body of literature on diet and human health can be broken down into two 
levels of study; research investigating the effect of dietary patterns on health and 
research investigating the effect of specific nutrients on health (James 2009).  In some 
cases the latter informs studies on the former. 
 
The health benefits of the Mediterranean diet (MD) have been known for half a century. 
The Seven Countries Study, which began in the 1940’s, was the first study to 
systematically examine the effect of diet (including MD) and lifestyle on heart disease. 
The MD is consistent with the traditional diet of southern Italy, Greece, and Spain, which 
includes high intake of olive oil and unrefined grains (Spreadbury 2012). MD typically 
contains very low saturated fats and cholesterol and very high monounsaturated fats, 
fiber, and carbohydrates (Sexton et al. 2013).  
 
The Western diet pattern is that of the developed world (i.e. Europe, United States, etc.). 
This diet is characterized by convenience and highly processed foods high in saturated 
and trans fats. The body of evidence supporting the deleterious effect of the Western 
diet on health is ever growing, but possibly the most persuasive data comes from studies 
looking at immigrants.  When immigrants from developing countries move to more 
developed countries they typically adopt some the host country’s dietary habits resulting 
in a natural experiment (Holmboe-Ottesen and Wandel 2012). It has been found that 
these ethnic minority groups are at risk for developing obesity, type 2 diabetes and CVD 
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(Abate and Chandalia 2001; Tillin et al. 2005; Fischbacher et al. 2007; Jenum et al. 
2005).  A meta-analysis of the available data has shown that the risk of these diseases 
is correlated with the adoption of a diet high in energy, low in fiber, and low in plant-
based micronutrients (Holmboe-Ottesen and Wandel 2012).  
 
A recent study analyzed data from the 4th Portuguese Annual Health Survey (Barros et 
al. 2015).  The study population was nearly 33,000, and within this population the 
prevalence of asthma was 5.3%.  The authors used Latent Trait Models to classify 
dietary intake into patterns.  After controlling for confounders, the authors found that two 
dietary patterns were associated with asthma.  The dietary pattern “high fat, sugar, and 
salt” was positively associated with asthma prevalence as well as severity.  The dietary 
pattern “fish, fruit, and vegetable” was negatively associated with asthma.  These results 
corroborate findings from a recent review by Brigham et al. that concluded that there is 
evidence to suggest that the Western diet pattern is associated with asthma morbidity 
(Brigham et al. 2014).  Gregory Diette from Johns Hopkins Bloomberg School of Public 
Health shared interim finding at the 2015 Children’s Environmental Health Network 
Conference from a clinical trial of dietary interventions in school aged asthmatic children 
in the context of an indoor air pollution monitoring program in inner city Maryland.  His 
research suggests that a prudent diet may be protective for asthma exacerbations from 
indoor air pollution, however, this data has not been finalized.  
 
Importance of the ω6:ω3 Ratio 
 One of the most obvious differences between Western and non-Western diets is the 
increase in the ω6:ω3 ratio (Chilton et al. 2014). The essential fatty acids were first 
discovered in 1929 by Evans and Burr, who showed that mammals lacked the enzymes 
necessary to synthesize ω6 or ω3 fatty acids. These ω3 fatty acids can be extended to 
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make eicosapetaenoic acid (EPA) and docosahezaenoic acid (DHA) by enzymes called 
desaturase and elongase (Simopoulos 2008). EPA and DHA can be used to make E and 
D-series resolvins which have anti-inflammatory effects (Bosma-den Boer et al. 2012). 
For more than a half-century, scientists have suspected that deficiencies in essential 
fatty acids could cause CIDs (HM 1953). According to Kromhout et al. controversial 
results have been published since the year 2000 regarding ω3 supplementation 
(Kromhout et al. 2012). The authors note that issues with omega 3 dose and source, 
statistical power and study design have made the data difficult to interpret. Cordain et al. 
estimate that some ancestral populations may have consumed as much as 58% of their 
energy as fat, however the ‘quality’ of the fat was better and still fell within the 
recommendations for ω6:ω3 ratio and saturated fat intake (Cordain et al. 2000). Data 
showing that populations such as the Greenland (Kromann and Green 1980) and Yup’ik 
(Makhoul et al. 2011) Eskimos consume high levels of ω3 and have lower levels of 
systemic inflammatory markers suggests an important role for the ω6:ω3 ratio. The 
ω6:ω3 ratio is potentially a very important player in the pathway leading to metabolic 
inflammation, or metaflammation. This type of inflammation is unique to obesity and is 
defined by chronic low-grade inflammation resulting from nutritional factors.  For 
example, linoleic acid (LA) can be converted in the liver to leukotoxins (LTX) by 
CYP2C9, which can further be modified by an epoxide hydrolase into leukotoxin diol 
(LTXD) or iso-LTXD (Bosma-den Boer et al. 2012; Ozawa et al. 1988).  In vitro models 
have shown that production of these metabolites can lead to systemic inflammation 
through the production of reactive oxygen species (ROS) and activation of transcription 
factors like NF-κB and AP-1 (Moghaddam et al. 1997; Viswanathan et al. 2003). In the 
context of respiratory health, there does not appear to be a consensus in the literature 
about the benefits of the ω3:ω6 ratio, however, there is a call for more research because 
a dietetic approach may be better tolerated and more cost effective than currently 
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available asthma management tools (D'Auria et al. 2014).  The mechanism whereby 
respiratory health is improved by eating a diet high in ω3 is likely too complex and 
possibly dependent on the severity of asthma among other factors.  
 
Dietary Fiber and a Potential Role for Inflammation 
Dietary fiber has recently received a rapid increase in attention for its potential role in 
immunoregulation. Dietary habits can influence the microbial diversity of the gut, which 
can contribute to low-grade inflammation through immune dysregulation.  Dietary fiber is 
at the interface between the gut microbiota and normal immune function (Kuo 2013).  It 
is estimated that there are more than 100 trillion resident microbes in the human gut and 
as much as 150-fold more genes in the ‘microbiome’ compared to the host genome(Qin 
et al. 2010).  The diversity and health of the gut microbiota is dependent on the 
nutritional intake of the host and fiber appears to play a key role in ensuring that 
nutrients reach the large intestine where the majority of the microbes reside (Kuo 2013).  
Therefore it is possible that the recent trends toward more processed foods in the 
Western diet could be compromising normal host immune function by undernourishing 
the gut microbiota. In this way, fiber has been used as a treatment for inflammatory 
diseases (Thorburn et al. 2014).  Kan et al. investigated fiber intake and respiratory 
health measures and chronic obstructive pulmonary disease.  In a population of nearly 
12,000 men and women from the Atherosclerosis Risk in Communities (ARIC) study, the 
authors found that dietary fiber intake was positively associated with several respiratory 
health metrics including percent predicted FEV1 (Kan et al. 2008).  The current literature 
supports the idea that fiber may be beneficial in controlling asthma in children. 
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Diet and Epigenetics 
Another way the diet may be influencing the development and/or exacerbation of CIDs, 
particularly asthma, is through DNA methylation.  Methyl groups can be added to 
cytosines in a cytosine guanine dinucleotide.  If this occurs in a functionally relevant 
region, this epigenetic mark can affect gene expression (Sharma and Litonjua 2014).  
Dietary methyl donors play an important role in one-carbon metabolism and the 
production of S-adenosylmethionine, which along with a methyltransferase is required 
for DNA methylation (see Figure 1.9.). Intake of methyl donors can influence patterns of 
methylation resulting in differences in gene transcription. Landmark studies, such as 
those looking at the methyl donor folate and its protective role for neural tube defects 
(Pitkin 2007), highlight the importance of these micronutrients.  However, recently there 
has been some research to suggest that the windows of exposure need to be revisited 
(Rozek et al. 2014).  The perinatal window may be the most sensitive time for the effects 
of these methyl donors and the therapeutic range may be more narrow than originally 
thought.  The findings from postnatal studies of folate and asthma have been mixed and 
the animal research has not helped untangle the relationship (Sharma and Litonjua 
2014).  In the context of asthma, even clinical trials of folate provide mixed results; 
evidence of the complexity of disease and also the mechanism.  
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Figure 1.9. Methyl donation. 
This is a simplified model depicting one-carbon metabolism.  DNA methylation is 
dependent on the availability of dietary methyl donors, highlighted yellow, to produce S-
adenosylmethionine (SAM). 
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IFNγ Methylation and Dietary Exposure 
To our knowledge there have not been any studies evaluating dietary exposures in 
humans in the context of IFNγ promoter methylation.  Recently, Meng et al. showed that 
IFNγ production is influenced by dietary variables and may predict upper respiratory tract 
infection incidence (Meng et al. 2015).  The authors did not investigate methylation in the 
IFNγ promoter region, however, this is one mechanism that could explain how exposure 
influences cytokine production. 
 
 
ARTIS: Description of Parent Study 
Aims 1 and 2 of my dissertation will occur within the context of this randomized trial and 
more specifically in final two years of this five-year study.  The rationale and methods for 
the Asthma Randomized Trial of Indoor Wood Smoke Study (ARTIS) have been 
described previously (Noonan and Ward 2012).  The objective of this study is to assess 
the effectiveness of residential intervention strategies for reducing wood stove generated 
PM2.5 and quantify the resulting improvement in health outcome measures among 
asthmatic children living in the home.  Similar studies have investigated PM reduction 
strategies in the urban environment (Johnston et al. 2013) and in the context of 
cookstoves (Alexander et al. 2014).  This novel study will be the first to investigate wood 
stove generated PM reduction strategies. The analysis for my study will take advantage 
of a very robust data collection strategy (see Figure 1.10.).  
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Figure 1.10.  ARTIS data collection strategy.   
Four sampling episodes occur at each participant home. Two sampling episodes occur 
during the pre-intervention winter, and two sampling episodes occur during the post-
intervention winter. Household interventions (i.e., active air filter or placebo filter) are 
introduced during the summer or fall between the two winter sampling seasons. Each 
sampling episode, days 1-3 in this Figure, includes data collection for both health 
outcomes and exposure assessment. The blue and green vertical arrows represent the 
addition of buccal cell collection and food frequency questionnaire administration 
respectively.  These two metrics take place during days 1-3. 
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Opportunity for an Animal Sentinel for Human Health 
There are often practical, logistical, and ethical considerations that make human 
community-based studies challenging.  Additionally, humans often have practices that 
are potentially confounding such as tobacco use, legal and illegal use of drugs, varying 
transportation and movement.  In such cases, there is utility in establishing a sentinel 
model for human health that could reduce the likelihood of potential confounding from 
these factors (Reif 2011).   
 
An animal sentinel is an animal that shares the same environment as humans and 
whose health is informative for human health.  In some cases the sentinel species may 
be more susceptible to the exposure or disease and in other cases may have a greater 
risk for exposure due to a difference in behavior (e.g., more breaths per minute 
translates to greater delivered dose for inhalation exposures).  A wide range of sentinel 
animals have proved useful including mammalian and nonmammalian speicies, 
domestic or companion animals, food animals, fish, amphibians, and wildlife (van der 
Schalie et al. 1999).  The classic example of a human sentinel is the canary in the 
coalmine shaft (Reif 2011).  In the early 1900’s miners would take a canary down the 
mineshaft with them because the bird was more susceptible to carbon monoxide 
exposure and would show signs of sickness before the miners.  This would give the 
miners time to escape to fresh air.    
 
Sentinel animals have been used to monitor for human health hazards (i.e. the canary), 
for risk assessment through field research programs, or serendipitous observation has 
signaled the alarm for human health.  Feral cats happened to be an example of the latter 
in Minamata Bay (Aronson 2005).  The dancing cats of Minamata were a sign that the 
fish supply had become toxic.  After an outbreak of anthrax in Russia, cattle and other 
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livestock were used as sentinels because they were more susceptible (Bezdenezhnykh 
and Nikiforov 1980).  Additionally, crows have been used as a sentinel of West Nile 
Virus infection (Julian et al. 2002).  
 
It could be argued that dogs, more than any other animal, have gone through a very 
intertwined evolution with humans over the last 5,000-15,000 years, which is the 
estimated time that dogs became domesticated (Boyko 2011).  In this time of co-
evolution, dogs have shared the human environment and likely the same pathogens and 
these shared exposures likely shaped both species’ immunological responses.  This 
makes the domestic dog a very plausible sentinel species.  In contrast to laboratory 
rodent models, which are typically used in acute high dose studies, domestic dogs are 
chronically exposed to many of the same environmental contaminates as their owners 
(Bukowski and Wartenberg 1997).   
 
An early observation on the effect of air pollution on dogs was made by a Russian 
scientist (Leake 1960).  He suggested that lung cancer occurred more often in dogs from 
larger cities compared to rural areas.  In the early 70’s Reif et al. conducted a 
retrospective study that looked at radiographic screenings for chronic pulmonary disease 
(CPD) in urban and rural domestic dogs.  In one of the study areas, the authors found 
that older urban dogs had a higher prevalence of CPD (Reif and Cohen 1970). In a 
follow up study of 1,892 dogs from three teaching hospitals, the author’s results showed 
that the prevalence of CPD was higher among older dogs from high pollution zones in 
two of the urban cities.  Dogs in Mexico City were studied in the early 2000’s and the 
researchers found that compared to dogs in more rural areas, urban dogs had structural 
lung changes likely due to an inflammatory response to chronic particulate and ozone 
exposure (Calderon-Garciduenas et al. 2001).  A follow up study was conducted and 
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found that this pollution could cause neuroinflammatory effects.  A study of dogs and 
cats in Pakistan showed that hair samples from domestic animals could be used as 
biomarkers for indoor air pollutants (Ali et al. 2013).  The authors concluded that dogs 
and other domestic animals were viable biosentinels for human health.   
 
It is unlikely that any sentinel species will ever be the sole determinant of health risk for 
humans, but animal sentinels can clearly inform risk assessments, provide early warning 
signs, and help monitor post-remediation exposure. Further, the use of animal models is 
critical to expanding our understanding of epigenetic regulation of gene expression and 
its contribution to complex disease phenotypes such as asthma (Dolinoy and Faulk 
2012).  Models that incorporate outbred strains and domestic animals may be 
particularly informative.  To succeed in elucidating the epigenetic mechanisms of 
complex diseases, Dolinoy suggests researchers must integrate animal models, human 
clinical research, and human epidemiological studies into the overall approach.   
 
Introduction Summary 
Our research strategy employs a multifaceted approach to determine the respiratory 
health impacts of diet and wood smoke particulate exposure on human health.  The 
following research will add to the body of literature by investigating a potential epigenetic 
mechanism whereby environmental exposures influence respiratory health outcomes.   
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Project Overview 
Title: DNA Methylation in Humans and Dogs:  Evaluating the Impact of Nutritional and 
Particulate Exposures  
My overall hypothesis is that PM2.5 and dietary factors will cause hypo- and 
hypermethylation changes modulating cytokine expression associated with asthma 
symptoms. 
 
Specific Aim 1 (Chapter 2):  Among asthmatic children (n=32), assess with 
repeated measures the impact of diet on (a) health outcome measures (i.e. quality 
of life and markers of respiratory health) and (b) methylation outcomes (i.e. LINE-1 
and IFNγ).  Data from winter 1 and winter 2 visits will be used.  However, only visits that 
include all health outcome measures, diet assessment, and buccal collection were 
included in the final analysis.  I hypothesize that intake of nutrients that are involved in 
methyl donation (i.e. folate, methionine, choline, B vitamins, etc.), reduction of oxidative 
stress (selenium), and linked to reduction of systemic inflammation (high in dietary fiber 
and ω3 compared to ω6) will be positively associated with health outcome measures.  
Further, I hypothesize that these nutrients will be associated with more LINE-1 
methylation and less methylation at CpG promoter sites of IFNγ, a Th1 response 
pathway related gene.   
 
Specific Aim 2 (Chapter 3):  Among asthmatic children (n=37), assess with 
repeated measures the impact of indoor PM2.5 exposure on buccal cell DNA 
methylation and health outcome measures.  Data from winter 1 and winter 2 visits will 
be used, however, only visits that include all health outcome measures and buccal 
collection will be included in the final analysis.  I hypothesize that PM2.5 will be negatively 
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associated with health outcome measures. Further, I hypothesize that PM2.5 will be 
negatively associated with methylation percentages of LINE-1 and positively associated 
with methylation at CpG promoter sites of IFNγ, a Th1 response pathway related gene.   
 
Specific Aim 3 (Chapter 4):  Identify three kennels of Alaskan sled dogs that are 
predicted to represent “high”, “medium”, and “low” winter-time ambient PM2.5 
exposures and determine if whole blood global DNA methylation differs by kennel. 
I hypothesize that PM2.5 will be negatively associated with methylation percentages of 
LUMA. Dogs in the high exposure kennel will have less global methylation compared to 
the dogs in the low exposure kennel. 
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Abstract 
Asthma is an increasingly common chronic disease among children, and data point 
toward a complex mechanism involving genetic, environmental and epigenetic factors. 
Epigenetic modifications such as DNA hypo- or hyper-methylation have been shown to 
occur in response to environmental exposures including particular dietary nutrients. 
Current research suggests that children may be especially susceptible to these 
exposures.   
 
Within the context of the Asthma Randomized Trial of Indoor wood Smoke (ARTIS) 
study we investigated relationships between diet, DNA methylation and asthma 
outcomes. Asthma health measures included a quality of life (PAQLQ) instrument and 
two-week daily monitoring of diurnal peak expiratory flow (dPEF) and forced expiratory 
volume in first second (FEV1).  Dietary intake was assessed using the 2004 
NutritionQuest Block Kids Food Frequency Questionnaire (FFQ). Buccal cells were 
collected using cytology brushes, and methylation of the LINE-1 repeated element and 
IFNγ (CpG -186 and -54) was measured by Pyromark Q96 (Quigen, Germantown, 
Maryland).  
 
Data were collected on 32 asthmatic children living in wood stove homes.  The mean 
(sd) age was 12.8 (2.5), ranging from 8-17 years, and 47% were male. Buccal samples 
(n=125) were collected 1 to 4 times per subject (n=32). Mean (sd) LINE-1 methylation 
was 65.3% (3.4) with a range of 56.1 – 73.2%.  Mean (sd) IFNγ CpG -54 was 79.6% 
(4.5) with a range of 68.6 - 92.4%.  Mean (sd) IFNγ CpG -186 was 70.1% (6.6) with a 
range of 49.1 - 81.6%.  
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In this cohort, methyl donors appear to be beneficial for respiratory health (i.e. higher 
percent predicted FEV1) and PAQLQ.  Several dietary constituents were associated with 
both global and gene specific methylation.  LINE-1 methylation was positively associated 
with intake of protein and several methyl donors.  The two IFNγ CpG sites that were 
investigated appear to be affected by intake of methyl donors in an opposite fashion.  
This was supported by our investigation of the relationship between methyl donors and 
the ratio of IFNγ CpG -54 to -186 (Me% 54/186).  Methylation at IFNγ CpG -186 was 
associated with more dPFV and lower PAQLQ.  While methylation at IFNγ CpG -54 was 
not associated with respiratory health, a higher Me% 54/186 was associated with less 
dPFV and better quality of life.  We explored the influence of diet on respiratory health 
measures through a DNA methylation pathway by crude mediation analysis.  This 
analysis did not support this hypothesis, however, further investigation is needed.  
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INTRODUCTION 
Asthma is an environmentally triggered disease and dietary nutrients represent a very 
important environmental exposure. Dietary manipulation has been used successfully to 
reduce symptoms of diseases, including asthma, however, few human studies have 
focused on elucidating the mechanistic pathways linking diet to chronic disease. One 
potential mechanism whereby diet affects respiratory health is through epigenetic 
modulation of inflammatory cytokines.   
 
Potential Impact of Diet on Asthma and Respiratory Health Outcomes 
Significant observational data exists to suggest that dietary status and intake of 
particular nutrients can affect respiratory health outcomes.  Recent studies suggest that 
some dietary nutrients may be protective for respiratory health (Thuesen et al. 2010; 
Mehta et al. 2010; Barros et al. 2008; Barros et al. 2011; Castro-Rodriguez et al. 2008; 
Chatzi et al. 2007, 2008; de Batlle et al. 2008; Garcia-Marcos et al. 2007; Romieu et al. 
2009).  In a study of nearly 12,000 men and women from the ARIC study, fiber was 
associated with several positive respiratory health measures including FEV1 (Kan et al. 
2008).  Interestingly, the authors were able to show that fiber from fruit and not cereal 
was responsible for the association.  A cross-sectional study by Berthon et al. showed 
that among asthmatics, a high fat diet was associated with increased airway eosinophilic 
inflammation, and low fiber was associated with poor lung function (Berthon et al. 2013). 
A group of researchers from Portugal found that, within a population of adult asthmatics, 
intake of a diet with a high ω6 to ω3 fatty acid ratio increased the odds of having 
uncontrolled asthma and intake of ω3 fatty acids predicted low exhaled nitric oxide 
(Barros et al. 2011). Supplementation of dietary folic acid and folates have been very 
important in the prevention of neural tube defects in the United States, however, some 
researchers have began to wonder if there may be a risk for unexpected effects because 
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folic acid is an important methyl donor (Lovinsky-Desir and Miller 2012).  Human studies 
have produced mixed results regarding maternal folic acid supplementation and asthma 
development (Lovinsky-Desir and Miller 2012; Cortessis et al. 2012).  A study in the 
murine model found that pups born to dams that ate a diet supplemented with methyl 
donors including folic acid had higher rates of allergic airway disease (Hollingsworth et 
al. 2008).  In this study, the allergic airway disease was related to differences in T-cell 
maturation.  Hollingsworth et al. also found differential methylation patterns for Runx3, a 
regulator of T-cell differentiation, in the exposure group relative to control. 
 
Potential for an Epigenetic Mechanism 
Several dietary nutrients are known to play a role in epigenetic mechanisms (see Table 
2.1 and Figure 2.1).  It is unclear if epigenetic changes are in the causal pathway 
whereby diet influences asthma outcomes or if these changes are markers of effect.  
There is likely a case to be made for each of the aforementioned circumstances 
depending on which gene and what exposure is measured.  For the current study, 
interferon gamma (IFNγ) was chosen for its involvement in the asthma pathway as a T 
helper (Th) cell 1 cytokine. IFNγ and its role in the Th1/Th2 balance can be found in the 
overall introduction.  After reviewing the literature, only one study has investigated the 
effect of diet on IFNγ production in humans (Meng et al. 2015) and this study did not 
consider DNA methylation.  This study showed that cells, which were extracted and 
purified from non-asthmatic adults, produced differential amounts of IFNγ and these 
amounts were associated with intake of specific dietary variables.  Further, it was found 
that dietary status and resulting IFNγ levels could predict upper respiratory tract infection 
incidence. 
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Nutrient Food Origin Epigenetic Role 
 
Methionine 
 
 
Sesame seeds, brazil nuts, 
fish, peppers, spinach 
 
 
SAM synthesis 
 
 
Folic Acid 
 
 
Leafy vegetables, 
sunflower seeds, baker's 
yeast, liver 
 
 
Methionine synthesis 
 
 
Vitamin B12 
 
 
Meat, liver, shellfish, milk 
 
 
Methionine synthesis 
 
 
Vitamin B6 
 
 
Meats, whole grain 
products, vegetables, nuts 
 
 
Methionine synthesis 
 
 
Choline 
 
 
Egg yolks, liver, soy, 
cooked beef, chicken, veal 
and turkey 
 
 
Methyl donor to SAM 
 
 
Betaine 
 
 
Wheat, spinach, shellfish, 
and sugar beets 
 
 
Break down the toxic byproducts of 
SAM synthesis 
 
 
Genistein 
 
 
Soy, soy products 
 
 
Increased methylation, cancer 
prevention, unknown mechanism 
 
 
Sulforaphane 
 
 
Broccoli 
 
 
Increased histone acetylation turning on 
anti-cancer genes 
 
 
 
Butyrate 
 
 
A compound produced in 
the intestine when dietary 
fiber is fermented 
 
 
Increased histone acetylation turning on 
'protective' genes, increased lifespan 
(shown in the lab in flies) 
 
 
Diallyl sulphide 
(DADS) 
 
 
Garlic 
 
 
Increased histone acetylation turning on 
anti-cancer genes 
 
 
             Table 2.1.  Dietary nutrients and their potential epigenetic role. 
            Adapted	  from	  http://learn.genetics.utah.edu/content/epigenetics/nutrition/	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Figure 2.1.  Dietary methyl donors. 
This cartoon shows how constituents of food can be involved in methyl donation.  
http://learn.genetics.utah.edu/content/epigenetics/nutrition  
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We hypothesized that within this asthmatic cohort of children there would be dietary 
nutrients associated with better respiratory health outcomes.  These dietary nutrients are 
expected to be components of a healthy diet (i.e. high in fiber, omega 3, and low in 
saturated fats) compared to the modern Western diet (i.e. low in fiber, omega 3, and 
high in saturated fats).  Additionally, nutrients such as folate, betaine, methionine, and 
choline would be associated with better respiratory health outcomes because of their 
methyl donating capabilities.  Methylation at the IFNγ CpG sites will serve as an indicator 
of the Th-1/Th-2 balance.  Within this asthmatic cohort, methylation profiles will likely be 
biased by Th-2 polarization however some nutrients may be inversely associated with 
methylation of IFNγ even within this context.    
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METHODS  
Subject Recruitment  
The ARTIS study included 114 subjects (children ages 6-17) from 97 homes.  In homes 
where two asthmatic children were recruited to the ARTIS study, the child with the worst 
asthmatic symptoms was designated as the primary asthmatic. The subcohort in this 
epigenetic study included 32 primary asthmatic subjects.  These subjects were given 
information about the buccal and FFQ collection and analysis and agreed to participate.  
In addition to the general ARTIS informed consent procedures, children were separately 
assented to participate in the epigenetics study and parents signed a separate 
permission form.   
 
Dietary Nutrient Collection 
Dietary data was collected using the 2004 Block Kids food frequency questionnaire 
(FFQ) (NutritionQuest, Berkley, CA) to characterize dietary intake among subjects.  This 
instrument has been validated in children, ages 6 – 17 years old (Block et al. 1994; 
Block and DiSogra 1995; Block et al. 1992; Block et al. 1990). Correlation coefficients for 
total energy, fat, saturated and monounsaturated fat, carbohydrate, fiber and calcium 
range from 0.40 to 0.50 (unpublished Abstract presented at the 4th International 
Conference on Dietary Assessment Methods). A recent study compared the Block Kids 
FFQ to two 24-hour recalls in 83 children from age 10 to 17 years. Correlations for 
nutrients ranged from 0.29 to 0.69 and for food groups from -0.03 to 0.74 (Cullen and 
Watson 2008). The questionnaire includes 77 food items and takes 25 to 30 minutes to 
complete. The questionnaire was administered to each individual subject by trained staff 
using serving size visual aides provided by NutritionQuest.  Parents or guardians were 
asked to be present during the interview to assist their child with portion size recognition 
and remembering foods they ate during the last week. All completed questionnaires 
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were sent to NutritionQuest for processing and calculating nutrient intake estimates. 
These data were returned to the University of Montana for analysis.   
 
Health Outcome Measures Collected in Parent Study 
The Pediatric Asthma Quality of Life Questionnaire (PAQLQ)  
PAQLQ is a 23-item asthma-specific battery which provides domain scores for 
symptoms (10 items), activity limitation (5 items), and emotional function (8 items) 
(Juniper et al. 1996).  The total PAQLQ score and each domain score are calculated as 
mean scores ranging from one to seven with seven as the optimal score.  This 
questionnaire was directly administered to children twice per winter period. The PAQLQ 
has been validated as an evaluative tool to measure within subject changes over time 
due to treatment, and changes in this scale of 0.5 or more points can be directly 
translated as a clinically significant outcome (Juniper et al. 1996). 
 
PiKo-1 Meter 
Using the PiKo-1 meter (Ferraris) subjects performed a test two times daily, in the 
morning and in the evening for a period of two weeks. These two-week periods were 
initiated at the beginning of each air sampling event.  For each sample event the 
instrument records the best result for both peak expiratory flow (PEF) and FEV1. 
Outcomes from these measures include average morning PEF and FEV1, average 
evening PEF and FEV1, and diurnal PEF variability (dPFV).  
 
Global and Gene-specific Methylation Analysis 
Buccal Cell Collection and DNA extraction 
Buccal cells were collected, stored, and processed according to a Gentra Puregene 
Buccal Cell DNA Kit (Qiagen, Valencia, CA). Briefly, the cells were collected from the 
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subject’s cheek using a cytology brush (see Figure 2.2) and stored in a buffer solution at 
room temperature until all samples were collected.  In compliance with this protocol, all 
samples were processed within 24 months from the day of collection.  To extract the 
DNA, the cells were lysed, the proteins were removed, and the DNA was washed.  The 
quantity of the purified DNA was measured using a Nanodrop spectrophotometer 
(Thermo Scientific, Wilmington, DE) and then stored at -20°C.  In the event that the 
primary sample did not yield sufficient DNA, secondary samples meant for RNA analysis 
were used.  Pilot data confirmed that DNA could be successfully extracted using a 
modified protocol. At the time of collection, samples meant for RNA extraction were 
collected and put immediately in RNAlater solution (instead of cell lysis buffer) and 
placed in a -80°C freezer upon returning to the university. The modified protocol for DNA 
extraction involved centrifuging the sample for 20 minutes at 20,000 x g to create a cell 
pellet and discarding the RNAlater-containing supernatant.  From this point, the Gentra 
Puregene Kit could be followed as written starting with the addition of the cell lysis 
solution. 
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Figure 2.2.  Location of buccal cell collection and brush. 
The buccal cells were collected from the 4 gutters of the mouth (Figure 2.3.a.).  Cells 
were collected on a cytology brush with a gentle scraping technique (Figure 2.3(.b.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a.	   b.	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Bisulfite Treatment and Methylation Analysis 
DNA bisulfite treatment was carried out using the EZ DNA Methylation-Direct Kit (Zymo 
Research, CA, USA) according to the manufacturer’s instruction. Briefly, buccal cell DNA 
denatured at 98°C for 10 min was incubated with modification reagents for 2.5 h at 64°C 
and cleaned and desulphonated. The bisulfite-modified DNA was stored at -20°C. PCR 
amplification and pyrosequencing steps have been described previously (Yang et al. 
2004).  Briefly, after sodium bisulfite conversion, the DNA was PCR amplified using a 
forward and reversion primer.  Gel electrophoresis was used to ensure proper 
amplification.  The PCR product was visualized using a Pyromark Q96 MD (Qiagen, 
Germantown, MD).  Each sample was PCR amplified using previously published primer 
sets for LINE-1, IFNγ -54, and IFNγ -186 (see Table 2.2).  Samples were run in duplicate 
for each assay until the coefficient of variation multiplied by 100 (%CV) was less than 5.  
Epitect (Qiagen) bisulfite treated controls, which include a methylated and unmethylated 
human genome sample, were used on each plate.
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Other Covariates 
Anthropometric measures were determined by trained staff using a digital scale and 
stadiometer.  Consistent with other studies of adolescent children, BMI percentile was 
calculated.  Age, ethnicity, and gender were captured by the food frequency 
questionnaire.   
 
Statistical analysis 
Prior to analysis in SAS v9.3 (Cary, NC), applicable dietary data were adjusted to total 
energy. Dietary nutrients were converted to tertiles of intake for comparison with 
outcomes. Selected dietary nutrients were considered separately and evaluated for 
associations using linear regression for continuous health outcome measures and 
logistic regression for categorical health outcome measures. Similarly, selected dietary 
nutrients were considered separately and evaluated for associations using linear 
regression for global methylation and gene-specific methylation.   
 
dPFV was dichotomized using the cut point of 20% (Jamison and McKinley 1993).  In a 
study comparing asthmatics to normal subjects, Jamison et al. showed that the peak 
flow variability of > 20% could be used as a discriminating index and this measurement 
was more sensitive than other measurements tested such as forced expiratory volume.  
For our study peak flow variability < 20% represents well controlled asthma.  PAQLQ 
scores were dichotomized at the median value of 5.8 (on a scale from 1-7) with higher 
values indicating better quality of life. Morning and evening FEV1 were dichotomized 
using the cut point of 80%, which is the cut point for moderate asthma in adolescent 
children according to the Asthma Severity and Control Monitoring Guide.   
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To account for repeated measures within subject, a generalized estimating equation 
(GEE) normal distribution model was used to determine if associations existed between 
dietary nutrients and measures of methylation.  In this model a parameter estimate of 
zero is the null value and values above zero indicate a positive association between 
dietary nutrients and the corresponding epigenetic marker.  A GEE binomial distribution 
model was used to determine if associations existed between dietary nutrients and 
categorical respiratory health measures.  This model estimates odds ratios with one 
being the null value, and odds ratio estimates less than one suggests that the dietary 
nutrient is protective for the corresponding asthma outcome measures.  For clarification, 
an odds ratio is informative about the relationship between an exposure and an 
outcome.  More specifically, an odds ratio tells you what the odds are for an outcome in 
the context of an exposure compared to the odds for that outcome without the exposure. 
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RESULTS 
A subcohort of 32 asthmatic children from the ARTIS study participated in this study of 
diet, respiratory health, and epigenetics.  The age of the children ranged from 8 to 17 
and 47% were male.  The study population was 94% non-Hispanic white.  The mean 
(sd) BMI percentile was 70.6 (20.1) and 34% (n=11) were above the 85th percentile, 
which is considered overweight according to the Centers for Disease Control (CDC). 
Buccal samples were collected 1 to 4 times for each of the 32 subjects (n=125 samples).  
52 total observations (includes repeated measures), where buccal sample, FFQ, and 
spirometry measurements were recorded, were used for analysis. Approximately 63% 
(n=20) of subjects had a year 1 and year 2 sample.  Mean (sd) LINE-1 methylation was 
65.3% (3.4) with a range of 56.1 – 73.2%.  Mean (sd) IFNγ CpG -54 was 79.6% (4.5) 
with a range of 68.6 - 92.4%.  Mean (sd) IFNγ CpG -186 was 70.1% (6.6) with a range of 
49.1 - 81.6%. Baseline respiratory health measures and PAQLQ values can be found in 
Table 2.3.  Baseline dietary nutrient values can be found in Table 2.4.    
 
The relationship between potential confounding variables (i.e. age, and sex) and 
methylation and respiratory outcomes were investigated.  Age was associated with 
higher percent methylation at the IFN CpG sites. For each year increase in age, 
methylation at IFNγ CpG  -186 was 0.5 percentage points higher (95%CI: 0.29, 1.01) 
and Me% 54/186 was 1.01 units higher (95%CI: 1.00, 1.02).  Age and sex were 
associated with PAQLQ.  For each year increase in age, there was 26% lower odds of 
having below median PAQLQ (95%CI: 44%, 3%). For boys, there were 491% higher 
odds of having below median PAQLQ relative to girls.  
 
In bivariate analysis of dietary constituents and DNA methylation or asthma outcomes, 
age and sex did not appreciably influence parameter estimates except where noted 
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below. Table 2.6, 2.7, and 2.8 presents bivariate analysis results unadjusted for age and 
sex.  
 
Global and Gene-specific methylation  
There was a modest positive association between IFNγ CpG  -54 and LINE-1 
methylation (p= 0.08).  IFNγ CpG  -186 was positively associated with LINE-1 
methylation (p= 0.02). IFNγ -54 CpG and IFNγ CpG  -186 were not associated (p= 0.86).  
Me% 54/186 tended to be negatively associated with LINE-1 methylation, however this 
relationship was not significant (p= 0.30). 
 
A percentage point increase in LINE-1 methylation was linked to a 4% (95% CI: 2%, 7%) 
greater odds of high dPFV (i.e., dPFV > 20%). LINE-1 methylation was not associated 
with PAQLQ or FEV1.   
 
A percentage point increase in methylation at IFNγ CpG -186 was linked to a 2% (95% 
CI: 0%, 3%) greater odds of high dPFV and a 2% (95% CI: 0%, 3%) greater odds of 
below median PAQLQ (i.e. QOL < 5.85).  Respiratory health measures were not 
significantly associated with methylation at IFNγ CpG -54, but Me% 54/186 was 
associated with better asthma outcomes. A unit increase in Me% 54/186 was linked to a 
41% (95% CI: 63%, 7%) lower odds of high dPFV and 44% (95% CI: 64%, 13%) lower 
odds of below median PAQLQ.  
  
Dietary nutrients with respect to methylation  
Several dietary constituents, comparing highest tertile to the lowest tertile of intake, were 
associated with higher average LINE-1 methylation.  For example, mean LINE-1 
methylation among those in the highest tertile of folate intake was 2.1 percentage points 
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higher (95% CI: -0.03, 4.2) than LINE-1 methylation among those in the lowest tertile of 
folate intake. Similarly, among children in the highest tertiles of intake compared to those 
in the lowest tertile for selenium, folate, and two measures of choline, LINE-1 
methylation was higher (see Table 2.7).    
 
Several dietary constituents were positively associated with methylation at IFNγ CpG -
54. Among those in the highest tertile of omega 3 to 6 ratio the mean methylation at 
IFNγ CpG -54 was 3.1 percentage points (95%CI: -0.1, 6.3) higher than the mean for 
those in the lowest tertile.  Similarly, those in the highest tertile of folate, 
phosphotidylcholine, and vitamin B-6 also had higher mean IFNγ CpG -54 methylation 
compared to those in the lowest tertile (see table Table 2.7).  In contrast to the 
relationship of diet and IFNγ CpG -54, several constituents were negatively associated 
with methylation at IFNγ CpG -186.  Among those in the highest tertile of fiber the mean 
methylation at IFNγ CpG -186 was 5.4 percentage points (95%CI: 10, -0.8) lower than 
the mean for those in the lowest tertile.  Similarly, those in the highest tertile of 
methionine, total choline, betaine and vitamin B-6 had lower mean IFNγ CpG -186 
methylation compared to those in the lowest tertile (see Table 2.7).  Those in the middle, 
rather than the highest, tertile of folate and vitamin B-2 had lower mean IFNγ CpG -186 
methylation compared to those in the lowest tertile. 
 
Intake of monosaturated fat and saturated fat was negatively associated with Me% 
54/186. Intake of fiber, folate, methionine, free choline, phosphotidylcholine, total 
choline, betaine, vitamin B-2, and vitamin B-6 was positively associated with Me% 
54/186. 
 
Dietary nutrients with respect to markers of respiratory health 
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Those in the highest tertile of protein intake had 80% lower odds of having poor percent 
predicted FEV1 (i.e., FEV1 < 80%) (95% CI: 94%, 10%) compared to those in the lowest 
tertile of protein intake.  Similarly, those in the highest tertile of monosaturated fat, 
saturated fat, methionine, free choline and the middle tertile of betaine had lower odds of 
having poor percent predicted FEV1 compared to those in the lowest tertile (see Table 
2.6). Those in the middle tertile of selenium intake had 80% lower odds of having below 
median PAQLQ (95% CI: 97%, 10%) compared to those in the lowest tertile of selenium 
intake. Similarly, those in the middle tertile of methionine, glycerophosphocholine, total 
choline, and betaine had lower odds of having below median PAQLQ compared to those 
in the lowest tertile (see Table 2.6).  These results remained robust after adjusting for 
age and sex (data not shown). The relationship between PAQLQ and the following 
nutrients: fiber (middle and high), free choline (middle), glycerophosphocholine (high), 
vitamin B-2 (middle and high), and vitamin B-6, were no longer significant after adjusting 
for age and sex. Dietary nutrients were not significantly associated with dPFV. 
 
Do nutrients affect respiratory health through an epigenetic mechanism? 
The relationship between diet, respiratory health and DNA methylation was explored 
through crude mediation analysis.  Individual methylation variables were added to the 
binomial GEE model where significant relationship existed between a diet variable and a 
respiratory health variable.  The results of the mediation analysis did not suggest that the 
diet variables selected were affecting respiratory health through modulation of DNA 
methylation. 
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N  Mean SD Minimum Maximum 
Age 32 12.81 2.47 8 17 
Gender 
         Male 15 (47%) 
        Female 17 (53%) 
    Ethnicity 
         Non-Hispanic white 30 (94%) 
    BMI percentile 32 70.64 24.14 5.83 98.97 
dPFV 32 20 14 2 66 
Morning FEV1 32 81.72 19.72 26.88 112.92 
Evening FEV1 32 82.32 19.33 19.26 110.10 
PAQLQ 32 5.68 1.05 3.10 7.00 
 
Table 2.3. Population characteristics  
Definitions: BMI, body mass index; dPFV, evening to morning peak flow variability; FEV1, 
forced expiratory volume in 1 second; PAQLQ, pediatric asthma quality of life questionnaire  
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  N Mean SD Minimum Maximum 
LINE-1 (%) 32 65.30 3.39 56.05 73.23 
IFNγ	  	  -­‐54	  	  (%)	   32 79.57 4.51 68.59 92.38 
IFNγ	  	  -­‐186	  	  (%)	   32 70.11 6.56 49.05 81.64 
IFNγ	  -­‐54/-­‐186	  	  	   32 1.15 0.15 0.93 1.85 
 
Table 2.5.  Global and gene-specific methylation measurements with repeated measures 
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Table 2.6.  Unadjusted results from GEE binomial distribution model evaluating associations 
between selected dietary nutrients and respiratory health outcomes.  Dietary nutrients were 
evaluated as highest or medium tertile relative to lowest and results are given as the odds ratio 
followed by the 95% confidence interval.  Definitions: dPFV, evening to morning peak flow 
variability; PAQLQ, pediatric asthma quality of life questionnaire; FEV1, forced expiratory volume 
in 1 second. 
Table 2.6.  Bivariate analysis of diet and respiratory health variables. 
Unadjusted results from GEE binomial distribution model evaluating associations between 
selected dietary nutrients and respiratory health outcomes. Dietary nutrients were evaluated as 
highest or medium tertile relative to lowest and results are given as the odds ratio followed by the 
95% confidence interval. Definitions: dPFV, evening to morning peak flow variability; PAQLQ, 
pediatric asthma quality of life questionnaire; FEV1, forced expiratory volume in the first second. 
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Table 2.7.  Unadjusted results from GEE normal distribution model evaluating associations 
between selected dietary nutrients and methylation outcomes.  Dietary nutrients were evaluated 
as highest or medium tertile relative to lowest and results are given as the exponentiated point 
estimate followed by the 95% confidence interval.   
Table 2.7.  Bivariate analysis of diet and methylation variables. 
Unadjusted results from GEE normal distribution model evaluating associations between selected 
dietary nutrients and methylation outcomes. Dietary nutrients were evaluated as highest or 
medium tertile relative to lowest and results are given as the odds ratio followed by the 95% 
confidence interval.  
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Table 2.8.  Unadjusted results from GEE binomial distribution model evaluating associations 
between selected methylation outcomes and respiratory health outcomes.  Results are given as 
the exponentiated point estimate followed by the 95% confidence interval.  Definitions: dPFV, 
evening to morning peak flow variability; PAQLQ, pediatric asthma quality of life questionnaire; 
FEV1, forced expiratory volume in 1 second. 
Table 2.8.  Bivaria e a alysis of ethylation and respiratory health variables. 
Unadjusted results from GEE bin mial distribution model evaluating associations between 
methylation variables and respiratory health outcomes. Results are given as the exponentiated 
point estimate followed by the 95% confidence interval. Definitions: dPFV, evening to morning 
peak flow variability; PAQLQ, pediatric asthma quality of life questionnaire; FEV1, forced expiratory 
volume in the first second. 
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DISCUSSION 
Within this cohort of childhood asthmatics, we sought to identify dietary nutrients that 
may be beneficial for respiratory health.  In addition we measured LINE-1 and IFNγ 
(CpG -54 and -186) methylation levels in hopes of identifying a potential mechanism 
whereby diet directly influences factors in the allergic asthma pathway. 
 
Diet and respiratory outcomes 
Percent predicted FEV1 in our cohort was influenced by several dietary nutrients 
including macro and micro nutrients.  Intake of methyl donors appears to be beneficial 
for this respiratory health marker.  Below median PAQLQ was associated with low intake 
of several nutrients including selenium, fiber, and methyl donors, however, the 
associations with selenium and fiber were no longer significant when adjusted for age 
and sex. The relationship between PAQLQ and several methyl donors were robust even 
after adjusting for age and sex. Methyl donors have been implicated as having a 
protective role for airway inflammation (Haberg et al. 2009).  Interestingly dPFV was not 
associated with any of the selected dietary nutrients in this cohort.  
 
The data for the respiratory health measures in this population were not normally 
distributed, therefore we chose to dichotomize on specific cut points.   A cut point of 20% 
was used for dPFV (i.e. high peak flow variability is > 20%) but this may warrant further 
investigation because depending on the study methods a cut point of 8% to 20% has 
been recommended (Reddel et al. 2009).  A cut point of 80% was chosen for percent 
predicted FEV1, which is an accepted guideline for discriminating between mild 
asthmatics and persistent asthmatics (Miller et al. 2005).  For PAQLQ, we conducted a 
median split. It should be noted that the median split was conducted because the data 
were skewed toward a high PAQLQ score and therefore the median was also relatively 
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high.   
 
One limitation of our study is that the FFQ that was used did not originally include 
several of the methyl donor metrics that we were interested in.  NutritionQuest included 
these seven metrics (i.e. methionine, free choline, glycerophosphocholine, 
phosphocholine, phosphotidylcholine, total choline, and betaine) in the analysis at our 
request.  While this investigation of the relationship between methyl donors and health 
outcomes is a novel aspect to our study it is also a limitation because the FFQ was not 
validated with these metrics.  Therefore, the interpretation of these metrics and their 
relationships with our outcomes of interests should be done with caution. 
 
Dietary nutrients with respect to Global methylation  
We found that %kcal of protein, selenium, folate and two measures of choline were 
positively associated with LINE-1 methylation, a proxy for global methylation. Selenium 
is a potent antioxidant and may play a role in respiratory health through systemic 
reduction of oxidative stress (Norton and Hoffmann 2012).  Folate and choline have 
been studied extensively for their role in one carbon metabolism and methyl donation.  In 
a subcohort from the COMIR study, researchers looked at white blood cell DNA from 
participants and found that folate from fortification was positively correlated with LINE-1 
methylation (Spearman r = 0.21, p = 0.007) and suggested that folate fortification of 
cereals and other grains may need to be revisited (Zhang et al. 2012). Protein could be 
an important proxy measurement for the child’s dietary pattern but it is difficult to make 
this designation using this FFQ. In some studies, high protein in the context of a Western 
diet has been shown to cause global hypomethylation, while a prudent diet has been 
shown to protect against hypomethylation (Zhang et al. 2011). Protein can come from a 
variety of sources and one possibility is that these children are eating protein from more 
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wild/organic sources.  The FFQ that was used does not differentiate between certain 
sources of the meat, like a deer steak versus a store-bought beef steak for example.  
 
Dietary nutrients with respect to IFNγ CpG methylation 
The omega 3 to 6 ratio and intake of several methyl donors were positively associated 
with methylation at IFNγ CpG -54.  The fatty acid ratio may be an important determining 
factor in the body’s ability to resolve inflammation (Bosma-den Boer et al. 2012) and 
research suggests that increasing the omega 3 to 6 ratio can improve measurements of 
systemic inflammatory markers (Urpi-Sarda et al. 2012).  Children who had more fiber 
and methyl donors in their diet had less IFNγ CpG -186 methylation.  These negative 
associations should be cautiously interpreted because it is unlikely that intake of dietary 
nutrients are resulting in direct demethylation at any CpG site. The literature suggests 
that hypomethylation in the IFNγ promoter region will result in increased transcription but 
the mechanism for active demethylation is not clear. One mechanism whereby diet could 
cause passive hypomethylation at an IFNγ CpG site would be through down regulation 
of a methyltransferase involved in maintenance DNA methylation (Jin et al. 2014).  
Further investigation into the methylation patterns of methyltransferases and other genes 
involved in the Th1/Th2 balance within the context of asthma and diet are needed. 
 
Global methylation with respect to respiratory health 
We found that methylation was positively associated with a marker of poor respiratory 
health, dPFV. Global methylation is difficult to interpret in the context of respiratory 
health and may be even more complex in this cohort of asthmatic children. Few studies 
have looked at buccal DNA LINE-1 global methylation in healthy children.  A study of 57 
healthy girls aged from 6-15 investigated LINE-1 global methylation in saliva samples 
and the average (SD) was 75.2 (3.4) (Wu et al. 2014). In our cohort of asthmatics, the 
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mean (sd) LINE-1 methylation from buccal cells was 65.3% (3.4), which is considerably 
lower.  Our data did not suggest that there was a significant difference in LINE-1 
methylation between boys and girls. The cells collected from buccal and saliva should be 
similar and would likely not account for such a discrepancy. In a study of 35 asthmatic 
children aged 8 to 11 years, the mean (sd) LINE-1 methylation from nasal cells was 72.3 
(4.1) (Baccarelli et al. 2012). It is difficult to compare buccal cells and nasal cells, 
however. These results suggest that our cohort has low LINE-1 methylation 
measurements on average even compared to other asthmatic children. Regarding global 
methylation and diet, researchers from the MESA study found no association between 
methyl donors and LINE-1 methylation in an adult atherosclerotic population, but the 
authors did report a correlation between BMI and LINE-1 methylation (Perng et al. 
2014).  We did not see a correlation between BMI and LINE-1 methylation in our cohort 
of asthmatic children.  
 
By convention, an increase in global methylation is thought to protective, while a shift 
toward genome-wide hypomethylation is often associated with a poor health outcome or 
disease (Rozek et al. 2014).  However, DNA methylation is dynamic and global 
methylation is a reflection of the epigenetic changes occurring at many gene locations.  
It is unclear if the changes that occur in response to acute exposures would be 
measurable or if these changes would be muted by the more pernicious epigenetic 
changes that are acquired over longer periods. The latter would suggest global 
methylation is more vulnerable to chronic exposures.  Our data suggests that global 
methylation is positively related to a marker of poor respiratory health, however, the 
average global methylation of the cohort was very low relative to other similar cohorts.   
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IFNγ CpG methylation with respect to respiratory health outcomes 
Children with more IFNγ CpG -186 methylation had more dPFV and below median 
PAQLQ scores.  Methylation at IFNγ CpG -54 was not associated with the selected 
measures of respiratory health.  Children with a higher Me% 54/186 had less dPFV and 
above median PAQLQ scores.   
 
IFNγ CpG -54 methylation was not correlated with IFNγ CpG -186 by general model of 
linear regression where clustering by subject repeated measure was accounted for. This 
is in contrast to Lovinsky-Desir et al. who found these CpG sites were weakly correlated 
(r = 0.24, p = 0.04) in a cohort of adult and child asthmatics.  There was a strong positive 
association between IFNγ CpG -186 and LINE-1 methylation, while there was only a 
weak association between IFNγ CpG -54 and LINE-1 methylation.   
 
One limitation of our study is that we did not measure RNA expression of IFNγ.  
However, if IFNγ is considered a proxy for Th1/Th2 balance and important for respiratory 
health, then methylation at IFNγ CpG -186 may be an important biomarker. IFNγ CpG -
186 methylation in this population could be influencing respiratory health by suppressing 
IFNγ production.  Our data suggest that IFNγ CpG -54 is having either no effect or 
potentially the inverse effect, meaning that methylation at this site could cause increased 
expression.  The IFNγ CpG -54 to -186 ratio was included in our analysis after finding 
that dietary nutrients were affecting methylation at the sites inversely. The data to 
support this proposed relationship is modest but the idea that dietary nutrients may be 
affecting two neighboring CpGs in the promoter of a gene in opposite ways is very 
interesting. The findings suggesting there is differential methylation patterns at these two 
CpG sites is inconsistent with prior studies (Runyon et al. 2012; Kohli et al. 2012).  In 
contrast to our study, both Runyon et al. and Kohli et al. were evaluating DNA 
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methylation in T cells purified from whole blood samples. Therefore, it is possible that 
DNA methylation is different between these two matrices. It is possible for methylation of 
a functional CpG to cause more transcription (Ngo and Sheppard 2015) and it can 
happen as a result of having more methyl donors in the diet (Li et al. 2014). Without 
RNA expression data, it is difficult to determine what impact methylation at these CpG 
sites is having.  It is intriguing that differential patterns were found at two proximally 
located CpGs and that the ratio, which appears to be influenced by diet, was associated 
with respiratory health and quality of life. 
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CONCLUSIONS 
In this cohort, methyl donors appear to be beneficial for respiratory health (i.e. higher 
percent predicted FEV1) and PAQLQ.  Several dietary constituents were associated with 
both global and gene specific methylation.  LINE-1 methylation was positively associated 
with intake of protein and several methyl donors.  The two IFNγ CpG sites that were 
investigated appear to be affected by intake of methyl donors in an opposite fashion.  
This was supported by our investigation of the relationship between methyl donors and 
the ratio of IFNγ CpG -54 to -186 (Me% 54/186).  Methylation at IFNγ CpG -186 was 
associated with more dPFV and below median PAQLQ.  While methylation at IFNγ CpG 
-54 was not associated with respiratory health, a higher Me% 54/186 was associated 
with less dPFV and above median PAQLQ.  We explored the influence of diet on 
respiratory health measures through a DNA methylation pathway by crude mediation 
analysis.  This analysis did not support this hypothesis, however, further investigation is 
needed.	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ABSTRACT 
Biomass fuels are used worldwide and wood is the most common of these fuel sources.  
Wood is of particular importance in the Rocky Mountain region not only because it is 
abundant and relatively easy to harvest but also because it is the primary fuel source for 
residential heating in rural areas where the infrastructure for gas does not exist.  
Historically, studies that target particulate exposure focus on urban sources such as 
diesel exhaust, so the ARTIS study will provide useful data to fill the knowledge gap on 
the efficacy of indoor PM intervention strategies in the Rocky Mountain region where 
wood smoke PM may be more important than other sources of PM such as diesel 
exhaust.  PM is a known trigger for asthma exacerbation, however the mechanism has 
not been fully elucidated. Epigenetic modifications such as DNA hypo- or hyper-
methylation have been shown to occur in response to environmental exposures 
including PM and it is possible that DNA methylation is involved in this mechanism. 
 
Within a subcohort of asthmatic children from the Asthma Randomized Trial of Indoor 
wood Smoke (ARTIS) study, the relationship between PM, DNA methylation, and 
respiratory health was evaluated.  Buccal cell DNA was analyzed for percent methylation 
of LINE-1 as a proxy for global methylation and for two IFNγ promoter CpG sites.  PM2.5, 
fine particle counts, and coarse particle counts were assessed.  Asthma health 
measures included a quality of life (PAQLQ) instrument and two-week daily monitoring of 
diurnal peak expiratory flow (PEF) and forced expiratory volume in first second (FEV1).   
 
Data were collected for 37 asthmatic children living in wood stove homes.  Mean (sd) 
LINE-1 methylation was 65.0% (3.5) with a range of 55.5 – 74.6%.  Mean (sd) IFNγ CpG 
-54 was 79.0% (4.9) with a range of 64.7 – 97.1%.  Mean (sd) IFNγ CpG -186 was 
71.0% (6.5) with a range of 49.1 – 95.9%.  In this cohort, age and sex were associated 
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with both IFNγ methylation and respiratory health. The filter intervention in the ARTIS 
study successfully reduced wintertime measurements of indoor PM in the homes of 
childhood asthmatics and these reductions were associated with better respiratory 
health outcomes. Methylation at CpG sites within the promoter of IFNγ was associated 
with indoor PM measurements and respiratory health measures, however we did not find 
that PM was affecting respiratory health through this epigenetic pathway.  Further 
investigation into RNA expression of IFNγ and other genes related to Th1/Th2 balance 
will help to clearly define the interplay between indoor PM exposure and 
immunoregulation among asthmatic children. 
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INTRODUCTION 
Wood Smoke Particulate Matter 
About half the world’s population uses a biomass fuel source to heat or cook with, and 
among these sources wood is the most common.  Biomass fuels are relatively inefficient 
and create more air pollution compared to other fuels, but these sources of fuel are 
cheap.  In contrast, sources like gas and electricity are more efficient and create less air 
pollution, but are also more expensive and often less accessible for rural communities 
(Sood 2012). The smoke generated from burning wood and other biomass combustion 
sources can be a complex mixture of pollutants including particulate matter, carbon 
monoxide, oxides of nitrogen and sulfur, benzene, formaldehyde, polycyclic aromatic 
hydrocarbons, free radicals, aldehydes, volatile organic compounds, chlorinated dioxins, 
and endotoxin (Kurmi et al. 2012).   
 
Fine particulate matter having an aerodynamic diameter <2.5 µm (PM2.5) has been 
suggested to serve as the best exposure metric for wood smoke because it tends to be 
among the most elevated pollutants in wood smoke emissions (Naeher et al. 2007).  
Source apportionment studies from several communities in the northern Rocky Mountain 
region have demonstrated that residential wood smoke contributes 56% to 77% of the 
measured wintertime ambient PM2.5 (Ward and Lange 2010).  Firewood is not only an 
abundant source of fuel in this geographical region of the United States, but for some 
residents of rural Montana, this may be one of the only choices for a heating source 
because the infrastructure for gas heat does not exist in their community.  
 
The Importance of Indoor PM2.5 
A large majority of the studies, which have evaluated the impact of PM2.5 on children’s 
respiratory health outcomes, have been focused on urban sources of exposure.  
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Because immunological responses are likely specific to the source, size and composition 
of the inhaled PM (Miyata and van Eeden 2011), there is a need to evaluate health 
outcomes in geographical locations where elevated ambient, non-urban sources of PM2.5 
occur.  Additionally, consideration should be given to the fact that people are spending 
more and more of their time indoors (Klepeis et al. 2001).   Indoor sources of biomass 
generated PM have been linked to poor health outcomes in developed and developing 
countries (Sood 2012; Pope et al. 2010).  The World Health Organization (WHO) 
estimates that nearly half of the 2 million premature deaths annually attributed to solid 
fuel indoor air pollution exposure are from cases of pneumonia in children less than 5 
years of age.   
 
In the United States, it is estimated that the number of susceptible individuals (elderly 
and children were considered susceptible) who are exposed to residential indoor wood 
smoke is approximately 5 million people (Noonan et al. 2015).  Noonan et al. note that 
this may be an underestimation because they did not include individuals with chronic 
diseases or infiltration of ambient wood smoke into houses without wood stoves.  Our 
laboratory has shown that significant reductions in ambient pollution can be achieved 
following a large-scale wood stove change in a western Montana community, and these 
reductions were correlated with better respiratory health outcomes in children (Noonan 
et al. 2012a).  By contrast, improvements in indoor air quality following stove technology 
upgrades has been shown to be highly variable (Noonan et al 2012) 
 
The Potential Epigenetic Link Between PM and Asthma 
Extensive data supports the relationship between ambient PM and asthma morbidity. 
Follow-up of cohorts or panels of asthmatic patients have demonstrated that elevations 
in PM10 and PM2.5 concentrations are associated with increases in severe asthma 
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attacks, asthma symptoms, asthma medication usage, and hospital emergency 
department visits for asthma and upper respiratory infections (Slaughter et al. 2003; 
Ostro et al. 2001; McConnell et al. 2003; Yu et al. 2000; Wong et al. 1999; Thompson et 
al. 2001; Lin et al. 2002; Jaffe et al. 2003; Norris et al. 1999; Sheppard et al. 1999; 
Lipsett et al. 1997; English et al. 1998; Peel et al. 2005; Schwartz et al. 1993). While it is 
accepted that the development of asthma is a consequence of both genetic susceptibility 
and environmental exposure (Holloway et al. 2010), the biological mechanism underlying 
development and exacerbation are still poorly understood.  
 
There is a need for biomarkers of exposures in the context of household air pollution 
exposure.  Epigenetic marks such as DNA methylation could serve in this role (Rylance 
et al. 2013). Although gestation and early infancy are sensitive time periods, epigenetic 
changes can occur throughout life (Miller and Ho 2008). A small number of studies in 
adults have evaluated short-term PM2.5 exposure and global measures of DNA 
methylation in LINE-1 and Alu repeated elements. A study of elderly subjects found that 
exposure to traffic-derived PM2.5 and black carbon was associated with decreased LINE-
1, but not Alu methylation (Madrigano et al. 2011; Baccarelli et al. 2009). This effect of 
LINE-1 hypomethylation was observed for PM2.5 and black carbon exposures on a sub-
chronic scale (Baccarelli et al. 2009). When considering a more chronic scale, the effect 
was evident for black carbon only (Madrigano et al. 2011). A Belgium study of non-
smoking adults found that several measures of air pollution, including PM2.5, were 
associated with global methylation, which was analyzed by HPLC (De Prins et al. 2013). 
In this study, only summer time PM2.5 was significantly associated with global 
methylation and men had more hypomethylation than women. 
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Global methylation can be informative in the context of respiratory health, but to 
elucidate a mechanism, gene specific analysis is key to understanding which 
immunological pathways are being affected. In a population of elderly men within the 
Normative Aging Study, sub-chronic exposure to air pollutants including non-traffic PM2.5 
were evaluated for associations with methylation changes in genes related to lung 
inflammation and immunity (Lepeule et al. 2014).  The researchers found that slope 
estimates for air pollutants were higher for participants with below median levels of 
methylation at several CpG locations for two out of nine airway inflammation related 
genes. 
 
Throughout the last decade, candidate gene and genome-wide association studies have 
shown that genetic variation of several cytokines and transcriptional factors relevant to 
the T-helper 1/ T-helper 2 (Th1/Th2) balance are associated with asthma (Vercelli 2008; 
Barnes 2011; Beghe et al. 2003; Moffatt et al. 2010; Kabesch et al. 2006; Robinson 
2010). For the current study, interferon gamma (IFNγ) was chosen for its involvement in 
the asthma pathway as a Th1 cytokine.  A review of the Th1/Th2 balance, the current 
literature on IFNγ, and its potential role in asthma can be found in the main introduction. 
Briefly, several studies have shown that IFNγ plays a key role in the counter-regulation 
of the Th2 polarization. Modulation of the methylation profile in the promoter region of 
IFNγ has been shown to affect T cell polarization and/or differentiation in humans and 
two CpG sites have been specifically chosen (IFNγ CpG -54 and -186) because they 
potentially play a role in asthma.   
 
Intervention Strategies 
In the United States, the prevalence of childhood asthma has increased over the last 
twenty years (Kay 2001) and the annual financial burden has inflated to over 2 billion 
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dollars (Landrigan, 2002).  There has been a call for efficient low-cost strategies to 
reduce exposures that exacerbate asthma symptoms and improve the quality of life for 
asthmatics, especially childhood asthmatics.  Children spend approximately 90% of their 
time indoors (Klepeis 2001), therefore intervention strategies that reduce indoor 
exposures should be considered.  Wood stove change outs have been used with some 
success but the reductions in the indoor PM2.5 levels can be variable (Ward et al. 2008; 
Noonan et al. 2012b).  The reduction in PM2.5 and possible improvements in respiratory 
health for the residents (including children) are dependent on the proper usage and 
maintenance of the wood stove, which is problematic.  In addition the EPA Burn Wise 
program suggests that the type of wood as well as the processing of the wood can have 
an impact on the amount of PM2.5 that is generated inside and outside the home.  Air 
filtration units can be used to reduce indoor PM2.5 and have been shown to improve 
symptoms in allergic asthmatics (McDonald et al. 2002; Fisk 2013).  Air filtration units 
are designed to capture asthma triggers such as pet allergens and particulate matter. Air 
filters have been shown to significantly reduce allergen-induced asthma attacks, improve 
quality of life scores in asthmatic children, and reduce medication usage in adult 
asthmatics (McDonald et al. 2002; Johnson et al. 2009; Eick and Richardson 2011). 
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METHODS 
Subject Recruitment  
The ARTIS study included 114 subjects from 97 homes.  In homes where two asthmatic 
children were recruited to the ARTIS study, the child with the worst asthmatic symptoms 
was designated as the primary asthmatic. The subcohort in this epigenetic study 
included 37 primary asthmatic subjects.  These subjects were given information about 
the buccal collection and analysis and agreed to participate.  In addition to the general 
ARTIS informed consent procedures, children were separately assented to participate in 
the epigenetics study and parents signed a separate permission form.   
 
Indoor Exposure Assessment 
During each 48-hour sampling event per each of two winters, a DustTrak 8530 (TSI, 
Shoreview, MN) that continuously measured PM2.5 mass was deployed within the home.  
The instrument was placed 3-5ft off the ground within the same room as the wood stove.  
The instrument was set to record at 60-second intervals and was zero calibrated prior to 
each sampling event.  A co-located 3016IAQ particle counter (Lighthouse Worldwide 
Solutions, Fremont, CA, USA) continuously recorded simultaneous counts of particles in 
multiple size ranges (0.3-0.49, 0.5-0.99, 1.0-2.49, 2.5-4.9 and 5.0-10.0 µm). Air was 
sampled at 2.83 LPM and data was recorded on 60-second averages. Particle counts for 
the fine fraction (PM2.5) were calculated to be the sum of the 0.3-0.49, 0.5-0.99, and 1.0-
2.49 µm particle counts while the coarse fraction was calculated to be the sum of the 
2.5-4.9 and 5.0-10.0 µm particle counts. 
 
Health Outcome Measures Collected in Parent Study 
The Pediatric Asthma Quality of Life Questionnaire (PAQLQ)  
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PAQLQ is a 23-item asthma-specific battery which provides domain scores for 
symptoms (10 items), activity limitation (5 items), and emotional function (8 items) 
(Juniper et al. 1996).  The total PAQLQ score and each domain score are calculated as 
mean scores ranging from one to seven with seven as the optimal score.  This 
questionnaire was directly administered to children twice per winter period. The PAQLQ 
has been validated as an evaluative tool to measure within subject changes over time 
due to treatment, and changes in this scale of 0.5 or more points can be directly 
translated as a clinically significant outcome (Juniper et al. 1996). 
 
PiKo-1 Meter 
Using the PiKo-1 meter (Ferraris) subjects performed a lung function test two times 
daily, in the morning and in the evening for a period of two weeks. These two-week 
periods were initiated at the beginning of each air sampling event.  For each sample 
event the instrument records the best result for both peak expiratory flow (PEF) and 
forced expiratory volume in the first second (FEV1). PEF and FEV1 measures were 
converted to percent predicted values according to the child’s age and height. Outcomes 
from these measures include average percent predicted morning PEF and FEV1, 
average percent predicted evening PEF and FEV1, and PEF variability. Daily diurnal 
PEF variability (dPFV) was calculated as evening PEF minus the prior morning PEF 
divided by the mean of the two measures.  
 
Global and Gene-specific Methylation Analysis 
Buccal Cell Collection and DNA extraction 
Buccal cells were collected, stored, and processed according to a Gentra Puregene 
Buccal Cell DNA Kit (Qiagen, Valencia, CA). Briefly, the cells were collected from the 
subject’s cheek using a cytology brush (see Figure 3.1) and stored in a buffer solution at 
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room temperature until all samples were collected.  In compliance with this protocol, all 
samples were processed within 24 months from the day of collection.  To extract the 
DNA, the cells were lysed, the proteins were removed, and the DNA was washed.  The 
quantity of the purified DNA was measured using a Nanodrop spectrophotometer 
(Thermo Scientific, Wilmington, DE) and then stored at -20°C.  In the event that the 
primary sample did not yield sufficient DNA, secondary samples meant for RNA analysis 
were used.  Pilot data confirmed that DNA could be successfully extracted using a 
modified protocol. At the time of collection, samples meant for RNA extraction were 
collected and put immediately in RNAlater solution (instead of cell lysis buffer) and 
placed in a -80°C freezer upon returning to the university. The modified protocol for DNA 
extraction involved centrifuging the sample for 20 minutes at 20,000 x g to create a cell 
pellet and discarding the RNAlater-containing supernatant.  From this point, the Gentra 
Puregene Kit could be followed as written starting with the addition of the cell lysis 
solution. 
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Figure 3.1.  Location of buccal cell collection and brush. 
The buccal cells were collected from the 4 gutters of the mouth (Figure 2.3a.).  Cells 
were collected on a cytology brush with a gentle scraping technique (Figure 2.3b.). 
 
 
 
 
 
 
 
 
 
a.	   b.	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Bisulfite Treatment and Methylation Analysis 
DNA bisulfite treatment was carried out using the EZ DNA Methylation-Direct Kit (Zymo 
Research, CA, USA) according to the manufacturer’s instruction. Briefly, buccal cell DNA 
denatured at 98°C for 10 min was incubated with modification reagents for 2.5 h at 64°C 
and cleaned and desulphonated. The bisulfite-modified DNA was stored at -20°C. PCR 
amplification and pyrosequencing steps have been described previously (Yang et al. 
2004).  Briefly, after sodium bisulfite conversion, the DNA was PCR amplified using a 
forward and reverse primer.  Gel electrophoresis was used to ensure proper 
amplification.  The PCR product was visualized using a Pyromark Q96 MD (Qiagen, 
Germantown, MD).  Each sample was PCR amplified using previously published primer 
sets for LINE-1, IFNγ -54, and IFNγ -186 (see Table 3.1).  Samples were run in duplicate 
for each assay until a %CV < 5 was achieved.  Epitect (Qiagen) bisulfite treated controls, 
which include a methylated and unmethylated human genome sample, were used on 
each plate.   
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Other Covariates 
Anthropometric measures were determined by trained staff using a digital scale and 
stadiometer.  Consistent with other studies of adolescent children, BMI percentile was 
calculated.  Age, ethnicity, and gender were captured by a questionnaire as part of the 
larger study design.  Descriptive home characteristics data, reported by an adult 
resident, were captured, including size and age of home, the presence of pets and 
secondary sources of heating.  
 
Statistical Analysis 
Methylation percentages resulting from pyrosequencing assays for LINE-1 and IFNγ 
were considered first as continuous variables. To provide meaningful results, PM 
exposures were evaluated as a change relative to the interquartile range (IQR). PM2.5 
IQR, fine particle counts IQR, and coarse particle counts IQR were evaluated for 
associations for Line-1 and IFNγ methylation using linear regression.  
 
Considering our cohort and this novel exposure setting, it is not clear from the literature 
whether the two IFNγ CpGs should be differentially methylated or methylated in concert.  
For this reason, we decided it may be prudent to evaluate the sites separately and in 
tandem.  To evaluate the affect of the sites together we chose to evaluate them as an 
average (IFNγaverage) and as a ratio (Me% 54/186).   
 
Diurnal peak flow variability was dichotomized using the cut point of 20% (Jamison and 
McKinley 1993).  In a study comparing asthmatics to normal subjects, Jamison et al. 
showed that the peak flow variability of > 20% could be used as a discriminating index 
and this measurement was more sensitive than other measurements tested such as 
forced expiratory volume.  For our study peak flow variability < 20% represents well 
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controlled asthma.  PAQLQ scores were dichotomized at the median value of 5.8 (on a 
scale from 1-7) with higher values indicating better quality of life. Morning and evening 
FEV1 were dichotomized using the cut point of 80%, which is the cut point for moderate 
asthma in adolescent children according to the Asthma Severity and Control Monitoring 
Guide.   
 
To account for repeated measures within subject, a generalized estimating equation 
(GEE) normal distribution model was used to determine if associations existed between 
PM exposures and measures of methylation.  In this model a parameter estimate of zero 
is the null value and values above zero indicate a positive association between PM 
exposures and the corresponding epigenetic marker.  A GEE binomial distribution model 
was used to determine if associations existed between PM exposures and categorical 
respiratory health measures.  This model estimates odds ratios with one being the null 
value, and odds ratio estimates greater than one suggests that the PM exposure is 
deleterious to the corresponding asthma outcome measures.  For clarification, an odds 
ratio is informative about the relationship between an exposure and an outcome.  More 
specifically, an odds ratio tells you what the odds are for an outcome in the context of an 
exposure compared to the odds for that outcome without the exposure. The final GEE 
model for both normal and binomial distribution included potential confounders (i.e. age 
and sex), adjusted for repeated measures, and considered the intervention.   
 
The primary analysis for this study was a mixed model that incorporated the affect of 
intervention and compared pre to post measurements for log transformed PM 
exposures, methylation markers, and respiratory health measurements. 
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RESULTS 
A subcohort of 37 asthmatic children from the ARTIS study participated in this study of 
indoor PM, respiratory health, and epigenetics.  The age of the children ranged from 7 to 
17 and 46% were male.  The study population was 89% non-Hispanic white.  The mean 
(sd) BMI percentile was 72.36 (23.83) and 43% (n=16) were above the 85th percentile, 
which is considered overweight according to the Centers for Disease Control (CDC).  
 
With repeated measures (n=37), the 48-hour mean (sd) for indoor PM2.5 concentration in 
the pre-intervention winter was 26.25 µg/m3 (26.20) with a range of 5-106 µg/m3. 
Similarly, the 48-hour mean (sd) for indoor fine particle counts and coarse particle 
counts were 5.5E7 (4.4E7) and 3.7E5 (3.1E5) respectively. 
 
With repeated measures (n=37), the mean (sd) for dPFV and PAQLQ in the pre-
intervention winter was 15.2% (9%) and 5.54 (1.03) respectively.  Similarly, the mean 
(sd) for morning and evening FEV1 was 83.69 (16.97) and 84.06 (17.68) respectively. 
 
Buccal samples were collected 1 to 4 times for each of the 37 subjects (n=125 samples) 
throughout both winters. Although the study was designed to collect 4 buccal samples 
from each participant, less than 4 collections were made for children who were lost to 
follow up or due to complications and a given visit did not occur.  Mean (sd) LINE-1 
methylation was 65.0% (3.5) with a range of 55.5 – 74.6%.  Mean (sd) IFNγ CpG -54 
was 79.0% (4.9) with a range of 64.7 – 97.1%.  Mean (sd) IFNγ CpG -186 was 71.0% 
(6.5) with a range of 49.1 – 95.9%.  LINE-1 global methylation was positively associated 
with IFNγ CpG  -54 methylation (p= <0.0001), IFNγ CpG  -186  (p= 0.001), and 
IFNγaverage (p= <0.0001) sites, but not with Me% 54/186.  Methylation at IFNγ -54 CpG 
and IFNγ CpG  -186 tended to be positively associated, but this relationship was not 
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significant. 
 
The relationship between potential confounding variables (i.e. age, and sex) and 
methylation and respiratory outcomes was investigated.  The sex of the child was 
associated with both methylation measures and respiratory health outcomes.  Boys 
relative to girls had 0.03 percentage points higher methylation at IFNγ CpG  -186 
(95%CI: 0.00, 0.64) and 0.13 percentage points higher IFNγaverage (95%CI: 0.02, 
0.73).  Boys had 74% lower odds of having below median PAQLQ (95%CI: 0.09, 0.73) 
and 64% lower odds of having poor morning FEV1 (95%CI: 0.12, 1.09) relative to girls.  
The age of the child was also associated with methylation measures and respiratory 
health outcomes.  For each year increase in age, methylation at IFNγ CpG  -186 was 0.4 
percentage points higher (95%CI: 0.2, 0.7%), IFNγaverage was 0.6 percentage points 
higher (95%CI: 0.4, 0.9), and Me% 54/186 was 1.0 units higher (95%CI: 1.00, 1.02). A 
year increase in age was associated with 20% lower odds of having high dPFV > 20% 
(95%CI: 0.66, 0.98) and 18% lower odds of having below median PAQLQ (95%CI: 0.66, 
1.01). 
 
In bivariate analysis of indoor PM and DNA methylation or asthma outcomes, age and 
sex did not appreciably influence parameter estimates except where noted below. 
Tables 3.4 and 3.5 present bivariate analysis results unadjusted for age and sex.  
 
 
Effect of treatment on indoor PM, methylation, and health outcomes 
There was a significant reduction in PM2.5 for the filter treatment group when pre 
intervention was compared to post intervention measurements.  The pre to post change 
in PM2.5 for the filter treatment group was significantly reduced relative to the change for 
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the placebo treatment group (see Table 3.3).  There was a similar reduction in fine 
particle counts for the filter treatment group when the pre treatment measurement was 
compared to the post treatment measurement. Pre to post change in fine particle counts 
for the filter treatment group was significantly reduced relative to the change for the 
placebo treatment group.  The pre to post change in coarse particle counts was 
significant for the filter treatment group. The pre to post change for the filter group 
relative to the change for the placebo treatment group was only modestly significant for 
coarse particle counts because there was a trend towards a pre to post reduction in the 
placebo treatment group. 
 
Considering pre to post measurements, methylation at IFNγ CpG -54 was significantly 
reduced in the filter and placebo treatment group.  Similarly, methylation at IFNγ CpG -
186 was also reduced in the filter and placebo treatment group.  There was no change in 
LINE-1 global methylation in the filter or placebo treatment group. 
 
When respiratory health measures were evaluated in the context of intervention, post 
intervention PAQLQ scores were significantly higher in the filter treatment group and this 
change was significant relative to the change in the placebo group.  There was a 
nonsignificant decrease in dPFV for the filter treatment group and a nonsignificant 
increase in the placebo treatment group.  This pre to post decrease in dPFV for the filter 
treatment group relative to the increase in placebo treatment group approached 
significance.  
 
Indoor PM and methylation measurements  
Indoor PM2.5 was associated with IFNγ CpG -54 methylation, Me% 54/186, and LINE-1 
methylation, however the relationship with LINE-1 methylation was no longer significant 
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after adjusting for age and sex.  An interquartile range increase in PM2.5 was associated 
with a 0.46 percentage point increase in IFNγ CpG -54 methylation (95%CI: 0.19, 1.14) 
and a 0.97 unit increase in Me% 54/186 (95%CI: 0.93, 1.01).  Indoor fine particle counts 
were associated with IFNγ CpG -54 methylation, IFNγ CpG -186 methylation, and with 
IFNγaverage, however these relationships were no longer significant when adjusting for 
age and sex.  Indoor coarse particle counts were associated with IFNγ CpG -54 
methylation, IFNγ CpG -186 methylation, and with IFNγaverage and after adjusting for 
age and sex these relationships remained significant.  An interquartile range increase in 
coarse particle counts was associated with a 1.55 percentage point increase in IFNγ 
CpG -54 methylation (95%CI: 1.18, 2.04), a 1.55 percentage point increase in IFNγ CpG 
-186 (95%CI: 1.04, 2.31), and a 1.56 percentage point increase in IFNγaverage (95%CI: 
1.16, 2.08).   
 
Indoor PM and respiratory health outcomes 
Indoor PM2.5, fine particle counts, and coarse particle counts were associated with poor 
PAQLQ and these relationships were robust even after adjusting for age and sex.  An 
interquartile range increase in PM2.5 was associated with 72% greater odds of having 
poor quality of life (95%CI: 0.95, 3.12).  Similarly, an interquartile range increase in fine 
fraction particle counts was associated with 69% greater odds of having poor quality of 
life (95%CI: 1.15, 2.48).  An interquartile range increase in coarse fraction particle 
counts was associated with 27% greater odds of having below median PAQLQ (95%CI: 
0.99, 1.64).   
 
Methylation measurements and respiratory health outcomes 
IFNγ CpG -186 methylation and Me% 54/186 were associated with dPFV and these 
relationships remained significant after adjusting for age and sex.  A percentage point 
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increase in IFNγ CpG -186 methylation was associated with 7% greater odds of having 
dPFV above 20% (95%CI: 1.01, 1.14).  A unit increase in the Me% 54/186 was 
associated with 99% reduced odds of having dPFV above 20% (95%CI: 0.00, 0.59). 
IFNγ CpG -186 methylation and Me% 54/186 were associated with PAQLQ but only the 
relationship between IFNγ CpG -186 and PAQLQ remained significant after adjusting for 
age and sex.  A percentage point increase in IFNγ CpG -186 methylation was 
associated with 5% greater odds of having poor PAQLQ (95%CI: 1.00, 1.11).   
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 N Mean SD Min Max 
Age 37 12.81 2.53 7 17 
Gender      
    Male 17 (46%)     
    Female 20 (54%)     
Ethnicity      
    Non-Hispanic White 33 (89%)     
BMI percentile 37* 72.36 23.83 6.79 99.46 
dPFV (%) 37* 15.2 9.0 3.8 42.4 
Morning FEV1 (%) 37* 83.69 16.97 23.79 111.85 
Evening FEV1 (%) 37* 84.06 17.68 15.63 108.28 
PAQLQ 37* 5.54 1.03 3.23 7.00 
Indoor PM2.5 (µg/m3) 37* 25.41 34.41 0.70 199.79 
Fine Fraction  
Particle Counts 
 
37* 
 
5.5E7 
 
4.4E7 
 
5.3E6 
 
1.7E9 
Coarse Fraction 
Particle  Counts  
 
37* 
 
3.7E5 
 
3.1E5 
 
5.0E4 
 
1.3E6 
IFNγ -54 37* 79.03 4.94 64.74 97.09 
IFNγ -186 37* 70.96 6.51 49.05 95.91 
IFNγ average 37* 74.99 4.55 64.50 96.50 
IFNγ ratio 37* 1.12 0.12 0.76 1.85 
LINE-1 37* 65.04 3.46 55.49 74.59 
* includes repeated measures within the pre-intervention winter  
Table	  3.2.	  Population	  characteristics.	  Definitions:	  BMI,	  body	  mass	  index;	  dPFV,	  
diurnal	  peak	  flow	  variability;	  FEV1,	  forced	  expiratory	  volume	  in	  one	  second;	  PAQLQ,	  
pediatric	  quality	  of	  life	  questionnaire.
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DISCUSSION 
In this cohort of asthmatic children, wintertime measurements of PM2.5, fine particle 
counts, and coarse particle counts were associated with poor quality of life.  With the 
introduction of a filter treatment in the home, we found that these indoor PM 
measurements were significantly reduced relative to the placebo treatment.  Additionally, 
we found that PAQLQ improved and dPFV decreased with the introduction of filter 
treatment relative to placebo treatment.   Interestingly, methylation at both of the IFNγ 
CpG sites that were measured was reduced for the filter treatment group and the 
placebo treatment group.  Coarse particle counts were positively associated with 
methylation for both of these sites and our results suggest that there was an unexpected 
reduction of coarse particles in the placebo filter group.  Visual inspections of the 
placebo filter in the home confirm this observation, as the placebo filters still trapped 
dust and other PM on the porous filter media.  We also hypothesize that the reduction 
IFNγ promoter methylation may have to do with the subjects increase in age.  The 
epigenome is known to change over time, however, it is difficult to speculate if these 
changes occur on the scale of a single year. 
 
In bivariate analysis, IFNγ CPG -186 was associated with a marker of poor respiratory 
health and with PAQLQ. The literature suggests that increased methylation at both CpG 
-54 and -186 of IFNγ is associated with suppression of IFNγ, but these studies did not 
evaluate buccal cell DNA.  Suppression of IFNγ would shift the balance from Th1 to Th2 
and this is consistent with observations of poor respiratory health.  However, to 
completely investigate the functionality of epigenetic modulation at these CpG sites, 
RNA expression data is necessary.  RNA expression analysis was outside the scope of 
this project and this is a major limitation for the interpretation of the methylation results. 
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Using a crude mediation analysis, we were able to evaluate whether PM exposures were 
affecting PAQLQ through an epigenetic pathway (data not shown).  Essentially, single 
methylation variables were added to the GEE binomial model to see if the effect of a PM 
variable on PAQLQ was appreciably influenced.  The results of this analysis did not 
suggest that methylation at the chosen CpG sites were important in this context. 
 
In this cohort we found some interesting results regarding the age and sex of the 
asthmatic children.  Boys had higher methylation at IFNγ  CpG -186 and IFNγaverage 
compared to girls.  Boys also had better PAQLQ and FEV1 compared to girls.  The 
findings with respect to sex appear to be contradictory if the literature on methylation of 
the IFNγ gene is correct.  We would expect more methylation to be associated with poor 
respiratory health. We found similar contradictory results for age. Older children had 
more IFNγ methylation and better respiratory health.  The finding that methylation 
increases at IFNγ CpG -186 with age is also intriguing because it suggest that the 
reduction in methylation at this site that we saw in response to treatment may not be due 
to the passing of time. 
 
It is important to remember that the literature informing our interpretation of these data 
were not conducted in the same cellular matrix and the subjects were not asthmatic.   
The findings from this novel application of epigenetic biomarkers within the context of an 
indoor PM intervention study with asthmatic participants warrant further investigation. 
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CONCLUSION 
The filter intervention in the ARTIS study successfully reduced wintertime measurements 
of indoor PM in the homes of childhood asthmatics and these reductions were 
associated with better respiratory health outcomes.  Global methylation measured with 
LINE-1 was not associated with respiratory health measures or PM exposure suggesting 
that this epigenetic marker may not be a sensitive marker for exposures in asthmatic 
children. Methylation at CpG sites within the promoter of IFNγ was associated with 
indoor PM measurements and respiratory health measures, however we did not find that 
PM was affecting respiratory health through this epigenetic pathway.  Further 
investigation into RNA expression of IFNγ and other genes related to the Th1/Th2 
balance will help to clearly define the interplay between indoor PM exposure and 
immunoregulation among asthmatic children.. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
	   124	  
REFERENCES	  
	  
	  
	  
Sood	  A.	  2012.	  Indoor	  fuel	  exposure	  and	  the	  lung	  in	  both	  developing	  and	  developed	  
countries:	  an	  update.	  Clin	  Chest	  Med	  33(4):	  649-­‐665.	  
	  
Kurmi	  OP,	  Lam	  KB,	  Ayres	  JG.	  2012.	  Indoor	  air	  pollution	  and	  the	  lung	  in	  low-­‐	  and	  
medium-­‐income	  countries.	  Eur	  Respir	  J	  40(1):	  239-­‐254.	  
	  
Naeher	  LP,	  Brauer	  M,	  Lipsett	  M,	  Zelikoff	  JT,	  Simpson	  CD,	  Koenig	  JQ,	  et	  al.	  2007.	  
Woodsmoke	  health	  effects:	  a	  review.	  Inhal	  Toxicol	  19(1):	  67-­‐106.	  
	  
Ward	  T,	  Lange	  T.	  2010.	  The	  impact	  of	  wood	  smoke	  on	  ambient	  PM2.5	  in	  northern	  
Rocky	  Mountain	  valley	  communities.	  Environ	  Pollut	  158(3):	  723-­‐729.	  
	  
Miyata	  R,	  van	  Eeden	  SF.	  2011.	  The	  innate	  and	  adaptive	  immune	  response	  induced	  
by	  alveolar	  macrophages	  exposed	  to	  ambient	  particulate	  matter.	  Toxicol	  Appl	  
Pharmacol	  257(2):	  209-­‐226.	  
	  
Klepeis	  NE,	  Nelson	  WC,	  Ott	  WR,	  Robinson	  JP,	  Tsang	  AM,	  Switzer	  P,	  et	  al.	  2001.	  The	  
National	  Human	  Activity	  Pattern	  Survey	  (NHAPS):	  a	  resource	  for	  assessing	  exposure	  
to	  environmental	  pollutants.	  J	  Expo	  Anal	  Environ	  Epidemiol	  11(3):	  231-­‐252.	  
	  
Pope	  DP,	  Mishra	  V,	  Thompson	  L,	  Siddiqui	  AR,	  Rehfuess	  EA,	  Weber	  M,	  et	  al.	  2010.	  
Risk	  of	  low	  birth	  weight	  and	  stillbirth	  associated	  with	  indoor	  air	  pollution	  from	  solid	  
fuel	  use	  in	  developing	  countries.	  Epidemiol	  Rev	  32(1):	  70-­‐81.	  
	  
Noonan	  CW,	  Ward	  TJ,	  Semmens	  EO.	  2015.	  Estimating	  the	  number	  of	  vulnerable	  
people	  in	  the	  United	  States	  exposed	  to	  residential	  wood	  smoke.	  Environ	  Health	  
Perspect	  123(2):	  A30.	  
	  
Noonan	  CW,	  Ward	  TJ,	  Navidi	  W,	  Sheppard	  L.	  2012a.	  A	  rural	  community	  intervention	  
targeting	  biomass	  combustion	  sources:	  effects	  on	  air	  quality	  and	  reporting	  of	  
children's	  respiratory	  outcomes.	  Occup	  Environ	  Med	  69(5):	  354-­‐360.	  
	  
Slaughter	  JC,	  Lumley	  T,	  Sheppard	  L,	  Koenig	  JQ,	  Shapiro	  GG.	  2003.	  Effects	  of	  ambient	  
air	  pollution	  on	  symptom	  severity	  and	  medication	  use	  in	  children	  with	  asthma.	  Ann	  
Allergy	  Asthma	  Immunol	  91(4):	  346-­‐353.	  
	  
Ostro	  B,	  Lipsett	  M,	  Mann	  J,	  Braxton-­‐Owens	  H,	  White	  M.	  2001.	  Air	  pollution	  and	  
exacerbation	  of	  asthma	  in	  African-­‐American	  children	  in	  Los	  Angeles.	  Epidemiology	  
12(2):	  200-­‐208.	  
	  
	   125	  
McConnell	  R,	  Berhane	  K,	  Gilliland	  F,	  Molitor	  J,	  Thomas	  D,	  Lurmann	  F,	  et	  al.	  2003.	  
Prospective	  Study	  of	  Air	  Pollution	  and	  Bronchitic	  Symptoms	  in	  Children	  with	  
Asthma.	  Am	  J	  Respir	  Crit	  Care	  Med	  168(7):	  790-­‐797.	  
	  
Yu	  O,	  Sheppard	  L,	  Lumley	  T,	  Koenig	  JQ,	  Shapiro	  GG.	  2000.	  Effects	  of	  ambient	  air	  
pollution	  on	  symptoms	  of	  asthma	  in	  Seattle-­‐area	  children	  enrolled	  in	  the	  CAMP	  
study.	  Environ	  Health	  Perspect	  108(12):	  1209-­‐1214.	  
	  
Wong	  TW,	  Lau	  TS,	  Yu	  TS,	  Neller	  A,	  Wong	  SL,	  Tam	  W,	  et	  al.	  1999.	  Air	  pollution	  and	  
hospital	  admissions	  for	  respiratory	  and	  cardiovascular	  diseases	  in	  Hong	  Kong.	  
Occup	  Environ	  Med	  56(10):	  679-­‐683.	  
	  
Thompson	  AJ,	  Shields	  MD,	  Patterson	  CC.	  2001.	  Acute	  asthma	  exacerbations	  and	  air	  
pollutants	  in	  children	  living	  in	  Belfast,	  Northern	  Ireland.	  Arch	  Environ	  Health	  56(3):	  
234-­‐241.	  
	  
Lin	  M,	  Chen	  Y,	  Burnett	  RT,	  Villeneuve	  PJ,	  Krewski	  D.	  2002.	  The	  influence	  of	  ambient	  
coarse	  particulate	  matter	  on	  asthma	  hospitalization	  in	  children:	  case-­‐crossover	  and	  
time-­‐series	  analyses.	  Environ	  Health	  Perspect	  110(6):	  575-­‐581.	  
	  
Jaffe	  DH,	  Singer	  ME,	  Rimm	  AA.	  2003.	  Air	  pollution	  and	  emergency	  department	  visits	  
for	  asthma	  among	  Ohio	  Medicaid	  recipients,	  1991-­‐1996.	  Environ	  Res	  91(1):	  21-­‐28.	  
	  
Norris	  G,	  YoungPong	  SN,	  Koenig	  JQ,	  Larson	  TV,	  Sheppard	  L,	  Stout	  JW.	  1999.	  An	  
association	  between	  fine	  particles	  and	  asthma	  emergency	  department	  visits	  for	  
children	  in	  Seattle.	  Environ	  Health	  Perspect	  107(6):	  489-­‐493.	  
	  
Sheppard	  L,	  Levy	  D,	  Norris	  G,	  Larson	  TV,	  Koenig	  JQ.	  1999.	  Effects	  of	  ambient	  air	  
pollution	  on	  nonelderly	  asthma	  hospital	  admissions	  in	  Seattle,	  Washington,	  1987-­‐
1994.	  Epidemiology	  10(1):	  23-­‐30.	  
	  
Lipsett	  M,	  Hurley	  S,	  Ostro	  B.	  1997.	  Air	  pollution	  and	  emergency	  room	  visits	  for	  
asthma	  in	  Santa	  Clara	  County,	  California.	  Environ	  Health	  Perspect	  105(2):	  216-­‐222.	  
	  
English	  PB,	  Von	  Behren	  J,	  Harnly	  M,	  Neutra	  RR.	  1998.	  Childhood	  asthma	  along	  the	  
United	  States/Mexico	  border:	  hospitalizations	  and	  air	  quality	  in	  two	  California	  
counties.	  Rev	  Panam	  Salud	  Publica	  3(6):	  392-­‐399.	  
	  
Peel	  JL,	  Tolbert	  PE,	  Klein	  M,	  Metzger	  KB,	  Flanders	  WD,	  Todd	  K,	  et	  al.	  2005.	  Ambient	  
air	  pollution	  and	  respiratory	  emergency	  department	  visits.	  Epidemiology	  16(2):	  
164-­‐174.	  
	  
Schwartz	  J,	  Slater	  D,	  Larson	  TV,	  Pierson	  WE,	  Koenig	  JQ.	  1993.	  Particulate	  air	  
pollution	  and	  hospital	  emergency	  room	  visits	  for	  asthma	  in	  Seattle.	  Am	  Rev	  Respir	  
Dis	  147(4):	  826-­‐831.	  
	   126	  
Holloway	  JW,	  Arshad	  SH,	  Holgate	  ST.	  2010.	  Using	  genetics	  to	  predict	  the	  natural	  
history	  of	  asthma?	  J	  Allergy	  Clin	  Immunol	  126(2):	  200-­‐209;	  quiz	  210-­‐201.	  
	  
Rylance	  J,	  Gordon	  SB,	  Naeher	  LP,	  Patel	  A,	  Balmes	  JR,	  Adetona	  O,	  et	  al.	  2013.	  
Household	  air	  pollution:	  a	  call	  for	  studies	  into	  biomarkers	  of	  exposure	  and	  
predictors	  of	  respiratory	  disease.	  Am	  J	  Physiol	  Lung	  Cell	  Mol	  Physiol	  304(9):	  L571-­‐
578.	  
	  
Vercelli	  D.	  2008.	  Discovering	  susceptibility	  genes	  for	  asthma	  and	  allergy.	  Nat	  Rev	  
Immunol	  8(3):	  169-­‐182.	  
	  
Barnes	  PJ.	  2011.	  Pathophysiology	  of	  allergic	  inflammation.	  Immunol	  Rev	  242(1):	  31-­‐
50.	  
	  
Beghe	  B,	  Barton	  S,	  Rorke	  S,	  Peng	  Q,	  Sayers	  I,	  Gaunt	  T,	  et	  al.	  2003.	  Polymorphisms	  in	  
the	  interleukin-­‐4	  and	  interleukin-­‐4	  receptor	  alpha	  chain	  genes	  confer	  susceptibility	  
to	  asthma	  and	  atopy	  in	  a	  Caucasian	  population.	  Clin	  Exp	  Allergy	  33(8):	  1111-­‐1117.	  
	  
Moffatt	  MF,	  Gut	  IG,	  Demenais	  F,	  Strachan	  DP,	  Bouzigon	  E,	  Heath	  S,	  et	  al.	  2010.	  A	  
large-­‐scale,	  consortium-­‐based	  genomewide	  association	  study	  of	  asthma.	  N	  Engl	  J	  
Med	  363(13):	  1211-­‐1221.	  
	  
Kabesch	  M,	  Schedel	  M,	  Carr	  D,	  Woitsch	  B,	  Fritzsch	  C,	  Weiland	  SK,	  et	  al.	  2006.	  IL-­‐
4/IL-­‐13	  pathway	  genetics	  strongly	  influence	  serum	  IgE	  levels	  and	  childhood	  asthma.	  
J	  Allergy	  Clin	  Immunol	  117(2):	  269-­‐274.	  
	  
Robinson	  DS.	  2010.	  The	  role	  of	  the	  T	  cell	  in	  asthma.	  J	  Allergy	  Clin	  Immunol	  126(6):	  
1081-­‐1091;	  quiz	  1092-­‐1083.	  
	  
Zhang	  H,	  Tong	  X,	  Holloway	  JW,	  Rezwan	  FI,	  Lockett	  GA,	  Patil	  V,	  et	  al.	  2014.	  The	  
interplay	  of	  DNA	  methylation	  over	  time	  with	  Th2	  pathway	  genetic	  variants	  on	  
asthma	  risk	  and	  temporal	  asthma	  transition.	  Clin	  Epigenetics	  6(1):	  8.	  
	  
Calderon	  C,	  Rivera	  L,	  Hutchinson	  P,	  Dagher	  H,	  Villanueva	  E,	  Ghildyal	  R,	  et	  al.	  2009.	  T-­‐
cell	  cytokine	  profiles	  are	  altered	  in	  childhood	  asthma	  exacerbation.	  Respirology	  
14(2):	  264-­‐269.	  
	  
Runyon	  RS,	  Cachola	  LM,	  Rajeshuni	  N,	  Hunter	  T,	  Garcia	  M,	  Ahn	  R,	  et	  al.	  2012.	  Asthma	  
discordance	  in	  twins	  is	  linked	  to	  epigenetic	  modifications	  of	  T	  cells.	  PLoS	  One	  7(11):	  
e48796.	  
	  
Dong	  J,	  Chang	  HD,	  Ivascu	  C,	  Qian	  Y,	  Rezai	  S,	  Okhrimenko	  A,	  et	  al.	  2013.	  Loss	  of	  
methylation	  at	  the	  IFNG	  promoter	  and	  CNS-­‐1	  is	  associated	  with	  the	  development	  of	  
functional	  IFN-­‐gamma	  memory	  in	  human	  CD4(+)	  T	  lymphocytes.	  Eur	  J	  Immunol	  
43(3):	  793-­‐804.	  
	   127	  
Tang	  WY,	  Levin	  L,	  Talaska	  G,	  Cheung	  YY,	  Herbstman	  J,	  Tang	  D,	  et	  al.	  2012.	  Maternal	  
exposure	  to	  polycyclic	  aromatic	  hydrocarbons	  and	  5'-­‐CpG	  methylation	  of	  interferon-­‐
gamma	  in	  cord	  white	  blood	  cells.	  Environ	  Health	  Perspect	  120(8):	  1195-­‐1200.	  
	  
Liu	  J,	  Ballaney	  M,	  Al-­‐alem	  U,	  Quan	  C,	  Jin	  X,	  Perera	  F,	  et	  al.	  2008a.	  Combined	  inhaled	  
diesel	  exhaust	  particles	  and	  allergen	  exposure	  alter	  methylation	  of	  T	  helper	  genes	  
and	  IgE	  production	  in	  vivo.	  Toxicol	  Sci	  102(1):	  76-­‐81.	  
	  
Brand	  S,	  Kesper	  DA,	  Teich	  R,	  Kilic-­‐Niebergall	  E,	  Pinkenburg	  O,	  Bothur	  E,	  et	  al.	  2012.	  
DNA	  methylation	  of	  TH1/TH2	  cytokine	  genes	  affects	  sensitization	  and	  progress	  of	  
experimental	  asthma.	  J	  Allergy	  Clin	  Immunol	  129(6):	  1602-­‐1610	  e1606.	  
	  
Kohli	  A,	  Garcia	  MA,	  Miller	  RL,	  Maher	  C,	  Humblet	  O,	  Hammond	  SK,	  et	  al.	  2012.	  
Secondhand	  smoke	  in	  combination	  with	  ambient	  air	  pollution	  exposure	  is	  
associated	  with	  increasedx	  CpG	  methylation	  and	  decreased	  expression	  of	  IFN-­‐
gamma	  in	  T	  effector	  cells	  and	  Foxp3	  in	  T	  regulatory	  cells	  in	  children.	  Clin	  
Epigenetics	  4(1):	  17.	  
	  
Lovinsky-­‐Desir	  S,	  Ridder	  R,	  Torrone	  D,	  Maher	  C,	  Narula	  S,	  Scheuerman	  M,	  et	  al.	  
2014.	  DNA	  methylation	  of	  the	  allergy	  regulatory	  gene	  interferon	  gamma	  varies	  by	  
age,	  sex,	  and	  tissue	  type	  in	  asthmatics.	  Clin	  Epigenetics	  6(1):	  9.	  
	  
Miller	  RL,	  Ho	  SM.	  2008.	  Environmental	  epigenetics	  and	  asthma:	  current	  concepts	  
and	  call	  for	  studies.	  Am	  J	  Respir	  Crit	  Care	  Med	  177(6):	  567-­‐573.	  
	  
Madrigano	  J,	  Baccarelli	  A,	  Mittleman	  MA,	  Wright	  RO,	  Sparrow	  D,	  Vokonas	  PS,	  et	  al.	  
2011.	  Prolonged	  exposure	  to	  particulate	  pollution,	  genes	  associated	  with	  
glutathione	  pathways,	  and	  DNA	  methylation	  in	  a	  cohort	  of	  older	  men.	  Environ	  
Health	  Perspect	  119(7):	  977-­‐982.	  
	  
Baccarelli	  A,	  Wright	  RO,	  Bollati	  V,	  Tarantini	  L,	  Litonjua	  AA,	  Suh	  HH,	  et	  al.	  2009.	  
Rapid	  DNA	  methylation	  changes	  after	  exposure	  to	  traffic	  particles.	  Am	  J	  Respir	  Crit	  
Care	  Med	  179(7):	  572-­‐578.	  
	  
De	  Prins	  S,	  Koppen	  G,	  Jacobs	  G,	  Dons	  E,	  Van	  de	  Mieroop	  E,	  Nelen	  V,	  et	  al.	  2013.	  
Influence	  of	  ambient	  air	  pollution	  on	  global	  DNA	  methylation	  in	  healthy	  adults:	  a	  
seasonal	  follow-­‐up.	  Environ	  Int	  59:	  418-­‐424.	  
	  
Lepeule	  J,	  Bind	  MA,	  Baccarelli	  AA,	  Koutrakis	  P,	  Tarantini	  L,	  Litonjua	  A,	  et	  al.	  2014.	  
Epigenetic	  Influences	  on	  Associations	  between	  Air	  Pollutants	  and	  Lung	  Function	  in	  
Elderly	  Men:	  The	  Normative	  Aging	  Study.	  Environ	  Health	  Perspect.	  
	  
Liu	  J,	  Ballaney	  M,	  Al-­‐alem	  U,	  Quan	  C,	  Jin	  X,	  Perera	  F,	  et	  al.	  2008b.	  Combined	  inhaled	  
diesel	  exhaust	  particles	  and	  allergen	  exposure	  alter	  methylation	  of	  T	  helper	  genes	  
and	  IgE	  production	  in	  vivo.	  Toxicol	  Sci	  102(1):	  76-­‐81.	  
	   128	  
Stiegel	  MA,	  Pleil	  JD,	  Sobus	  JR,	  Morgan	  MK,	  Madden	  MC.	  2015.	  Analysis	  of	  
inflammatory	  cytokines	  in	  human	  blood,	  breath	  condensate,	  and	  urine	  using	  a	  
multiplex	  immunoassay	  platform.	  Biomarkers	  20(1):	  35-­‐46.	  
	  
Kay	  AB.	  2001.	  Allergy	  and	  allergic	  diseases.	  First	  of	  two	  parts.	  N	  Engl	  J	  Med	  344(1):	  
30-­‐37.	  
	  
Klepeis	  NE,	  Nelson,	  W.C.,	  Ott,	  W.R.,	  Robinson,	  J.P.,	  Tsang,	  A.M.,	  Switzer,	  P.,	  Behar,	  J.V.,	  
Hern,	  S.C.,	  Engelmann,	  W.H.	  2001.	  The	  National	  Human	  Activity	  Pattern	  Survey	  
(NHAPS):	  a	  resource	  for	  assessing	  exposure	  to	  environmental	  pollutants.	  J	  Expo	  
Anal	  Environ	  Epidemiol	  11(3):	  231-­‐252.	  
	  
Ward	  T,	  Palmer	  C,	  Bergauff	  M,	  Hooper	  K,	  Noonan	  C.	  2008.	  Results	  of	  a	  residential	  
indoor	  PM2.5	  sampling	  program	  before	  and	  after	  a	  woodstove	  changeout.	  Indoor	  
Air	  18(5):	  408-­‐415.	  
	  
Noonan	  CW,	  Navidi	  W,	  Sheppard	  L,	  Palmer	  CP,	  Bergauff	  M,	  Hooper	  K,	  et	  al.	  2012b.	  
Residential	  indoor	  PM2.5	  in	  wood	  stove	  homes:	  follow-­‐up	  of	  the	  Libby	  changeout	  
program.	  Indoor	  Air	  22:	  492-­‐500.	  
	  
McDonald	  E,	  Cook	  D,	  Newman	  T,	  Griffith	  L,	  Cox	  G,	  Guyatt	  G.	  2002.	  Effect	  of	  air	  
filtration	  systems	  on	  asthma:	  a	  systematic	  review	  of	  randomized	  trials.	  Chest	  
122(5):	  1535-­‐1542.	  
	  
Fisk	  W.	  2013.	  Health	  benefits	  of	  particle	  filtration.	  Indoor	  Air	  ePub	  ahead	  of	  print.	  
Johnson	  L,	  Ciaccio	  C,	  Barnes	  CS,	  Kennedy	  K,	  Forrest	  E,	  Gard	  LC,	  et	  al.	  2009.	  Low-­‐cost	  
interventions	  improve	  indoor	  air	  quality	  and	  children's	  health.	  Allergy	  Asthma	  Proc	  
30(4):	  377-­‐385.	  
	  
Eick	  SA,	  Richardson	  G.	  2011.	  Investigation	  of	  different	  approaches	  to	  reduce	  
allergens	  in	  asthmatic	  children's	  homes-­‐-­‐the	  Breath	  of	  Fresh	  Air	  Project,	  Cornwall,	  
United	  Kingdom.	  Sci	  Total	  Environ	  409(19):	  3628-­‐3633.	  
	  
Rozek	  LS,	  Dolinoy	  DC,	  Sartor	  MA,	  Omenn	  GS.	  2014.	  Epigenetics:	  relevance	  and	  
implications	  for	  public	  health.	  Annu	  Rev	  Public	  Health	  35:	  105-­‐122.	  
	  
Juniper	  EF,	  Guyatt	  GH,	  Feeny	  DH,	  Ferrie	  PJ,	  Griffith	  LE,	  Townsend	  M.	  1996.	  
Measuring	  quality	  of	  life	  in	  children	  with	  asthma.	  Qual	  Life	  Res	  5(1):	  35-­‐46.	  
	  
Yang	  AS,	  Estecio	  MR,	  Doshi	  K,	  Kondo	  Y,	  Tajara	  EH,	  Issa	  JP.	  2004.	  A	  simple	  method	  for	  
estimating	  global	  DNA	  methylation	  using	  bisulfite	  PCR	  of	  repetitive	  DNA	  elements.	  
Nucleic	  Acids	  Res	  32(3):	  e38.	  
	  
Hazbun	  ME,	  Hamilton	  R,	  Holian	  A,	  Eschenbacher	  WL.	  1993.	  Ozone-­‐induced	  
increases	  in	  substance	  P	  and	  8-­‐epi-­‐prostaglandin	  F2	  alpha	  in	  the	  airways	  of	  human	  
subjects.	  Am	  J	  Respir	  Cell	  Mol	  Biol	  9(5):	  568-­‐572.	  
	   129	  
Montuschi	  P,	  Corradi	  M,	  Ciabattoni	  G,	  Nightingale	  J,	  Kharitonov	  SA,	  Barnes	  PJ.	  1999.	  
Increased	  8-­‐isoprostane,	  a	  marker	  of	  oxidative	  stress,	  in	  exhaled	  condensate	  of	  
asthma	  patients.	  Am	  J	  Respir	  Crit	  Care	  Med	  160(1):	  216-­‐220.	  
	  
Baraldi	  E,	  Ghiro	  L,	  Piovan	  V,	  Carraro	  S,	  Ciabattoni	  G,	  Barnes	  PJ,	  et	  al.	  2003.	  Increased	  
exhaled	  8-­‐isoprostane	  in	  childhood	  asthma.	  Chest	  124(1):	  25-­‐31.	  
	  
Zanconato	  S,	  Carraro	  S,	  Corradi	  M,	  Alinovi	  R,	  Pasquale	  MF,	  Piacentini	  G,	  et	  al.	  2004.	  
Leukotrienes	  and	  8-­‐isoprostane	  in	  exhaled	  breath	  condensate	  of	  children	  with	  
stable	  and	  unstable	  asthma.	  J	  Allergy	  Clin	  Immunol	  113(2):	  257-­‐263.	  
	  
Block	  G,	  Coyle	  LM,	  Hartman	  AM,	  Scoppa	  SM.	  1994.	  Revision	  of	  dietary	  analysis	  
software	  for	  the	  Health	  Habits	  and	  History	  Questionnaire.	  Am	  J	  Epidemiol	  139(12):	  
1190-­‐1196.	  
	  
Block	  G,	  DiSogra	  C.	  1995.	  WIC	  dietary	  assessment	  validation	  study.	  Final	  report.	  
Alexandria,	  VA:US	  Department	  of	  Agriculture,	  Food	  and	  Nutrition	  Service.	  
Block	  G,	  Thompson	  F,	  Hartman	  A,	  Larkin	  F,	  Guire	  K.	  1992.	  Comparison	  of	  two	  
dietary	  questionnaires	  validated	  against	  multiple	  dietary	  records	  collected	  during	  a	  
1-­‐year	  period.	  J	  Am	  Diet	  Assoc	  92:	  686-­‐693.	  
	  
Block	  G,	  Woods	  M,	  Potosky	  A,	  Clifford	  C.	  1990.	  Validation	  of	  a	  self-­‐administered	  diet	  
history	  questionnaire	  using	  multiple	  diet	  records.	  J	  Clin	  Epidemiol	  43(12):	  1327-­‐
1335.	  
	  
Cullen	  K,	  Watson	  K.	  2008.	  Relative	  reliability	  and	  validity	  of	  the	  Block	  Kids	  
Questionnaire	  among	  youth	  aged	  10	  to	  17	  years.	  J	  Am	  Diet	  Assoc	  108:	  862-­‐866.	  
	  
White	  GP,	  Watt	  PM,	  Holt	  BJ,	  Holt	  PG.	  2002.	  Differential	  patterns	  of	  methylation	  of	  
the	  IFN-­‐gamma	  promoter	  at	  CpG	  and	  non-­‐CpG	  sites	  underlie	  differences	  in	  IFN-­‐
gamma	  gene	  expression	  between	  human	  neonatal	  and	  adult	  CD45RO-­‐	  T	  cells.	  J	  
Immunol	  168(6):	  2820-­‐2827.	  
	  
Kwon	  NH,	  Kim	  JS,	  Lee	  JY,	  Oh	  MJ,	  Choi	  DC.	  2008.	  DNA	  methylation	  and	  the	  expression	  
of	  IL-­‐4	  and	  IFN-­‐gamma	  promoter	  genes	  in	  patients	  with	  bronchial	  asthma.	  J	  Clin	  
Immunol	  28(2):	  139-­‐146.	  
	  
 
 
 
 
 
 
 
 
 
	   130	  
 
 
 
 
 
 
CHAPTER 4 
 
Evaluating the effect of ambient particulate pollution on DNA methylation in 
Alaskan sled dogs: Potential applications for a sentinel model of human health 
 
Authors 
 
Luke Montrose, Curtis Noonan, Yoon Hee Cho, Joongwon Lee, John Harley, Todd 
O’Hara, Catherine Cahill and Tony Ward 
 
Corresponding Author 
Dr. Tony Ward 
Address: University of Montana 
Center for Environmental Health Sciences 
 32 Campus Drive- 179 Skaggs 
 Missoula, MT 59812 
 Telephone: (406) 243-4092 
 Fax: (406) 243-2807 
Email: tony.ward@mso.umt.edu 
 
 
 
 
 
 
 
	   131	  
Abstract 
Exposure to ambient particulate matter (PM) is known to be associated with increased 
morbidity and mortality in human populations.  During the winter months in Fairbanks, 
Alaska, severe temperature inversions lead to elevated concentrations of ambient PM 
smaller than 2.5 microns (PM2.5).  Sled dogs represent an easily accessible 
environmentally exposed population that may yield findings informative for human health 
risk assessment.   
 
In this pilot study, we evaluated whether ambient PM was associated with markers of 
global methylation in sled dogs.  Kennels were strategically recruited to provide a wide 
PM2.5 exposure gradient for the Fairbanks area.  Continuous monitoring of ambient PM2.5 
was conducted at each kennel during the winter of 2012/13 using a DustTrak 8530.  
Dogs received a physical examination and assessment of standard hematology and 
clinical chemistries.  Global methylation was determined using the LUminometric 
Methylation Assay (LUMA) and 5-Methycytosine (5-mC) Quantification.  
 
Three sled dog kennels (n ~30 dogs/kennel) were evaluated and sampled.  The average 
PM2.5 concentrations measured for kennels A, B, and C were 90 µg/m3, 48 µg/m3, 16 
µg/m3 (p< 0.0001), respectively.   The average (standard deviation) global methylation 
percentage for each kennel measured by LUMA was 76.22 (1.85), 76.52 (1.82), and 
76.72 (2.26), respectively.  The average (standard deviation) global methylation 
percentage for each kennel measured by 5-mC was 0.16 (0.04), 0.15 (0.04), and 0.15 
(0.05), respectively.  There was no statistically significant difference between the three 
kennels and their average global methylation percentage either by LUMA or 5-mC.   
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In this study we evaluated global methylation using LUMA and 5-mC and found no 
differences between kennels, though exposure to ambient PM2.5 was significantly 
different between kennels. As more information becomes available regarding 
immunologically-related canine genes and functionally active promoter subunits, the 
utility of this surrogate could increase.   
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INTRODUCTION 
Ambient particulate matter (PM) is known to be associated with increased morbidity and 
mortality in many exposed human populations, with these adverse effects particularly 
evident among individuals with pre-existing respiratory or cardiovascular conditions 
(Sacks et al. 2011). However, the mechanisms whereby PM causes adverse health 
outcomes in the general population including those with pre-existing conditions remain 
unclear.  
 
The inflammatory response generated from human exposure to airborne PM is largely 
determined by source and size of the particles (Kocbach et al. 2008). Source 
apportionment studies show that the Fairbanks airshed is dominated by wood smoke PM 
(Ward et al. 2012), which is at least partially due to the low cost and availability of wood 
relative to other popular fuel sources such as heating oil or natural gas.  During the cold 
winter months in Fairbanks, severe temperature inversions (characterized by stagnant 
air) and extreme low temperatures lead to significant PM exposures for extended 
periods of time.  It is not uncommon to see 24-hour average concentrations of ambient 
PM smaller than 2.5 microns (PM2.5) reach 50 – 60 µg/m3 for several consecutive days, 
significantly above the Environmental Protection Agency’s (EPA) 24-hour National 
Ambient Air Quality Standard (NAAQS) for PM2.5 (35 µg/m3).  These elevated wintertime 
PM2.5 concentrations have resulted in Fairbanks having some of the highest measured 
PM2.5 concentrations throughout the entire EPA monitoring network, and a designation of 
nonattainment for PM2.5.  
 
There is considerable evidence suggesting that traffic related pollution is a risk factor for 
poor respiratory and cardiovascular outcomes (Ruckerl et al. 2011). Previously, we have 
demonstrated that elevated ambient PM2.5 concentrations due to residential wood smoke 
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was associated with respiratory conditions and symptoms (Noonan et al. 2012). 
Because immunological responses are likely specific to the source, size and composition 
of the inhaled PM (Miyata and van Eeden 2011), there is a need to evaluate health 
outcomes in geographical locations where high ambient PM2.5 occur.   
 
There are often practical, logistical, and ethical considerations that make human 
community-based studies challenging.  Additionally, humans often have practices that 
are potentially confounding such as tobacco use, legal and illegal use of drugs, varying 
transportation and movement.  In such cases, there is utility in establishing a sentinel 
model for human health that could reduce the likelihood of potential confounding from 
these factors (Reif 2011).  Groups such as the Morris Animal Foundation have 
highlighted the utility of the domestic dog as a biomedical model for researching the 
genetic and epigenetic etiologies of canine cancers (Morris Animal Foundation).  
Domestic dogs have been used previously to study the public health effects of air 
pollution both in lieu of human studies (Calderon-Garciduenas et al. 2001) and in parallel 
(Calderon-Garciduenas et al. 2008).  
 
This study represents a novel application of sled dogs as sentinel animals for health 
impacts associated with exposure to ambient air pollution.   The long winters and pristine 
mushing topography makes Fairbanks ideal for such a study.  For example, Fairbanks is 
home to a large potential cohort of thousands of sled dogs, with these working domestic 
animals clustered in large groups of up to 100 per kennel. The relatively place-bound 
subjects, the spatial distribution of kennels, and the elevated but varied concentrations of 
ambient PM2.5 provide an ideal opportunity to accurately assess ambient air exposures 
in this setting.   
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Uniform diets, structured exercise routines, and multigenerational pedigrees add 
elements that are similar to experimental animal studies and a clear advantage over 
human subjects with high variability in these and other factors.  Considering body size, 
life span, and behavior, which can all impact disease pathology, a dog may serve as a 
more biologically relevant model for human health compared to mice or rats.  Dogs have 
also shared a living environment with humans longer than any other domestic animal 
and very likely also shared pathogens, which may have equally shaped the way both 
species’ immune systems defend against disease (Boyko 2011).  
 
Epigenetics play an important role in developmental processes, cell proliferation, and the 
maintenance of genome stability (Jones and Baylin 2007). Global DNA hypomethylation 
is one type of epigenetic alteration and is hypothesized to play a role early in 
carcinogenesis by activating oncogenes and/or genomic instability (Feinberg 2004). 
Recently, epigenetic modifications such as DNA hypo- or hyper-methylation have been 
shown to occur in response to environmental exposures, and both human and animal 
studies suggest that such changes are relevant to risk for chronic disease. In particular, 
studies have found that exposure to air pollution can affect methylation patterns at the 
global (Madrigano et al. 2011; Baccarelli et al. 2009; Tarantini et al. 2009) and gene-
specific levels (Liu et al. 2008; Salam et al. 2012; Nadeau et al. 2010).  The current body 
of literature clearly indicates a role for methylation pattern changes in genes responsible 
for the regulation of the T-effector pathway, T-regulatory pathway, and airway 
inflammation (Lovinsky-Desir and Miller 2012).  Deciphering the epigenetic landscape of 
exposed populations could lead to potential treatments because of the reversible nature 
of epigenetic markers (Wright 2013).  
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In this manuscript, we for the first time evaluate global methylation in Alaskan sled dogs 
in order to determine the effect of exposure to ambient PM (composed predominantly of 
residential wood smoke) on global DNA methylation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   137	  
METHODS 
Kennel Recruitment 
Data from both stationary and mobile PM2.5 air monitors were used to identify kennels 
located in “high”, “medium”, and “low” PM2.5 areas around the city of Fairbanks.  
Ultimately three kennels were strategically recruited with the intention of yielding a wide 
PM2.5 exposure gradient across sample locations.  To be considered for inclusion, the 
kennel had to have greater than 30 sled dogs on site and access to an electrical outlet. 
Kennel A was an urban kennel located inside the Fairbanks EPA PM2.5 designated non-
attainment area, Kennel B was an urban kennel located approximately 15 miles 
Southwest of Fairbanks, and Kennel C was a rural kennel located approximately 50 
miles Southeast of Fairbanks.  The sled dog owners were contacted and given 
information about the study.  Those owners who agreed to participate were asked to 
sign a consent form.  This study was approved by the University of Montana (UM) and 
University of Alaska Fairbanks (UAF) Institutional Animal Care ad Use Committee 
(IACUC #283615-4) before any onsite work was conducted. 
 
PM2.5 Exposure Characterization 
During the winter of 2012/13, a DustTrak 8530 (TSI, Shoreview, MN) that continuously 
measured PM2.5 mass was deployed to each of the three kennels.  The DustTrak was 
housed in an insulated and heated enclosure to protect it from the extreme winter 
temperatures. While sampling, this monitor was placed approximately 1 meter off of the 
ground within 15 meters from the dog yard.  The sled dogs in this study were all housed 
in very close proximity to each other at their respective kennel.  The DustTrak was on a 
60-second recording interval, and was zero calibrated prior to each sampling event.  
Field staff collected PM2.5 mass data at each kennel from November 21, 2012 through 
February 27, 2013. 
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Veterinary Examination, Hematology and Clinical Chemistry 
Following the winter sampling period, field staff and a licensed veterinarian visited each 
dog kennel to conduct a standard physical examination and collect three blood samples 
from all study animals. Serum samples, collected in serum separator tubes, were used 
for comprehensive clinical chemistry panels to analyze general health markers.  Whole 
blood samples were collected for hematocrit and complete blood counts.  Whole blood 
and serum samples were processed and analyzed at the UAF Animal Resource Center 
clinical laboratory and the Wildlife Toxicology Laboratory (WTL). Blood samples for DNA 
analysis were collected in a PreAnalytix DNeasy blood tube (Qiagen, Germantown, MD) 
and shipped to the University of Montana for processing. 
 
Global Methylation Analysis 
DNA was extracted using a PreAnalytix DNeasy Kit (Qiagen, Germantown, MD).  
Concentration of DNA was assessed using a Nanodrop spectrophotometer (Thermo 
Scientific, Wilmington, DE). 
   
LUminometric Methylation Assay (LUMA) 
Global methylation was determined using LUMA (Karimi et al. 2006). The assay was run 
in duplicate using 500ng of total DNA with samples analyzed in a randomized order to 
reduce the effect of inter-plate variation.  Each plate included 21 DNA samples, as well 
as positive, negative, and water controls.  The assay was visualized using a Pyromark 
Q96 MD (Qiagen, Germantown, MD). All samples used in the final analysis had an intra-
assay coefficient of variation of ≤ 5%.  Lambda DNA (NEB, Ipswich, MA) was used as a 
negative control, and was methylated using CpG methyltransferase (NEB, Ipswich, MA) 
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and a New England Biolabs optimized protocol, which was then used as a positive 
control. 
 
5-Methylcytosine (5-mC) Quantification 
Global DNA methylation levels also were evaluated using the ELISA-based 
MethylflashTM Methylated  DNA Quantification Kit (Colorimetric) (Epigentek, NY, USA). 
The Kit measures the 5-mC content as a percentage of the total cytosine in the DNA 
sample. The assay was performed in duplicate according to manufacturer’s instructions 
with 100ng of total DNA. The 5-mC in DNA was detected using capture and detection 
antibodies and then quantified colorimetrically by reading the absorbance in a microplate 
spectrophotometer. Absolute quantification standard curves were obtained by plotting 
the concentration of the positive control (methylated polynucleotide containing 50% of 5-
methylcytosine (5-mC)) supplied with the assay kit against the optical density (OD) at 
450nm. The assay was validated by calibrating the different amounts of 5-mC DNA in a 
commercially available standard (CpGenome™ 5-mC ) (EMD Millipore, Billerica, USA). 
The percentage of 5-mC in genomic DNA was calculated using the following formula: 5-
mC % = !"#$%&  !"!!"#$%&'"  !"#$%"&  !"
!∗  ×  !"#$%  ×  !"#$%  !"#  !"#$%&  
  ×100% 
 * 2 is a factor to normalize 5-mC in the positive control to 100%, as the positive control 
contains only 50% of 5-mC 
 
Statistical Analysis 
Descriptive factors including dog sex, age, and weight were compared between kennels 
using analysis of variance or chi-square tests. Clinical chemistry and hematology 
variables were evaluated as pairwise comparisons relative to the lowest exposure group, 
Kennel C. Ambient PM2.5 concentrations at each kennel site were summarized for the 
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total monitoring periods and by the two-week period prior to the day of data collection for 
dogs at the kennels. Differences in mean ambient PM2.5 concentrations and mean global 
methylation percentage between kennel sites were evaluated by analysis of variance, 
followed by post-hoc t-tests when appropriate. Pearson correlations were used to 
compare global methylation percentage and the 35 clinical chemistry variables across 
and within kennels. 
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RESULTS 
In total, 87 sled dogs participated in this study, including 29 from Kennel A, 30 from 
Kennel B, and 28 from Kennel C.  Two UAF veterinarians, who were blinded to the 
kennel designation, evaluated the clinical chemistry data in an effort to identify if animals 
should be removed based on health characteristics.  Following this evaluation, the 
veterinarians advised that four animals should be excluded.  An additional four animals 
were excluded because they had more than five clinical chemistry values that were 
greater than two standard deviations away from the mean. Therefore a population of 75 
sled dogs was used in the following analysis. The weight and sex of the excluded 
animals were not significantly different from the included population of sled dogs (p = 
0.94 and 0.38 respectively), however, the dogs that were removed from the study were 
more likely to be older compared to those included in the study (p= 0.07). With respect 
to kennel designation there was a significant difference in age and weight.   Dogs in 
Kennel C were significantly younger than dog in the other kennels (p= 0.01), and dogs in 
kennel A weighed significantly less than dogs in the other kennels (p= 0.01; table 4.1.).  
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Characteristics a 
 
Kennel A 
(n=27) 
Kennel B 
(n=25) 
Kennel C 
(n=23) 
Age, years 6.1  (3.2) 6.0  (3.3) 3.6 ( 2.8) 
Weight  (lbs) 49.6  (6.3) 55.5  (7.4) 52.6  (6.6) 
Sex    
  Female 17  (63) 13  (52) 10  (43) 
  Male 10  (37) 12  (48) 13  (57) 
Pregnant b 2  (12) 1  (8) 0 
a mean (sd) or n (%) 
b n (% female) 
Table 4.1. Population characteristics. 
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Ambient PM2.5  Concentrations at the Kennels 
PM2.5 data were collected at each kennel from November 21, 2012 through February 27, 
2013.  Although samples were collected at each site the majority of the time, due to 
logistic issues including weather and power outages, each kennel was sampled for a 
subset of the total study period (see table 4.2.).  The average PM2.5 concentration (sd) 
measured during the study period for each site was, 90 (15) µg/m3 for Kennel A, 48 (22) 
µg/m3 for Kennel B, and 16 (8) µg/m3 for Kennel C (p< 0.0001).  For the 2-week period 
prior to the dog sampling and examination at each kennel, the measured average PM2.5 
concentration (sd) was 46 (32) µg/m3 for Kennel A, 42 (32) µg/m3 for Kennel B, and 9 (4) 
µg/m3 for Kennel C (p< 0.001). 
 
The average daily temperature for the winter period was -20°C (max 0°C, min -37°C) 
and the relative humidity was 79% (max 100%, min 60%) (Fairbanks North Star Borough 
; Western Regional Climate Center).  From January 27, 2013 to February 27, 2013, the 
average daily temperature was -18°C (max -12°C, min -37°C) and the relative humidity 
was 81% (max 93%, min 62%), (Fairbanks North Star Borough ; Western Regional 
Climate Center). 
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  Kennel A Kennel B Kennel C  p value 
Sample Days 78 59 46  
Percentage of Day Above 35µg/m3 69 49 4  
Percentage of Day Above 100µg/m3 35 12 0  
Average PM2.5 (µg/m3)      
  Nov 21 - Feb 27 mean (sd) 90 (15) 48 (22) 16 (8) < 0.0001 
  2 weeks prior to exam mean (sd) 46 (32) 42 (32) 9 (4) < 0.001 
 
Table 4.2. Ambient PM2.5 Collection Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   145	  
Global Methylation 
DNA was extracted and analyzed for 83 dogs out of the original population of 87.  Figure 
4.1. shows the percent global methylation (%gMe) for the dogs included in this study 
(n=75).  The average %gMe (SD) was 76.22 (1.85) for Kennel A, 76.52 (1.82) for Kennel 
B, and 76.72 (2.26) for Kennel C (p= 0.66). While the PM2.5 exposure of Kennels A and 
B were different over the course of the study, there was no difference in exposure in the 
two-week period prior to blood draw. If Kennels A and B are combined, there is no 
difference between the average %gMe of Kennel A+B  relative to Kennel C measured by 
LUMA or 5-mC (data not shown). Global methylation was not associated with age, 
weight, or sex. The average (standard deviation) global methylation percentage for each 
kennel measured by 5-mC was 0.16 (0.04) for Kennel A, 0.15 (0.04) for Kennel B, and 
0.15 (0.05) for Kennel C (p= 0.24). The methylation percentages from the LUMA and 5-
mC assay were not significantly correlated.  The above findings were not influenced by 
the exclusion criteria based on aberrant veterinary examinations and outlying clinical 
chemistry values. Global methylation values among the excluded dogs (n=8) were 
similar to the other dogs. Inclusion of all dogs in the analyses did not result in any 
statistical differences in mean global methylation by kennel or other descriptive 
characteristics (data not shown). 
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Figure	  4.1.	  	  Global	  DNA	  methylation	  in	  sled	  dogs.	  
Box	  plots	  showing	  the	  %	  global	  methylation	  for	  the	  three	  kennels	  quantified	  by	  
LUMA	  (p=	  0.66)	  and	  5mC	  (p=	  0.24)	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Standard Hematology and Clinical Chemistry 
A total of 35 parameters were evaluated (see table 4.3. and 4.4).  Sodium (Na) (p= 
0.01), glucose (GLU) (p= 0.05), and granulocytes (GRAN) (p= 0.05), were significantly 
correlated and monocyte percentage (MPR) (p= 0.06) and white blood cell count (WBC)  
(p= 0.07) were marginally correlated with global methylation values analyzed by LUMA.   
White blood cell counts (WBC) (p= 0.004) and mid-sized cells (MID) (p= 0.01) were 
significantly correlated with global methylation values analyzed by 5-mC. 
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Variable	  a 
	   
Kennel	  A 
(n=27) 
Kennel	  B 
(n=25) 
Kennel	  C 
(n=23) 
	  	  Na 146.14	  	  (1.23)b 146.48	  	  (1.66) 147.13	  	  (1.82) 
	  	  K 4.47	  	  (0.34) 4.31	  	  (0.22) 4.41	  	  (0.32) 
	  	  Cl 110.00	  	  (2.76) 104.88	  	  (3.66)b 109.22	  	  (3.19)	  	   
	  	  ALP 44.58	  	  (17.57)b 44.60	  	  (41.41) 29.93	  	  (11.98) 
	  	  ALT 63.62	  	  (46.50) 49.36	  	  (29.23) 47.73	  	  (21.24) 
	  	  BUN 17.19	  	  (4.14) 21.48	  	  (4.32) 25.08	  	  (19.66) 
	  	  Ca 9.15	  	  (0.44) 9.52	  	  (0.45) 9.89	  	  (4.56) 
	  	  CRE 0.44	  	  (0.09) 0.50	  	  (0.09) 2.00	  	  (4.71) 
	  	  GGT 14.88	  	  (2.47) 15.28	  	  (3.80) 19.09	  	  (17.81) 
	  	  GLU 97.54	  	  (6.51) 110.52	  	  (11.15)b 94.12	  	  (25.69)	   
	  	  TP 5.87	  	  (0.39) 6.04	  	  (0.37) 5.63	  	  (1.16) 
	  	  TBIL 0.22	  	  (0.15) 0.22	  	  (0.17) 1.60	  	  (6.85) 
	  	  ALB 3.62	  	  (0.23)b 3.87	  	  (0.26) 3.91	  	  (0.30) 
	  	  TCHO 246.92	  	  (74.13) 225.48	  	  (74.92) 219.13	  	  (58.07) 
	  	  IP 4.05	  	  (0.56) 3.84	  	  (0.59) 15.94	  	  (59.09) 
	  	  GLOB 2.25	  	  (0.34)b 2.17	  	  (0.32)b 1.96	  	  (0.30) 
	  	  NaKRatio 32.89	  	  (2.33) 34.08	  	  (1.87) 33.57	  	  (2.50) 
a	  mean	  (sd)	  
b	  p	  <	  0.05	  compared	  to	  Kennel	  C	  
Abbreviations:	  	  Na:	  Sodium,	  K:	  Potassium,	  CL:	  Chloride,	  ALP:	  Alkaline	  Phosphatase,	  ALT:	  Alanine	  
Transferase,	  BUN:	  Blood	  Urea	  Nitrogen,	  Ca:	  Calcium,	  CRE:	  Creatinine,	  GGT:	  Gamma-­‐Glutamyl	  
Transpeptidase,	  GLU:	  Glucose,	  TP:	  Total	  Protein,	  TBIL:	  Total	  Bilirubin,	  ALB:	  Albumin,	  TCHO:	  Total	  
Cholesterol,	  IP:	  Phosphorus,	  GLOB:	  Globulins,	  NaKRatio:	  Sodium	  Potassium	  Ratio	  
 
Table	  4.3.	  	  Clinical	  chemistry	  values.	  
Selected	  clinical	  chemistry	  mean	  (sd)	  values	  for	  subjects	  at	  the	  time	  of	  sample	  collection.	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Variable	  a Kennel	  A Kennel	  B Kennel	  C 
	   (n=27) (n=25) (n=23) 
	  	  WBC 7.52	  	  (1.96) 8.98	  	  (2.59) 7.79	  	  (1.97) 
	  	  LYMF 1.20	  	  (0.61)	  b 1.62	  	  (0.62) 1.56	  	  (0.54)	   
	  	  MID 0.76	  	  (0.22)	  b 0.77	  	  (0.25)	  b 0.60	  	  (0.12) 
	  	  GRAN 5.56	  	  (1.62) 6.58	  	  (2.39) 5.63	  	  (1.75) 
	  	  LPR 16.55	  	  (7.44)	  b 19.29	  	  (6.56) 20.90	  (6.56) 
	  	  MPR 9.36	  	  (1.45)	  b 7.99	  	  (1.93) 7.54	  	  (1.83)	  	   
	  	  GPR 74.09	  	  (7.82) 72.72	  	  (6.95) 71.56	  	  (6.99) 
	  	  HCT 44.26	  	  (5.02)	  b 46.04	  	  (4.74) 47.98	  	  (4.18)	  	   
	  	  MCV 64.48	  	  (1.84) 61.31	  	  (2.99)	  b 63.31	  	  (2.31)	  	   
	  	  RDWR 22.97	  	  (1.08)	  b 23.69	  	  (1.25)	  b 24.63	  	  (1.80)	  	   
	  	  RBC 6.86	  	  (0.75)	  b 7.51	  	  (0.70) 7.60	  	  (0.84)	   
	  	  HGB 16.02	  	  (1.70)	  b 16.68	  	  (1.69) 17.54	  	  (1.46)	  	   
	  	  MCHC 36.23	  	  (0.55)	  b 36.25	  	  (0.51) 36.57	  	  (0.64) 
	  	  MCH 23.37	  	  (0.67) 22.22	  	  (1.14)	  b 23.14	  	  (0.93)	  	   
	  	  PLT 343.48	  	  (92.54)	  b 364.28	  	  (107.51)	  b 279.13	  	  (62.89)	   
	  	  MPV 8.75	  	  (0.76) 8.68	  	  	  (0.69) 9.14	  	  (0.98) 
	  	  TRBC 12.69	  	  (0.06)	  b 12.68	  	  (0.05)	  b 12.53	  	  (0.05)	  	   
	  	  TWBC 12.88	  	  (0.04)	  b 12.82	  	  (0.04)	  b 12.66	  	  (0.05)	   
a	  mean	  (sd)	  	  
b	  p	  <	  0.05	  compared	  to	  Kennel	  C	  
	  
Abbreviations	  (units):	  WBC:	  White	  Blood	  Cells	  (103/µl),	  LYMF:	  Lymphocytes	  (103/µl),	  MID:	  Mid-­‐
sized	  Cells	  (103/µl),	  GRAN:	  Granulocytes	  (103/µl),	  LPR:	  Lymphocyte	  Percentage	  (%),	  MPR:	  Monocyte	  
Percentage	  (%),	  GPR:	  Granulocyte	  Percentage	  (%),	  HCT:	  Hematocrit	  (%),	  MCV:	  Red	  Blood	  Cell	  Count	  
Derivative	  (fl),	  RDWR:	  Red	  Blood	  Cell	  Count	  Derivative	  (%),	  MCHC:	  Red	  Blood	  Cell	  Count	  Derivative	  
(g/dl),	  MCH:	  Red	  Blood	  Cell	  Count	  Derivatives	  (pg),	  RBC:	  Red	  Blood	  Cells	  (106/µl),	  HGB:	  Hemoglobin	  
(g/dl),	  PLT:	  Platelets	  (103/µl),	  MPV:	  Platelet	  Count	  Derivative	  (fl),	  TRBC:	  Red	  Blood	  Cell	  Count	  Time	  
(sec),	  TWBC:	  White	  Blood	  Cell	  Count	  Time	  (sec)	  
	  
Table	  4.4.	  Hematology	  values.	  
	  Selected	  hematology	  mean	  (sd)	  values	  for	  subjects	  at	  the	  time	  of	  sample	  collection.	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DISCUSSION 
In this study, two approaches were used to summarize genome-wide DNA methylation. 
Our results suggest that global methylation is not associated with elevated levels of 
ambient PM2.5 compared to relatively low levels when using sled dogs as sentinels. It is 
suggested that hypomethylation of the genome does occur with age in animals (Dolinoy 
and Faulk 2012).  However, age was not associated with global methylation in this study. 
We had no a priori hypotheses with respect to clinical chemistries and global 
methylation.  Thus, these finding should be interpreted with caution and perhaps warrant 
further investigation. 
 
Global methylation quantified by LUMA for dogs appears to be consistent with recent 
work published by Head et al., which suggests that mammals have intermediate global 
methylation (Head et al. 2014).  This publication found that fish had higher global 
methylation relative to mammals, while birds had lower. 
 
There have been recent publications that suggest some genes may be up regulated in 
response to hypomethylation (Spruijt and Vermeulen 2014), but it is generally accepted 
that promoter region hypermethylation of a gene suppresses protein production and 
global hypomethylation causes genome instability.  Several genes in the T-helper 2 
(Th2) pathway have been found to be susceptible to methylation (Lovinsky-Desir and 
Miller 2012).  It is hypothesized that there is interplay between environmental factors 
such as PM2.5 and respiratory phenotypes, which may be mediated by epigenetic factors 
such as DNA methylation (Zhang et al. 2014).  A recent genome wide study investigated 
19,000 genes in 141 subjects for the Normative Aging Study and concluded that 
airborne particulate matter was associated with the methylation pattern of genes 
involved in the asthma pathway (Sofer et al. 2013).  The literature regarding the 
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temporal nature and sustainability of these epigenetic changes in vivo is sparse 
(Lovinsky-Desir and Miller 2012).  It is possible that the time course from exposure to the 
resulting epigenetic change ranges from minutes to months and is gene specific. 
 
Two exposure sampling time frames are described in Figure 4.2, which shows the total 
study period and the two-week period leading up to the physical exam and blood 
collection.  Two weeks is an arbitrary cut-point, but it does draw attention to the idea that 
proximity of the clinical examination to an air pollution event should be considered.  For 
example, differential methylation patterns of the iNOS gene, which is involved in asthma 
and other obstructive pulmonary conditions, have been found in welders after an 8-hour 
shift (Kile et al. 2013). The authors used Line-1 and Alu as proxies for global methylation 
but did not find differences relative to exposure. However, short-term exposure was 
associated with epigenetic changes to the iNOS gene promoter region.   
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Figure	  4.2.	  	  	  Acute	  PM2.5	  exposure	  prior	  to	  examination.	  
PM2.5	  was	  measured	  at	  three	  sled	  dog	  kennels	  over	  the	  2012/13	  winter.	  Kennel	  A,	  
Kennel	  B,	  and	  Kennel	  C	  were	  sampled	  for	  78,	  59,	  and	  46	  days	  respectively.	  This	  
figure	  shows	  a	  subset	  of	  these	  days	  representing	  the	  acute	  exposure	  levels	  that	  were	  
measured	  leading	  up	  to	  the	  sample	  collections.	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In this study LUMA and 5mC were used to detect differential global methylation profiles 
between three kennels using samples collected at a single visit. Future studies could 
consider broadening the focus to include gene-specific methylation profiles and conduct 
more frequent blood collections, including a pre-winter blood collection, to increase the 
likelihood of capturing PM2.5 event-related changes in global and or gene-specific 
methylation.  As more epigenetic information becomes available for the canine genome, 
genes responsible for the production of immuno-regulatory cytokines and methylation-
related enzymes should be evaluated.  
 
Human cell lineages by nature are epigenetically distinct and therefore data from studies 
that utilize whole blood samples should be evaluated with caution (Reinius et al. 2012). 
As strategies for partitioning cell populations are developed, the domestic dog model 
could be used to inform and validate these new methods.   
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CONCLUSION 
In this study we identified PM2.5 micro climates in and around the Fairbanks non-
attainment area for PM2.5.  However, when global methylation was evaluated using 
LUMA and 5-mC, we found no differences between kennels.  Several hematology and 
clinical chemistry variables were correlated with both LUMA and 5-mC, but these results 
are difficult to interpret and warrant further investigation.   
 
The number of funded epigenetic studies has increased exponentially over the last 
twenty years.  However, only a small percentage of those studies focused on 
environmental exposures (Burris and Baccarelli 2014). There is increasing interest in 
animal models for human diseases with environmental exposure and epigenetic 
components. With improvements in gene and whole-genome techniques, these sentinels 
can be valuable tools for approaches that are not feasible in humans (Dolinoy and Faulk 
2012). Additional research to identify and characterize canine repetitive elements and 
specific genes that have human homologues will increase the utility of the domestic dog 
as a surrogate for environmental exposures and impacts on human health.   
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Conclusion 
 
In a cohort of asthmatic children living in homes that heat with wood stoves in western 
Montana, we found that respiratory health was associated with several diet variables.  
Most of the diet variables that were positively associated with good respiratory health 
would be considered part of a prudent diet.  This suggests that for asthmatics, eating a 
non-Western diet (i.e. one with less sugar and fat and more fruits, vegetables, and 
omega 3s) may help with controlling asthma symptoms and exacerbations.  This is a 
positive finding that adds to the overall goal of the ARTIS study.  As observed in the 
larger ARTIS study, the households investigated in this sub-study supported the filter 
intervention was effective in reducing indoor air pollution and improving respiratory 
health.   
 
The novelty of this project was the addition of global and gene specific DNA methylation 
as a target for potential biomarkers.  We hypothesized that environmental exposures 
(i.e. indoor PM and dietary nutrients) may be influencing respiratory health through an 
epigenetic mechanism.  In our evaluation of this hypothesis, we did not find data to 
suggest this to be correct in the case of LINE-1, IFNγ CpG -54, or -186 methylation.  
Interestingly we did find that both indoor PM and some dietary factors were associated 
with methylation patterns.  Despite the overall repeated measures association between 
indoor PM2.5 concentrations and lower methylation at the two IFNγ CpG sites, we were 
unable to demonstrate a change in DNA methylation with respect to filter intervention 
despite the strong exposure reduction efficacy. Further, from winter one to winter two, 
there was a reduction in methylation at both IFNγ CpG sites, but not LINE-1, regardless 
of whether the child lived in a filter intervention or placebo home.  At this point, we have 
not identified the cause of this reduction, but it does not appear to be directly related to 
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the reductions in indoor PM because there were not significant reductions of indoor PM 
in the placebo group.   
 
The secular trend in lower average percent DNA methylation across winters also does 
not appear to be associated with dietary changes despite an overall relationship 
between some dietary factors and DNA methylation. In our initial evaluation of FFQ 
results regarding consistency between winter one and winter two for this cohort the 
results suggest that intake of selected nutrients was similar year to year, though this 
question may warrant further investigation.  Thus, the year-to-year changes in DNA 
methylation markers are unlikely to be due to corresponding year-to-year changes in 
indoor PM or diet. Our findings in the sled dog study also fail to support a direct 
relationship between PM exposure and DNA methylation, although this study is not 
directly parallel to the child asthma study and did not include gene specific CpG 
markers. 
 
The change in DNA methylation markers could be associated with year-to-year changes 
in an unmeasured factor that was not captured by the study design.  For example, it is 
conceivable that all the children in our study were exposed to ambient PM from wildfires 
between winter assessments and this exposure could have influenced the IFNγ CpG 
methylation profile.  The overall ARTIS study was less susceptible to this type of secular 
effect because the study populations were widely distributed geographically, whereas 
the sub-study was limited to the western Montana study households. 
 
One other possibility could be an effect of a laboratory process.  For example, there was 
a year between the collection of these samples and the samples from both winter one 
and winter two were not processed until the study’s end.  This is also unlikely because 
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Qiagen has validated the protocol and the reagents for use up to 24 months from 
collection to processing.  Further, DNA degradation is not likely to lead to demethylation, 
rather it would lead to fragmentation.  Within the pyrosequencing protocol, there are 
QA/QC measures that ensure data collected from fragmented DNA is not used and 
requires the sample to be repeated.  In this situation, our protocol would be to extract 
DNA from a sample stored in RNAlater, which was stored at -80°C. 
 
Global methylation was affected by diet but not by indoor PM in aims 1 and 2, 
respectively.  In the cases where LINE-1 methylation was significantly different when 
comparing tertiles of nutrients, the actual difference in LINE-1 methylation were relatively 
small.  However, it is difficult to translate percentage point difference in LINE-1 
methylation to clinical significance.  It is interesting to note the difference in the range of 
global methylation between asthmatic children and sled dogs.  For LINE-1 methylation 
measurements in asthmatic children there was a range of approximately 20 percentage 
points and for LUMA in sled dogs there was a range of approximately 10 percentage 
points.  These two assays are only proxies for global methylation and they interrogate 
the epigenome in two very different ways.  That being the case, if we consider the two 
assays to be comparable for the sake of this argument, why should the data from the 
human cohort be so much more variable than the canine cohort?  As it was noted in the 
introduction, regarding sled dogs, there is much less variability in diet, exercise, age, 
breeding (in some cases), and exposure.  The sled dogs included in the final analysis 
were also all considered healthy after a veterinary examination and this is in contrast to 
a cohort of children who have a disease characterized by chronic inflammation. 
 
In the rapidly evolving field of epigenetics, the use and understanding of global 
methylation analysis has changed in the short period of time from our design of the 
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ARTIS epigenetics sub-study to the present.  After a thorough literature review and 
consulting leaders in the field of epigenetics in the context of childhood asthma, LINE-1 
was the proxy measurement of choice for global methylation in humans.  Global 
hypomethyation in the context of cancer epigenetics is indicative of genome instability 
and a hallmark of the disease.  The epigenetic field has been molded by the findings 
from the cancer field and this likely was a driver for the fact that global methylation was 
part of nearly every epigenetic study that was published in the early 2000’s. Presently, 
this measurement has gone out of favor in most published papers because the field is 
moving from descriptive to mechanistic studies.  Global methylation is difficult to interpret 
because it represents changes that occur throughout the entire epigenome, which 
encompasses gene regions that may become hypomethylated in response to a given 
exposure and others that become hypermethylated.  There could be substantial 
epigenetic changes at specific loci that occur in response to an exposure, but if overall 
hypo/hyper methylation changes are averaged across the genome as with global 
methylation markers, the result of such analysis may fail to elucidate epigenetic 
associations with exposure factors of interest.  This could explain why LUMA 
measurements were similar for three groups of dogs that were exposed to variable 
levels of PM2.5.  
 
In addition to the ideals regarding the usefulness of global methylation analysis, there 
were also recent findings in the epigenetic research community that required us to 
abandon our initial intention to include the IL-4 promoter CpG markers in our Aim 1 and 
Aim 2 studies.  Several groups had published data in the murine model that suggested 
there were functionally relevant CpGs or CpG islands in the promoter region of IL-4 that 
were important for respiratory health.  Rachel Miller and others investigated several of 
these IL-4 CpGs in humans, and they were not found to be associated with urban PM 
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and PAH exposure and respiratory health.  Recent studies have further suggested that 
IL-4 may be controlled by micro-RNAs and not by DNA methylation.  These findings 
suggest that with regard to IL-4 promoter methylation analysis, our resources would be 
better used on a different strategy.   
 
The original purpose of including IL-4 CpG sites in the methylation analysis was to 
investigate the Th1/Th2 balance concept.  At this point, we have IFNγ data, which is only 
half of that story.  There are other cytokines that are important in the Th2 pathway such 
as IL-5 and IL-13.  Our lab has taken steps to evaluate the function of several CpGs in 
the promoter region of these additional Th2 cytokines.  In the future, archived samples 
could be used to evaluate how methylation as promoter sites for Th2 cytokines such as 
IL-5 and IL-13 are affected by dietary and particulate exposures in our asthmatic child 
cohort. 
 
This dissertation has focused mostly on epigenetic responses to environmental 
exposures, which were measured in adolescence (humans and dogs) and adulthood 
(dogs).  We have also conducted preliminary studies focused on perinatal exposure 
windows and these results will hopefully be used to inform study design for future work 
focused on Developmental Origins of Health and Disease (DOHaD).  This specialized 
field is interested in elucidating the early causes of diseases that occur later in life, for 
example cancer or obesity. The results from Aim 1 regarding the ability of diet to 
influence the epigenome are very intriguing.  While these effects are possibly important 
in the ability of the asthmatic child to control their asthma in this stage of life, it is 
conceivable that asthma status and nutritional status may have an affect on their 
progeny.  This has grand implications for the future of our species.  We are exposed to 
more chemicals now than any other time in history.  The airshed in some countries has 
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reached toxic levels for pollutants known to be harmful for health.  Humans are 
ubiquitously exposed to foodstuffs. Through these and other exposures, we may be 
changing the trajectory for our species’ health into the future.  Decisions that we make 
as individuals and as a community that affect the environment including the food we 
consume and the air we breathe are possibly impacting our grandchildren.  Therefore 
findings from epigenetic research that help to inform personal choices as well as public 
policy have the capacity to improve health for people worldwide today and for 
generations to come. 	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Bisulfite Treatment Protocol 
 
Note -First perform nanodrop to determine concentration of DNA 
 
Use Zymo Research EZ DNA Methylation-Direct Kit (D5021) 
When Opening New Box: 
• Prepare CT Conversion Reagent (enough for 9 samples) 
o Add 790 uL Solubilization Buffer 
o Add 300 uL Dilution Buffer 
o Vortex for 10 minutes 
o Add 160 uL Reaction Buffer 
o Vortex additional minute 
• Prepare M-Wash Buffer 
o Add 96-mL of 100% EtOH 
• Will not usually use Proteinase K, if needed, see protocol that came with 
Zymo Kit 
Bisulfite Conversion of DNA 
1) Make a 500 ng DNA/20 uL dilution (w/ autoclaved ddH2O) in 0.2 uL PCR tubes 
• See Excel Spreadsheet for conversion 
2) Add 130 uL of CT Conversion Reagent to each  
3) Place tubes directly in Thermocycler 
4) Run Program “bisulfite” – takes ~3.5 hours 
5) In an IC-column (looks like Eppie w/ filter) that is placed in a collection tube add: 
• 600 uL M-binding buffer 
• 150 uL Sample + CT Conversion Reagent 
• Close cap, invert gently several times being careful to hold on to both the IC-
column and collection tube 
Centrifuge in 5430R at 11,000 rcf for 30 seconds, discard flow-through 
6) Add 100 uL M-Wash Buffer 
Centrifuge in 5430R at 11,000 rcf for 30 seconds, discard flow-through 
7) Add 200 uL M-Desulphonation Buffer 
Let stand at room temp for 15 minutes 
Centrifuge in 5430R at 11,000 rcf for 30 seconds, discard flow-through 
8) Add 200 uL M-Wash Buffer 
Centrifuge in 5430R at 11,000 rcf for 30 seconds, discard flow-through 
Repeat Step 8 
9) Place IC column into 1.5 mL Eppendorf tube (label lid) 
10) Add 10 uL M-Elution Buffer **Get pipette tip as close to filter as possible before 
dispensing elution buffer** 
Centrifuge in 5430R at 11,000 rcf for 30 seconds **Do NOT discard flow-through** 
Repeat Step 10 
11) Final Centrifuge in 5430R at 11,000 rcf for 30 seconds 
12) Sample is contained in 1.5 mL Eppendorf and is ready for PCR, or can be stored at 
4° C 
 
****All reagents can be stored at room temperature with exception of: 
• CT Conversion Reagent – Store at -20° C 
• Final Product – Store at 4° C 
• Proteinase K prepared solution – Store at -20° C 
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PCR Protocol 
 
Use PyroMark PCR Kit (in -20° C Freezer) 
* Notes Before Starting: 
• One primer must be biotinylated (biotin label) at the 5’ end for sequencing 
• Do not use Q-solution or additional MgCl2 
• Perform calculations for primer to have a final concentration of 0.2 uM 
o Example: LINE-1: 40.2nmoles/40.2 uL H2O = 1 nm/uL= 1mM 
o Stock: 1 mM 
o Working: (1000 uM)*(x uL) = (0.2 uM)*(25 uL) 
o                x=.005 uL which is an unrealistic amount of primer to add,  
 make a 1/100 dilution 
1 uL stock/99 uL ddH2O for a 10 uM Working solution 
 Add 0.5 uL primer to 25 uL for 0.2 uM final concentration 
 
1) Remove box from freezer and allow reagents to thaw 
2) Vortex each component briefly to ensure they are mixed 
3) Create a Reaction Mix Stock for X+2* Samples as follows: 
Component Volume per Reaction 
(uL) 
Volume * (X+2) 
(uL) 
Final Concentration 
PCR Master Mix 12.5  12.5*_____ 1X 
CoralLoad Conc, 10X 2.5  2.5*_____ 1X 
Forward Primer 0.5  0.5*_____ 0.2 uM 
Reverse Primer 0.5 0.5*_____ 0.2 uM 
RNase-free H2O 8.0 8.0*_____  
Total: 24 24* (X+2)  
*Make enough for 2 extra samples to ensure there is enough mix for all the samples 
4) In PCR tubes add: 
• 24 uL of Reaction Mix 
• 1 uL of sample (product from bisulfite reaction) 
5) Place directly in thermocycler (into smaller holes) 
6) Run program LINE-1 (takes ~2.5 hrs) 
7) Remove sample. Ready for pyrosequencing, gel electrophoresis, or store at -20° C 
 
Gel Electrophoresis – To test amplification 
 
5X TBE Buffer Stock Recipe 
• 27 g Tris-Base 
• 13.75 g Boric Acid 
• 10 mL 0.5 M EDTA, pH 8.0 
• Mix in 500 mL graduated cylinder with stir bar, bring to ~450 mL with ddH2O 
• Once dissolved bring to 500 mL with ddH2O, add to glass container, label.  
0.5X TBE Buffer Recipe 
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• 100 mL 5X TBE Buffer Stock 
• 900 mL ddH2O 
• Mix in 1000 mL Erlenmeyer Flask 
• Label & cover with parafilm 
 
1) Make a 3% gel by adding 1.5 g of SeaKem Agarose to 50 mL of 0.5X TBE buffer in 
100 mL Erlenmeyer flask 
• Microwave @ 40% for ~1:15 minutes, with a paper towel in the top of the 
flask 
• Stir gently, careful to not create bubbles 
2) Once cool (can touch flask to skin), add 1.5 uL EtBr (10mg/ml) 
Stir gently. 
• ***EtBr is a carcinogen. Use caution and ALWAYS wear gloves*** 
3) While cooling, set up gel rig, make sure gel plate is tight in holder 
4) Slowly poor agarose solution into gel plate, add comb 
• Can use pipette tip to move bubbles to bottom of gel 
• Wash 100 mL Erlenmeyer flask immediately 
5) Allow to solidify, ~ 10 minutes 
6) While gel is setting up, prepare well solutions as follows: 
Component Volume 
Sample or Ladder 5 uL 
ddH2O 5 uL 
6X Loading Dye 2 uL 
Total: 12 uL 
* Prepared volumes by tightly applying parafilm to eppy-tube holder to make shallow 
wells 
7) Once gel is solid, turn so that the well are near the black (Run to Red) 
8) Add 0.5X TBE buffer to fill line 
9) Load wells, from right to left, starting with the ladder 
10) Run at 100 V for ~20 minutes or until bands have migrated about 1 inch. 
• Start at 75 V for 1 min, then 85 V for 1 min, then 100V for 20 min. 
11) Place gel on clear tray, with wells towards the back. 
12) Take picture with imager, make sure setting is set to “Ethidium Bromide” 
13) Copy to flash drive, open on desktop with Windows Image and Fax Viewer & Save 
as a JPEG with format: DD.MM.YYYYSample NameInitials 
Email to yourself and to PI if necessary. 
14) Dispose of gel in BioHazard bin.  
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Pyrosequencing Protocol 
 
To Do Before Starting: 
• Make sure all reagents are to room temperature before beginning. 
o Binding Buffer, Annealing Buffer, Sepharose Beads, etc. 
o Remove PCR product from -20 Freezer 
• Turn on Hot Plate to 80° C 
• Turn on PyroMark Q96 MD, and start-up computer 
 
1) Perform calculations for sequencing primer. 
• Example: LINE-1 Sequencing primer, 39.2 nmoles/39.2 uL = 1 nm/uL = 1 mM 
= 1000 uM 
• Working: Want 10 uM  1/100 dilution 
o Add 5 uL of stock to 495 uL autoclaved ddH2O  
• Annealing: Want 0.3 uM in 12 uL/sample Annealing buffer 
o Make up in 1.5 mL eppie 
o 12 uL/sample * (4+2) samples = 72 uL 
o (0.3 uM)*(72 uL) = (10 uM)(x uL) 
o x= 2.16 uL of 10 uM Working + 69.84 uL of Qiagen Annealing Buffer 
2) Prepare plate set up with template below 
ASSAY___________________________________DATE______________ 
ú  ú 1 ú 2 ú 3 ú 4 ú 5 ú 6 ú 7 ú 8 ú 9 
ú 1
0 
ú 1
1 
ú 1
2 
ú A ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú B ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú C ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú D ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú E ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú F ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú G ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
ú H ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  ú  
 
3) Turn on PyroMark, Heat plate (80° C), and PC (no password, just hit enter) 
Setting up Run on Computer 
1) Double Click on PyroMark CpG software 
2) If assay is not already set up: 
File à New assay, or click on the Double Helix icon 
3) Enter your sequence to analyze 
• All methylation sites should be represented by a Y 
• Click on “Generate Dispensation Order” or type in your own 
4) Save the Entry under “Examples” on harddrive 
• C:  
o Program Files à Qiagen à PyroMark CpG à “Ex 
5) File à New Run, or click on the Play button 
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6) Select Instrument parameters (MD or HS(A)Code0005CDT) 
7) Select a set of wells, from plate set up above), and drag assay into the group to 
populate the entire group 
8) Enter Sample ID into each well (either manually or by importing from an excel 
spreadsheet saved as .txt or .csv, right click, plate setup, and insert sample layout file) 
9) Tools à Volume information, print or record 
10) Save the run to hard drive in Example Files folder 
11) Computer is ready for the sample. Go to Preparing Plate for Pyrosequencing. 
 
Preparing Plate for Pyrosequencing 
1) Prepare the Vacuum Work Station 
1 EtOH (70%) 110 mL 
2 Denaturation 
Solution(NaOH) 
90 mL 
3 Wash Buffer, 1x 110 mL 
4 MilliQ Water 110 mL 
Park MilliQ Water 180 mL 
2) Prepare the PyroMaster Mix in 1.5 mL eppy, vortex 
 
Component Volume Volume X+2 
Sepharose Beads 2 uL  2* (X+2) uL 
Binding Buffer 40 uL 40* (X+2) uL 
RNase-Free H2O 28 uL 28* (X+2) uL 
*Note: Gently shake sepharose beads until completely dissolved 
3) Vortex Mix right before use. In a 96 well shallow plate add 70 uL of Master mix & 10 
uL of PCR product for a total of 80 uL/well 
4)Place on shaker (secure to plate with adhesive plate cover) for 10 minutes @ 1400 
RPM at room temperature 
5) Meanwhile, on PyroMark Plate (opaque, white plate), add 12 uL of 0.3 uM Annealing 
Sequencing Primer to each well. 
6) Placed PyroMark Plate on worktable (bottom right) – slide in 
7) Remove PCR tubes from shaker, place on a plate on worktable (bottom left) 
*Note: Beads will settle at the bottom so do not let sit for more than 1 minute before 
starting the vacuum. If it has been more than 1 minute, place back on shaker 
8) Turn vacuum on, turn on vacuum switch, rinse filter probes in the Park position by 
“sucking” up the milliQ water. 
9) Carefully lowered filter probes into PCR tubes, held for 15 seconds 
• Made sure to get to VERY bottom of the tubes, and rotate right, left, back, 
forward in order to get all of the beads 
• Take care to keep filter probes in same orientation throughout!! 
10) Placed probes into EtOH for 5 seconds 
11) Placed probes into Denaturation Solution for 5 seconds 
12) Placed probes into 1X Wash Buffer for 10 seconds 
13) Raise the tool beyond 90° vertical for 5 seconds to drain liquid from the filter 
14) Hold filter over (NOT IN) PyroMark Plate, turn off vacuum switch, lower probes into 
plate in SAME orientation as PCR plate. Shake filter tips gently to release beads into the 
wells of PyroMark Plate. 
15) Place filter probes in MilliQ H2O, turn vacuum on and wash. Wash again in the MilliQ 
water in the Park position.  Turn vacuum off.  
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15) Place PyroMark plate on heating block (80°C), cover with Qiagen block, for 2 
minutes 
16) Let cool at room temperature for at least 5 minutes. Cover with parafilm, so well 
contents don’t evaporate. 
17) Plate ready to read, but first set up tip holder and perform drip test. 
 
Setting Up Tip Holder & Drip Test 
1) Obtain CDT capillary tubes from black box in drawer under PyroMark and Nucleotides 
from CDT Reagent box in 4 degree fridge 
• Remove rubber ends off of tips, save to put back on when finished 
2) Placed capillary tubes in order as shown in image below: 
 
           E           S   
 
 
             A    C     G     T 
 
 
 
3) Added the volumes determined from the software (Tools – Volume Info) 
• Make sure to pipette as close to the bottom corners of the tips as possible.  
4) Place Tip holder inside PyroMark 
• Open the smaller top lid and place holder with orange label facing you. 
5) Performed Drip Test: 
• Open Lid with “open lid” icon on software 
• Place blank plate in holder (PyroMark Plate with tape covering the wells) 
• Close Lid with “close lid” icon on software 
• Click on           icon, wait a few seconds.  
• When complete, Open lid, Remove plate and look for 6 small drops in the 
middle of the plate in this pattern: 
o *     *  
o * * * * 
• Wipe off plate with KimWipe and place back on top of PyroMark 
6) If drip test is not successful, make sure that the capillary tube tips are not clogged.  
 
7) If drip test is successful, you are ready for your run!!  
Open Lid & Place plate in, close lid 
8) Click the large Play icon. 
 
Analyzing the Run: 
1) Pop-up says Run Finished! Click OK 
2) Select all of the wells ran, Click on “Analyze Selected” 
 
Clean-Up 
1) Clean up the vacuum workstation: 
• Empty troughs into sink with copious quantities of water 
• Rinse troughs with DI water 
• Place on workstation upside down to dry 
2) Clean up after run: 
• Remove plate and throw away 
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• “Milk” the capillary tubes, place plastic tip protectors back on tubes 
• Place all reagents back in storage (mostly in the fridge) 
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Luminometric Methylation Assay (LUMA) 
Global DNA methylation was also determined using the LUminometric Methylation 
Assay (LUMA), which is based on the ability of two isoschizomers (MspI and HpaII) to 
digest sequences differentially depending on the methylation status of the CpG site 
contained within the sequence as described in Karimi et al. (2006). In brief, 300 ng of 
genomic DNA were cleaved at 37°C for 4 hours and 80°C for 20 minutes with 
HpaII/EcoRI or MspI/EcoRI in two separate 20µl reactions containing 2 µl of Tango 
buffer (Thermo Scientific, Waltham, MA) and 5 units of each restriction enzyme (NEB, 
Ipswich, MA). 15µl of annealing buffer (20 mM TRIS-acetate, 2 mM Mg-acetate pH 7.6) 
were mixed with the digested samples and placed in a PyroMark Q96 MD system. The 
dispensation order used for sequencing was: GTGTCACATGTGTG. For calculations, 
the peak heights of dispensations 9 and 10 were used. Samples with peaks lower than 
3, the cut-off value for DNA quality, were discarded. Percentage of DNA methylation was 
expressed as [1-(HpaII/EcoRIΣG/ΣT)/ (MspI/ EcoRIΣG/ΣT)]*100. The samples were 
analyzed in technical duplicates and each plate included a positive, negative, and water 
control. Lambda DNA (NEB) was used as a negative control and methylated Lambda 
DNA using M.SssI methyltransferase was then used as a positive control. All samples 
used in the final analysis had an intra-assay coefficient of variation of ≤ 5%. 
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Buccal	  Cell	  Collection	  Protocol	  
	  
Subjects:	  subjects	  will	  include	  the	  consented	  asthmatic	  children	  and	  when	  
applicable	  their	  consented	  non-­‐asthmatic	  sibling	  between	  the	  ages	  of	  7	  and	  17.	  	  	  
Mark	  the	  DNA/RNA	  tube	  with	  the	  appropriate	  “subject	  ID”.	  	  (For	  example:	  	  101-­‐	  
asthmatic	  child	  #1,	  201-­‐asthmatic	  child	  #2,	  801-­‐	  non-­‐asthmatic	  sibling)	  
	  
Supplies	  needed	  for	  each	  subject:	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  	  	  	  	  	  	  	  General	  Supplies:	  
1-­‐	  Blue	  DNA	  Tube	   	   	   	   	   Scissors	  
3-­‐	  Red	  RNA	  Tubes	   	   	   	   	   Alcohol	  wipes	  
4-­‐	  Cytology	  brushes	  	  	  	   	   	   	   Gloves	  
	   	   	   	   	   	   	   Cooler/ice	  pack	  
	   	   	   	   	   	   	   Binder	  with	  labels	  
	  
Explanation:	  Explain	  the	  process	  to	  the	  participant	  as	  follows:	  	  “As	  part	  of	  this	  study,	  
we	  are	  going	  to	  collect	  cheek	  swabs	  from	  you	  today.	  	  I	  will	  need	  you	  to	  rinse	  your	  
mouth	  out	  with	  some	  water	  (tap	  water	  is	  fine).	  The	  collection	  brush	  (figure	  1)	  is	  
very	  soft	  and	  should	  not	  hurt	  your	  cheek	  at	  all,	  but	  if	  it	  does	  we	  can	  stop	  at	  any	  time.	  	  
I	  am	  going	  to	  unwrap	  the	  brush	  and	  place	  it	  inside	  your	  mouth	  (figure	  2),	  spinning	  it	  
and	  moving	  it	  back,	  forth	  for	  15-­‐20	  seconds.	  	  Then,	  I	  will	  remove	  the	  brush	  from	  
your	  mouth	  and	  place	  it	  in	  this	  tube,	  cut	  off	  the	  shaft,	  and	  close	  the	  tube.	  	  We	  will	  do	  
this	  a	  total	  of	  4	  times,	  one	  brush	  per	  gutter	  (figure	  2).	  	  Do	  you	  have	  any	  questions	  
before	  we	  begin?”	  
	  
Labels:	  Label	  the	  3	  RED	  tubes	  with	  “RNA”	  labels	  and	  the	  1	  BLUE	  tubes	  with	  “DNA”	  
labels.	  	  Place	  the	  tubes	  in	  the	  transport	  box	  and	  remember	  to	  keep	  the	  box	  in	  an	  
upright	  position	  so	  the	  buffer	  does	  not	  leak.	  	  Transport	  samples	  in	  a	  cooler	  with	  an	  
ice	  pack.	  	  Place	  “RNA”	  buccal	  samples	  in	  a	  -­‐80	  degree	  freezer	  within	  two	  hours	  of	  
collection.	  	  “DNA”	  samples	  are	  safe	  at	  room	  temperature.	  	  Mark	  the	  storage	  time	  on	  
the	  sample	  collection	  record	  log	  in	  the	  buccal	  cell	  binder.	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Figure	  A.1.	  	  Location	  of	  buccal	  collection	  and	  brush.	  
Buccal	  collection	  was	  conducted	  using	  a	  cytology	  brush	  (pictured	  on	  the	  left).	  	  
Buccal	  cells	  were	  collected	  from	  the	  gutters	  (pictured	  on	  the	  right)	  of	  the	  
participant’s	  mouth.	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
 
	  
